,document_id,paragraph_id,paragraph
3504,270,1,"Price 30-Oct-2020 USD 23.70 Potential UpsideDownside 39.2% COVID-19 mods : A significant portion of prior deferrals expired in 3Q20. As of Oct 21, Tickers BAC BAC had $9.8bn $28.5bn at July 23 of deferred consumer and small business loans"
3505,270,2,"At 3Q20, BAC had 343k 334k at 2Q20 PPP loans totaling $24.7bn $25.1bn at Free Float % 87.96 2Q20. BAC has begun to process applications for forgiveness. Wk Avg Daily Volume mn 66.0 Dividend Yield % 3.04 Asset quality: Commercial reservable criticized utilized exposure was $35.7bn $9.7bn Return on Equity TTM % 7.35 or 37% vs. 2Q20, following 50% increase in each of the prior two quarters, with 84% Current BVPS USD 28.34 secured at 3Q20 vs. 83% at 2Q20."
3506,270,3,Asset sensitivity increased YTD in 52 Week range USD 35.72-17.95 both up-rate and down-rate scenarios primarily due to higher deposit balances.
3507,270,4,Unrealized AFS debt gains were $6.3bn at 3Q20 $6.3bn gain at 2Q20.
3508,270,5,"Line utilization: The utilization rate across commercial lending including SBLCs, LOCs, etc. was 58% at 3Q20 60% at 2Q20, 64% at 1Q20 and 58% at 4Q19."
3509,270,6,utilization rate was 44% at 3Q20 45% at 2Q20. Legalmortgage: Combined legal and mortgage RW RPL was $0 to $1.3bn in excess of the accrued liability at 3Q20 $0-1.6bn at 2Q20 after $636mn in legal charges in 3Q20. Mortgage RW reserve was $1.4bn unchd.
3510,270,7,"andor one of its affiliates does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the BCI, US firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision."
3511,270,9,"Substantial improvements BAC has made in consumer bank and the benefits of Pre-provision earnings 39,331 31,055 31,277 31,950 -6.7% technology investments are not yet fully appreciated Loan loss provisions 3,590 12,374 6,680 5,057 12.1% by investors. We also expect further market share Pre-tax income 32,754 17,722 23,647 25,943 -7.5% gains in wholesale. BAC appears well positioned to Net income 27,430 16,809 19,627 21,533 -7.8% navigate through uncertain economic environment. Our price target is $33 based on 15x our 2021 EPS Balance sheet $bn Average estimate of $2.20. Total assets 2,434 2,725 2,856 2,893 2,727 Risk-weighted assets 1,495 1,445 1,499 1,503 1,485 Upside case USD 45.00 Non-performing loans $mn 3,797 5,217 6,261 5,635 5,227 Significantly improving economic outlook vs. current Allowance for loan losses 9 20 17 14 15 expectations, resulting in a much stronger capital Loans 983.4 964.7 996.6 1,021.6 991.6 markets backdrop, and improving revenue Deposits 1,435 1,756 1,818 1,884 1,723 environment could drive 2021 EPS higher to $3.00. In Tier 1 capital 188 199 199 196 196 this scenario, we could see a $45 upside case 15x EPS of $3.00. Tier 1 common capital 167 176 175 173 173 Shareholders equity 241 248 248 245 246 Downside case USD 16.00 Tangible common equity 172 178 178 175 176 If the economy were to experience signifficant further Loandeposit ratio % 69.4 60.8 60.5 59.7 62.6 deterioration, impacting both domestic and international markets, we envision a scenario where Valuation and leverage metrics Average BAC shares could trade down to 0.8x 2020E tangible PE reported x 8.6 13.5 10.8 9.1 10.5 book value, or $16 per share."
3512,270,10,"Barclays Bank of America Economic outlook: Various economic outlooks were used in 3Q20 estimates for allowance for credit losses that included consensus estimates, multiple downside scenarios which assumed a significantly longer period until economic recovery, a tail risk scenario similar to the severely adverse scenario used in stress testing and an upside scenario to reflect the potential for continued improvement in the consensus outlooks. The unemployment rate under this weighted economic outlook is nearly 9% as of 4Q20"
3513,270,11,"Additionally, in this economic outlook, GDP returns to pre-pandemic levels in late 2022. BAC also factored into its allowance for credit losses an estimated impact from higher-risk segments that included"
3514,270,12,"leveraged loans and industries such as travel and entertainment, which have been adversely impacted from the effects of COVID-19, as well as the energy sector. BAC also holds additional reserves for borrowers who requested deferrals that take into account their credit characteristics and payment behavior subsequent to deferral. Net interest income: BAC expects net interest income to remain relatively flat or to modestly increase in 4Q20 as compared to 3Q20 assuming economic conditions do not deteriorate and interest rates remain stable as compared to 3Q20. Expenses: Absent unexpected changes, BAC expects noninterest expense will be approximately $13.7bn in 4Q20 assuming both lower COVID-19 related costs and litigation expense. Tax rate : BAC expects the effective tax rate for 4Q20 to be approximately 10%, excluding unusual items. Absent tax credits, the effective tax rate would be"
3515,270,13,"Consumer and commercial loan modification programs: A significant portion of deferrals expired in 3Q20, reflecting a decline in customer requests for assistance. As of October 21, deferred consumer and small business loans totaled $9.8bn $28.5bn at July"
3516,270,14,"23, consisting of $9.0bn of residential mortgage and home equity loans, including loans serviced by others, that are well-collateralized, $298mn of consumer credit card loans and $582mn of small business and consumer vehicle loans."
3517,270,15,"mortgage and home equity loans, the weighted average loan-to-value LTV and combined LTV CLTV ratios were 61% and 57%, respectively. Of the consumer credit card loans for which payment deferral programs have expired, 91% of cardholders have"
3518,270,16,"As of October 21, 2020, excluding small business, deferred commercial balances totaled $1.4bn, or 0.29% of total commercial loans."
3519,270,17,"Paycheck Protection Program Loans: As of 3Q20, BAC had 343k 334k at 2Q20 loans under the PPP totaling $24.7bn $25.1bn at 2Q20. In addition, BAC has begun to process applications for forgiveness."
3520,270,18,"Deduction of Unsecured Debt of G-SIBs: On October 20, the Fed, FIDC and OCC finalized a rule requiring Advanced approaches institutions to deduct from regulatory capital certain investments in TLAC-eligible long-term debt and other pari passu or subordinated debt instruments issued by G-SIBs above a specified threshold. The final rule is intended to limit the interconnectedness between G-SIBs and is complementary"
3521,270,19,"to existing regulatory capital requirements that generally require banks to deduct investments in the regulatory capital of financial institutions. The final rule is effective April 1, 2021. The impact to BAC is not expected to be significant."
3522,270,20,"Net Stable Funding Ratio Final Rule: On October 20, 2020, the U.S. regulators finalized the Net Stable Funding Ratio, a rule requiring large banks to maintain a minimum level 2 November 2020 3"
3523,270,21,"The final rule is intended to support the ability of banks to lend to households and businesses in both normal and adverse economic conditions and is complementary to the LCR rule, which focuses on short-term liquidity"
3524,270,22,"The final rule is effective July 1, 2021. The impact to BAC is not expected to be significant."
3525,270,23,"In June 2020, the Board of Governors of the Federal Reserve System Federal Reserve notified BHCs of their 2020 Comprehensive Capital Analysis and Review CCAR supervisory stress test results, which included a preliminary stress capital buffer SCB that was finalized in August 2020. Based on BACs results, it is subject to a 2.5% SCB for the period beginning 4Q20 and ending after 3Q21."
3526,270,24,"Due to economic uncertainty resulting from the COVID-19 pandemic, the Federal Reserve required all large banks to suspend share repurchase programs in 3Q20, except for repurchases to offset shares awarded under equity-based compensation plans, and to limit dividends to existing rates that do not exceed the average of the last four quarters net income. In Sept 2020, the Fed announced that these measures would remain in place for 4Q20. Large banks will also be required to resubmit and update their capital plans in Nov 2020 based on the Feds updated supervisory stress test scenarios."
3527,270,25,"The Fed announced that they will publish the results of the additional supervisory stress tests by Dec 31, 2020. BAC will continue its current suspension of common stock repurchases in 4Q20, except for repurchases to offset shares awarded under its equity-based compensation plans, which have previously been authorized by the Board."
3528,270,26,"dilutive potential common shares associated with the Series L preferred stock were not included in the diluted share count because the result would have been antidilutive under the if-converted method. Dividends: On Oct 21, the Board of Directors declared a quarterly common stock dividend at the current rate of $0.18 per share. BAC intends to maintain the quarterly common stock dividend at this rate until further notice, subject to approval by the Board. Given the widespread impact the COVID-19 pandemic is having on the U.S. and global economy, a number of industries have been and continue to be adversely impacted. BAC continues to monitor all industries, particularly higher risk industries, which are experiencing or could experience a more significant impact to their financial condition. The impact of the COVID-19 pandemic has also placed significant stress on global demand for oil, resulting in a steep decline in prices. BACs energy- related committed exposure was $34.5bn at 3Q20 $37.4bn at 2Q20 with a decline"
3529,270,27,"Legal Mortgage RPL: For those disclosed matters where an estimate of the range of possible loss is possible, as well as for representations and warranties exposures, management currently estimates the aggregate range of reasonably possible loss for these exposures is $0 to $1.3bn $0 to $1.6bn at 2Q20 in excess of the accrued liability, if any, at 3Q20. Mortgage repurchase reserve: Its liability for representations and warranties i.e. reserve was $1.4bn at 3Q20 $1.4bn at 2Q20."
3530,270,28,"At 3Q20, net notional credit default protection purchased in its credit derivatives portfolio to hedge it funded and unfunded exposures for which it elected the fair value option, as well as certain other credit exposures, was $5.2bn $5.4bn at 2Q20. BAC recorded net losses on these positions of $104mn in 3Q20 net loss of $231mn in 2Q20. The gains and losses on these instruments were offset by gains and losses on the related exposures."
3531,270,29,"Forward commitments: At 3Q20, BAC had commitments to purchase loans e.g., residential mortgage and commercial real estate of $169mn $169mn at 2Q20, which upon settlement will be included in loans or LHFS, and commitments to purchase commercial loans of $365mn $430mn at 2Q20, which upon settlement will be included in trading account assets. At 3Q20, BAC had commitments to purchase commodities, primarily liquefied natural gas, of $539mn $498mn at 2Q20, which upon settlement will be included in trading account assets."
3532,270,30,"commitments expire primarily within the next 12 months. At 3Q20, BAC had a commitment to originate or purchase up to $3.8bn $3.5bn at 2Q20 on a rolling 12- month basis, of auto loans and leases from a strategic partner."
3533,270,31,"At 3Q20, BAC had a headcount of approximately 211,000 213,000 at 2Q20 employees. Market risk management: BAC has been affected, and expect to continue to be affected, by market stress resulting from the COVID-19 pandemic that began in 1Q20. Libor transition: BAC continues to identify, assess and monitor risks associated with the expected discontinuation or unavailability of LIBOR and other benchmarks. Additionally, BAC continues to evaluate and address documentation and contractual mechanics of outstanding IBOR-based products and contracts that may mature after"
3534,270,32,"LIBOR is no longer deemed a representative benchmark, as well as new and potential future ARR-based products and contracts to achieve operational readiness. This program, which is led by BACs Chief Operating Officer, includes active involvement of"
3535,270,33,"The program is structured to address BACs industry and regulatory engagement, client and financial contract changes, internal and external communications, technology and operations"
3536,270,34,"As the markets for ARRs continue to grow, BAC continues to monitor and participate in the development and usage of ARRs, including the Secured"
3537,270,35,"BAC issued debt and deposits linked to SOFR and SONIA, facilitated debt issuances by clients linked to SOFR and SONIA, and executed SOFR- and SONIA-based derivative contracts to make markets and facilitate client activities. In accordance with the industry-wide transition from IBORs to ARRs, central clearing counterparties CCPs in Europe and the U.S., which act as intermediaries and require collateral deposits for the"
3538,270,36,"clearing and settlement of interest rate swap products and other derivatives, changed the interest rate used to calculate amounts due to counterparties for collateral deposits posted with them from the European Overnight Index Average EONIA to the Euro Short-Term Rate ESTR and the Effective Fed Funds Rate EFFR to SOFR in July and October 2020, respectively. In connection with this transition, BAC updated its operational models, systems, procedures and internal infrastructure."
3539,270,37,impact from the changes in net valuations of these derivatives was not significant at the 2 November 2020 5
3540,270,38,"Barclays Bank of America point of conversion, as BAC either provided or received compensation tofrom the CCPs. Additionally, in October 2020, BAC and certain of its subsidiaries adhered to the International Swaps and Derivatives Association, Inc. 2020"
3541,270,39,"effective January 25, 2021, which provides a mechanism to enable market participants to incorporate fall-backs for certain legacy non-cleared derivatives linked to certain IBORs. BAC continues to monitor the impact of COVID-19 on the market and industry transition to ARRs, including the readiness of impacted clients and their operational readiness to transition to ARRs."
3542,270,40,"balance was $392.8bn $391.1bn at 2Q20. Its TLAC Percentage of risk-weighted assets ratio was 26.9% 26.0% at 2Q20 at 3Q20 vs. regulatory minimum of 22%, and Percentage of SLR leverage exposure was 13.7% 14.2% at 2Q20 vs. regulatory"
3543,270,41,"Its TLAC eligible long term debt totalled $188.0bn at 3Q20 $185.8bn at 2Q20, and its long term debt Percentage of risk-weighted assets TLAC ratio was 12.9% 12.4% at 2Q20 vs. regulatory minimum of 8.5% and the ratio of TLAC"
3544,270,42,"long term debt as percentage of SLR leverage exposure was 6.6% 6.7% at 2Q20 vs. regulatory minimum of 4.5%. Under the Basel 3 standardized approach, it estimated the common equity tier 1 capital ratio to be 11.9% at 3Q20 11.6% at 2Q20 with $173.2bn of common equity Tier 1 capital $171.0bn at 2Q20 and $1,460bn of risk-weighted assets $1,475bn at 2Q20. Under the Basel 3 advanced approach, it estimated the common equity tier 1 capital ratio to be 12.7% at 3Q20 11.4% at 2Q20 with $173.2bn of common equity Tier 1 capital $171.0bn at 2Q20 and $1,364bn of risk-weighted assets $1,504bn at 2Q20. BACs SLR was 7.4% at 3Q20 7.1% at 2Q20, which was above the 5.0% required minimum. Its average global liquidity sources were $859bn at 3Q20 $796bn at 2Q20 . The excess liquidity available to the parent company and nonbank subs is held in cash and"
3545,270,43,"Its bank subsidiaries excess liquidity sources consisted of $690bn $637bn at 2Q20 in cash on deposit at the Federal Reserve and high-quality, liquid, unencumbered"
3546,270,44,"In 3Q20, BACs average consolidated HQLA, on a net basis, was $562bn $549bn in 2Q20 and the consolidated average LCR was 122% 121% in 2Q20. BACs LCR will fluctuate due to normal business flows from customer activity. Minimum Capital Requirements: In order to avoid restrictions on capital distributions and discretionary bonus payments, BAC must meet risk based capital ratio requirements that include a capital conservation buffer greater than 2.5%, plus any applicable countercyclical capital buffer and a G-SIB surcharge."
3547,270,45,capital conservation buffer was replaced by the SCB for BACs Standardized approach ratio requirements . The buffers and surcharge must be comprised solely of CET1 capital. BAC is also required to maintain a minimum supplementary leverage ratio
3548,270,46,BACs insured depository institution subsidiaries are required to maintain a minimum 6.0% SLR to be considered well capitalized under the PCA framework.
3549,270,47,Barclays Bank of America Credit ratings: The ratings and outlooks from Fitch Ratings for BAC and its subsidiaries have not changed from those disclosed in the BACs 2Q20
3550,270,48,"Ratings SP for BAC and its subsidiaries did not change from those disclosed in BACs 2019 Annual Report on Form 10-K. Collateral: If BACs debt were downgraded by a one incremental notch, BAC would be required to post $303mn $337mn at 2Q20 of additional collateral at 3Q20."
3551,270,49,notch downgrade would require $724mn $707mn at 2Q20 of additional collateral to be posted.
3552,270,50,"The asset sensitivity of BACs balance sheet increased in both up-rate and down-rate scenarios primarily due to higher deposit balances. BAC continues to be asset sensitive to a parallel upward move in interest rates with the majority of that impact coming from the short end of the yield curve. Additionally, higher interest rates impact the fair value of debt securities and, accordingly, for debt securities classified as AFS,"
3553,270,51,"Under instantaneous upward parallel shifts, the near-term adverse impact to Basel 3 capital is reduced over time by offsetting positive impacts to net interest income."
3554,270,52,Rate sensitivity: A 100bp instantaneous parallel increase in rates from the forward curve increases core net interest income by $9.6bn $8.8bn at 2Q20. A 25bp instantaneous parallel decrease in rates from the forward curve decreases core net interest income by $2.5bn -$1.7bn at 2Q20.
3555,270,53,"inversion from the forward market curve increase in short-term rates increases net interest income by $6.4bn $5.5bn at 2Q20, while a 100bp instantaneous curve steepening increase in long-term rates, increases net interest income by $3.3bn $3.3bn at 2Q20. AFS debt securities portfolio totaled $233.7bn $190.4bn at 2Q20 at fair value, with net unrealized gain of $6.3bn net unrealized gain of $6.3bn at 2Q20. BAC had $2.7bn $3.0bn at 2Q20 of AFS debt securities in an unrealized loss position for 12 months or longer at 3Q20 with a loss of $44mn $62mn loss at 2Q20. MSR hedge: During 3Q20, BAC recorded a gain of $85mn a gain of $65mn in 2Q20 related to the change in fair value of the MSRs, IRLCs and LHFS, net of gains and losses on the hedge portfolio."
3556,270,54,"The residential mortgage portfolio made up the largest percentage of BACs consumer loan portfolio at 53% 53% at 2Q20 of consumer loans and leases at 3Q20. At 3Q20, approximately 53% 54% at 2Q20 of the residential mortgage portfolio is in Consumer"
3557,270,55,"Banking and 39% 37% at 2Q20 is in GWIM. The remaining portion of the residential mortgage portfolio is in All Other and is comprised of originated loans, purchased loans used in BACs overall ALM activities, delinquent FHA loans repurchased pursuant to"
3558,270,56,"Insured loans: At 3Q20, the residential mortgage portfolio included $11.7bn $11.7bn at 2Q20 of outstanding fully-insured loans, of which $3.0bn $3.1bn at 2Q20 had FHA 2 November 2020 7"
3559,270,57,The decline was primarily driven by sales of loans with FHA insurance during 3Q20.
3560,270,58,"Credit protection : BAC has entered into long-term credit protection agreements with Fannie Mae and Freddie Mac on loans totaling $8.8bn $8.6bn at 2Q20, providing full credit protection on residential mortgage loans that become severely delinquent. All of these loans are individually insured and therefore BAC does not record an allowance for credit losses related to these loans."
3561,270,59,"At 3Q20, mortgage loans totaled $232.7bn $239.5bn at 2Q20."
3562,270,60,"2% 2% at 2Q20 has a refreshed LTV between 90-100%, 1% 1% at 2Q20 has a refreshed LTV over 100%, 2% 2% at 2Q20 has a FICO score below 620, and 3% 3% at 2Q20 is from origination vintages. Of the $221.0bn $222.7bn at 2Q20 in total residential mortgage loans excluding fully insured loans, 27% 26% at 2Q20 were originated as interest-only. The outstanding balance of interest-only residential mortgage loans that have entered the amortization period was $6.3bn $6.4bn at 2Q20, or 11% at 3Q20 11% at 2Q20."
3563,270,61,mortgage loans that have entered the amortization period generally have experienced a higher rate of early stage delinquencies and nonperforming status compared to the residential mortgage portfolio as a whole.
3564,270,62,"2Q20 of outstanding interest-only residential mortgages that had entered the amortization period were accruing past due 30 days or more compared to $1.4bn or 1% $895mn, or 1% at 2Q20 for the entire residential mortgage portfolio."
3565,270,63,"at 3Q20, $329mn or 5% $295mn, or 4% at 2Q20 of outstanding interest-only residential mortgage loans that had entered the amortization period were nonperforming, of which $71mn $111mn at 2Q20 were contractually current, compared to $1.7bn or 1% $1.6bn, or 1% at 2Q20 for the entire residential mortgage portfolio. Loans that have yet to enter the amortization period in its interest-only residential mortgage portfolio are primarily well-collateralized loans to its wealth"
3566,270,64,Approximately 97% 96% at 2Q20 of these loans that have yet to enter the amortization period will not be required to make a fully-amortizing payment until 2022
3567,270,65,"At 3Q20, the home equity portfolio made up 8% 9% at 2Q20 of the consumer portfolio and is comprised of home equity lines of credit HELOCs, home equity loans and reverse mortgages. At 3Q20, BACs HELOC portfolio had an"
3568,270,66,"At 3Q20, home equity loans totaled $36.5bn $38.4bn at 2Q20. Of this portfolio, 1% has a refreshed CLTV between 90-100% 1% at 2Q20, 2% had a CLTV over 100% 2% at"
3569,270,67,"2Q20, 3% had a refreshed FICO below 620 3% at 2Q20, and 16% was from 2006-07 origination vintages 17% at 2Q20. Reverse mortgage: At 3Q20, BACs reverse mortgage portfolio had an outstanding balance of $1.3bn, or 3% of the total home equity portfolio, compared to $1.4bn, or 3%, at 2Q20. HELOCs: The outstanding balance of HELOCs that have entered the amortization period was $9.9bn $10.6bn at 2Q20 at 3Q20. The HELOCs that have entered the amortization period have experienced a higher percentage of early stage delinquencies and"
3570,270,68,"At 3Q20, $145mn, or 1% $124mn, or 1% at 2Q20, of outstanding HELOCs that had entered the amortization period were accruing past due 30 days or more."
3571,270,69,"Barclays Bank of America During 3Q20, 17% 18% in 2Q20 of HELOC customers with an outstanding balance did not pay any principal on their HELOCs. Unused HELOCs totaled $43.5bn at 3Q20 $44.4bn at 2Q20. The HELOC utilization rate was 44% at 3Q20 45% at 2Q20."
3572,270,70,"At 3Q20, residential mortgage TDRs were $3.9bn $4.1bn at 2Q20, including $1.1bn $1.1bn at 2Q20 deemed collateral dependent and $1.6bn $1.6bn at 2Q20 fully insured loans. Home equity TDRs were $1.1bn $1.2bn, including $408mn $422mn at 2Q20 deemed collateral dependent."
3573,270,71,"Consumer real estate loans of $385mn $396mn at 2Q20 that have been discharged in Chapter 7 bankruptcy with no change in repayment terms and not reaffirmed by the borrower were included in TDRs at 3Q20, of which $98mn $98mn at 2Q20 were classified as nonperforming and $101mn $75mn at 2Q20 were loans fully insured by the FHA. At 3Q20, remaining commitments to lend additional funds to debtors whose terms have been modified in a commercial loan TDR were $471mn $445mn at 4Q19 The balance of commercial TDRs in payment default was $391mn at 3Q20 $207mn at 4Q19. Credit cards: At 3Q20, 97% 97% at 2Q20 of the credit card portfolio was managed in Consumer Banking with the remainder in GWIM. Outstandings in the credit card portfolio decreased to $79.8bn $84.2bn at 2Q20 due to lower retail spending. Unused lines of credit for credit card were $344.6bn at 3Q20 vs $348.1bn at 2Q20."
3574,270,72,"Commercial reservable criticized utilized exposure was $35.7bn compared to $26.0bn at 2Q20, as a result of weaker economic conditions arising from COVID-19. 84% of commercial reservable criticized utilized exposure was secured at 3Q20 83% at 2Q20. Line utilization: Total commercial utilized credit exposure was $631.2bn at 3Q20 $667.7bn at 2Q20. The utilization rate for loans and leases, standby letters of credit SBLCs and financial guarantees, and commercial letters of credit, in the aggregate, was 58% at 3Q20 60% at 2Q20, 64% at 1Q20 and 58% at 4Q19."
3575,270,73,"Non-US exposures: BACs largest emerging market country exposure at 3Q20 was China, with net exposure of $12.5bn -$0.3bn from 2Q20 . BACs largest non-U.S. country exposure at 3Q20 was the U.K. with net exposure of $55.0bn -$6.0bn from 2Q20 . Its second largest non-U.S. country exposure was Germany with net exposure"
3576,270,74,"Derivative balances: Derivatives are entered into on behalf of customers, for trading or to support risk management activities. At 3Q20, total derivative assets were $44.3n"
3577,270,75,"Cash Flow and Net Investment Hedges: Of the $408mn after-tax net gain $332mn pre-tax on derivatives in accumulated OCI at 3Q20, gains of $191mn after-tax $198mn pre-tax related to open cash flow hedges are expected to be reclassified into earnings in the next 12 months . Certain of BACs derivative contracts contain credit risk-related contingent features, primarily in the form of ISDA master netting agreements and credit support documentation that enhance the 2 November 2020 9"
3578,270,76,Barclays Bank of America creditworthiness of these instruments compared to other obligations of the respective counterparty with whom BAC has transacted. These contingent features may be for the benefit of BAC as well as its counterparties with respect to changes in BACs
3579,270,77,"At 3Q20, it held cash and securities collateral of $91.7bn $89.0bn at 2Q20 and posted cash and securities collateral of $79.9bn $85.3bn at 2Q20 in the normal course of"
3580,270,78,"business under derivative agreements, excluding cross-product margining agreements where clients are permitted to margin on a net basis for both derivative and secured financing arrangements ."
3581,270,79,"contracts and other trading agreements, BAC can be required to provide additional collateral or to terminate transactions with certain counterparties in the event of a downgrade of the senior debt ratings of BAC or certain subsidiaries."
3582,270,80,"amount of collateral, calculated based on the terms of the contracts, that BAC and certain subsidiaries could be required to post to counterparties but had not yet posted to counterparties was $1.9bn $2.2bn at 2Q20 including $945mn $1.3bn at 2Q20 for BAC. Some counterparties are currently able to unilaterally terminate certain contracts, or BAC or certain subsidiaries may be required to take other action such as find a suitable replacement or obtain a guarantee ."
3583,270,81,"U.K. tax change : On July 22, 2020, the U.K. enacted a reversal of the final two percent of scheduled decreases in the U.K. corporation tax rate, which had been previously"
3584,270,82,"This change will unfavorably affect income tax expense on future U.K. earnings, and requires a reversal of the adjustment to the U.K. net deferred tax assets recognized at the time the related tax rate decrease was originally enacted."
3585,270,83,"3Q20, BAC recorded a positive income tax adjustment of approximately $700mn along with a corresponding increase to the U.K. net deferred tax assets. Bank-owned Life Insurance Book Value Protection: BAC sells products that offer book value protection to insurance carriers who offer group life insurance policies to corporations, primarily banks. At 3Q20, the notional amount of these guarantees, which are recorded as derivatives totaled $7.1bn $7.1bn at 2Q20. At 3Q20, BACs maximum exposure related to these guarantees totaled $1.1bn $1.0bn at 2Q20,"
3586,270,84,"Merchant Services: Prior to July 1, 2020, a significant portion of BACs merchant processing activity was performed by a joint venture in which it held a 49% ownership interest. On July 29, 2019, BAC gave notice to the joint venture partner of the"
3587,270,85,"Effective July 1, 2020, BAC received its share of the joint ventures merchant contracts and began performing merchant processing services for these merchants."
3588,270,86,"While merchants bear responsibility for any credit or debit card charges properly reversed by the cardholder, BAC, in its role as merchant acquirer, may be held liable for any reversed charges that cannot be collected from the merchants due to, among other things, merchant fraud or insolvency. BAC, as a card network member bank, also sponsors other merchant acquirers, principally its former joint venture partner with respect to merchants distributed to that partner upon the termination of the joint venture."
3589,270,87,"merchants cannot be collected from either the merchants or merchant acquirers, BAC may be held liable for these reversed charges. BACs risk in this area primarily relates to circumstances where a cardholder has purchased goods or services for future delivery."
3590,270,88,"The total amount of transactions processed for the preceding six-month period, which was $311.7bn, is an estimate of BACs maximum potential exposure as of 3Q20."
3591,270,89,"BAC does not believe the maximum potential exposure is representative of the actual potential loss exposure. At 3Q20, BACs reserves for contingent losses and the losses incurred related to the merchant processing activity were not significant."
3592,270,90,Fixed Income Clearing Corporation Sponsored Member Repo Program: BAC acts as a sponsoring member in a repo program whereby BAC clears certain eligible resale and repurchase agreements through the Government Securities Division of the Fixed Income Clearing Corporation on behalf of clients that are sponsored members in accordance with the Fixed Income Clearing Corporations rules.
3593,270,91,"BACs guarantee obligation is secured by a security interest in cash or high-quality securities collateral placed by clients with the clearinghouse and therefore, the potential for BAC to incur significant losses under this arrangement is remote. BACs maximum potential exposure, without taking into consideration the related collateral, was $8.0bn at 3Q20 $3.8bn at 2Q20. Other Guarantees: BAC has entered into additional guarantee agreements and commitments, including sold risk participation swaps, liquidity facilities, lease-end obligation agreements, partial credit guarantees on certain leases, real estate joint venture guarantees, divested business commitments and sold put options that require gross settlement. The maximum potential future payment under these agreements was $9.0bn at 3Q20 $8.8bn 2Q20. The estimated maturity dates of these obligations extend up to 2049. BAC has made no material payments under these guarantees."
3594,270,92,"normal course of business, BAC periodically guarantees the obligations of its affiliates in a variety of transactions including ISDA-related transactions and non-ISDA related transactions such as commodities trading, repurchase agreements, prime brokerage agreements and other transactions. During 3Q20, positive trading-related revenue was recorded for 100% 100% in 2Q20 of the trading days, of which 95% 95% in 2Q20 were daily trading gains of over $25mn and the largest loss was $0mn $0mn loss in 2Q20."
3595,270,93,"risk VAR 99% for trading portfolio in 3Q20 was $134mn, and $126mn at period end range of $99mn-$160mn, compared to $120mn average in 2Q20 range of $76mn-$159mn ."
3596,270,94,"trading revenue had losses that exceeded BACs total covered portfolio VaR, utilizing a one-day holding period. Credit Card Securitizations: BAC securitizes originated and purchased credit card loans. BACs continuing involvement with the securitization trust includes servicing the receivables, retaining an undivided interest sellers interest in the receivables, and holding certain retained interests including subordinate interests in accrued interest and fees on the securitized receivables and cash reserve accounts."
3597,270,95,"securities were issued to third-party investors from the credit card securitization trust during 3Q20 none in 2Q20. At 3Q20, BAC held subordinate securities issued by the credit card securitization trust with a notional principal amount of $6.9bn"
3598,270,96,These securities serve as a form of credit enhancement to the senior debt securities and have a stated interest rate of 0%.
3599,270,97,"trust, and no single investor has the unilateral ability to liquidate the trust. BAC resecuritized $8.3bn during 3Q20 $10.7bn in 2Q20. Securities received from the resecuritization VIEs were recognized at their fair value of $598mn during 3Q20."
3600,270,98,the securities received as resecuritization proceeds during 3Q2020 were classified as trading account assets. Substantially all of the trading account securities and debt securities carried at fair value were categorized as Level 2 within the fair value hierarchy.
3601,270,99,"Municipal Bond Trusts: BAC administers municipal bond trusts that hold highly-rated, long-term, fixed-rate municipal bonds. The trusts obtain financing by issuing floating rate trust certificates that reprice on a weekly or other short-term basis to third party investors."
3602,270,100,"including those for which BAC was transferor, totaled $3.3bn at 3Q20 $3.3bn at 2Q20. The weighted-average remaining life of bonds held in the trusts at 3Q20 was 6.9 years 7.0 years at 2Q20."
3603,270,101,"Customer VIEs: Customer VIEs include credit-linked, equity-linked and commodity- linked note VIEs, repackaging VIEs and asset acquisition VIEs, which are typically created on behalf of customers who wish to obtain market or credit exposure to a specific company, index, commodity or financial instrument. BACs maximum loss exposure to consolidated and unconsolidated customer VIEs totaled $2.4bn at 3Q20 $2.1bn at 2Q20 including the notional amount of derivatives to which BAC is a counterparty, net of losses previously recorded, and BACs investment, if any, in securities issued by the VIEs. BAC receives fees for structuring CDO VIEs, which hold diversified pools of fixed-income securities, typically corporate debt or ABS, which the CDO VIEs fund by issuing multiple tranches of debt and equity securities. CDOs are generally managed by third-party portfolio managers. BAC typically transfers assets to these CDOs, holds securities issued by the CDOs and may be a derivative counterparty to the CDOs. BACs maximum loss exposure to consolidated and unconsolidated CDOs totaled $252mn at 3Q20 $245mn at 2Q20. Investment VIEs: BAC sponsors, invests in or provides financing, which may be in connection with the sale of assets, to a variety of investment VIEs that hold loans, real estate, debt securities or other financial instruments and are designed to provide the desired investment profile to investors or BAC."
3604,270,102,"BACs maximum loss exposure associated with both consolidated and unconsolidated investment VIEs totaled $5.9bn at 3Q20 $6.3bn at 2Q20 comprised primarily of on- balance sheet assets less non-recourse liabilities. Leveraged Lease Trusts: BACs net investment in consolidated leveraged lease trusts totaled $1.7bn 3Q20 $1.7bn at 2Q20. The trusts hold long-lived equipment such as rail cars, power generation and distribution equipment, and commercial aircraft."
3605,270,103,The net investment represents BACs maximum loss exposure to the trusts in the unlikely event that the leveraged lease investments become worthless.
3606,270,104,trusts is non-recourse to BAC. 2 November 2020 12
3607,270,105,"Barclays Bank of America Tax Credit VIEs : BAC holds investments in unconsolidated limited partnerships and similar entities that construct, own and operate affordable housing, wind and solar projects. An unrelated third party is typically the general partner or managing member"
3608,270,106,BAC earns a return primarily through the receipt of tax credits allocated to the projects. The maximum loss exposure included in the Other VIEs table was $20.0bn at 3Q20 and $19.6bn at 2Q20.
3609,270,107,"is generally mitigated by policies requiring that the project qualify for the expected tax credits prior to making its investment. BACs investments in affordable housing partnerships, which are reported in other assets on the Consolidated Balance Sheet, totaled $10.6bn $10.3bn at 2Q20, including unfunded commitments to provide capital contributions of $4.8bn $4.6bn at 2Q20 at 3Q20. The unfunded commitments are expected to be paid over the next five years. BAC recognized tax credits and other"
3610,270,108,Tax credits are recognized as part of BACs annual effective tax rate
3611,270,109,"Accordingly, the portion of a years expected tax benefits recognized in any given quarter may differ from 25%. BAC may from time to time be asked to invest additional amounts to support a troubled"
3612,270,110,Such additional investments have not been and are not expected to be significant.
3613,270,111,"Retail bank: BACs retail banking footprint covers all major markets in the U.S., and BAC serves 66mn 66mn at 2Q20 consumer and small business clients with 4,300 4,300 at 2Q20 retail financial centers, 17,000 16,900 at 2Q20 ATMs, and digital banking platforms with more than 39mn more than 39mn at 2Q20 active users, including 31mn 30mn at 2Q20 active mobile users."
3614,270,112,"Reference Rate Reform: In March 2020, the FASB issued a new accounting standard related to contracts or hedging relationships that reference LIBOR or other reference rates that are expected to be discontinued due to reference rate reform. The new standard provides for optional expedients and other guidance regarding the accounting related to modifications of contracts, hedging relationships and other transactions"
3615,270,113,"BAC has elected to retrospectively adopt the new standard as of January 1, 2020 which resulted in no immediate impact. While reference rate reform is not expected to have a material accounting impact on BACs consolidated"
3616,270,114,"financial position or results of operations, the standard will ease the administrative burden in accounting for the future effects of reference rate reform. Accounting for Financial Instruments -- Credit Losses: On January 1, 2020, BAC adopted the new accounting standard that requires the measurement of the allowance for credit losses to be based on managements best estimate of lifetime expected credit losses ECL inherent in BACs relevant financial assets. Upon adoption of the standard in 1Q20, BAC recorded a $3.3bn, or 32%, increase to the allowance for credit losses."
3617,270,115,"After adjusting for deferred taxes and other adoption effects, a $2.4bn decrease was recorded in retained earnings through a cumulative-effect adjustment."
3618,270,116,"For a limited number of the matters disclosed in the prior commitments and contingencies disclosure, for which a loss, whether in excess of a related accrued liability or where there is no accrued liability, is reasonably possible in future periods, BAC is able 2 November 2020 13"
3619,270,117,"Barclays Bank of America to estimate a range of possible loss. In determining whether it is possible to estimate a range of possible loss, BAC reviews and evaluates these matters on an ongoing basis, in conjunction with any outside counsel handling the matter, in light of potentially relevant"
3620,270,118,"With respect to such matters, in cases in which BAC possesses sufficient appropriate information to estimate a range of possible loss, that estimate is aggregated and disclosed below."
3621,270,119,"which a loss is probable or reasonably possible but such an estimate of the range of possible loss may not be possible. For those disclosed matters where an estimate of the range of possible loss is possible, as well as for representations and warranties"
3622,270,120,"exposures, management currently estimates the aggregate range of reasonably possible loss for these exposures is $0 to $1.3bn $0 to $1.6bn at 2Q20 in excess of the accrued liability, if any, at 3Q20."
3623,270,121,"accrued liability, is based upon currently available information and is subject to significant judgment, a variety of assumptions and known and unknown uncertainties. The matters underlying the estimated range of possible loss and liability accrual are"
3624,270,122,"unpredictable and will change from time to time, and actual losses may vary significantly from the current estimate or accrual. Therefore, this estimated range of possible loss represents what BAC believes to be an estimate of possible loss only for"
3625,270,123,It does not represent BACs maximum loss exposure.
3626,270,125,"Barclays Bank of America FIGURE 2 BAC Earnings Model Balance Sheet and Performance Metrics $ in millions, except where noted 2 November 2020 16"
5467,433,1,"OVERWEIGHT Stock Rating Unchanged POSITIVE Industry View Unchanged USD 144.00 Price Target Outlook: It expects full-year 2020 net interest income to be $56bn market Unchanged dependent, while expenses for the full-year 2020 are expected to be $65bn."
5468,433,2,"Loan accommodations : At 2Q20, it had $17bn of wholesale loans under deferral, Price 03-Aug-2020 USD 96.10 almost all short-term, and included $8.8bn it proactively offered to performing auto Potential UpsideDownside 49.8% dealer clients where the deferral period ended on June 30, and the majority returned to Tickers JPM their original loan terms. On the consumer side, although borrowers are not required to Market Cap USD mn 292875 make payments while under deferral, 50% made at least one payment between March Shares Outstanding mn 3047.60 and June. At 2Q20, it had $28.3bn of consumer loans under deferral including $20.5bn Free Float % 97.32 of resi RE, $3.4bn auto, and $4.4bn credit card. At 2Q20, JPM had $28bn of PPP loans. Wk Avg Daily Volume mn 17.3 Card Rewards: In 2Q20, JPM reclassified certain spend-based credit card reward costs Dividend Yield % 3.75 from marketing expense to be a reduction of card income. Legal RPLs was up to $1.7bn at 2Q20, up $0.4bn from 1Q20. It booked legal expense of $118mn in 2Q20, compared to $69mn in 2Q19."
5469,433,3,"Price Performance Exchange-NYSE Rates : Its sensitivity to rates is primarily from assets repricing at a faster pace than 52 Week range USD 141.10-76.91 deposits. Based on current and implied market rates, scenarios reflecting lower rates could result in negative interest rates. Unrealized AFS gains were $9.5bn, up from $5.8bn at 1Q20."
5470,433,4,"Asset quality: Criticized loans were $39.4bn at 2Q20 $17.7bn from 1Q20, including $4.3bn of NPLs $2.7bn at 1Q20. Energy exposure was $43.0bn $0.2bn with 49% 52% at 1Q20 IG. Its U.K. exposure was $58.7bn at 2Q20, up from $52.6bn in 1Q20."
5471,433,5,"In 2Q20, JPM observed 2 VaR band break and posted gains on 38 of the 65 trading days in the quarter. Its average VaR was $130mn $71mn from 1Q20, reflecting the substantial increase in volatility as a result of the COVID-19 pandemic, most significantly in the fixed income and commodities risk types."
5472,433,6,"andor one of its affiliates does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the BCI, US firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision."
5473,433,8,"U.S. Large-Cap Banks Industry View: POSITIVE Stock Rating: OVERWEIGHT Income statement $mn 2019A 2020E 2021E 2022E CAGR Price 03-Aug-2020 USD 96.10 Price Target USD 144.00 Net interest income 57,245.0 55,935.8 54,354.6 56,560.8 -0.4% Operating expenses 65,316 65,478 67,094 68,986 1.8% Why Overweight? We are attracted to JPMs competitive position and believe it has addressed a Pre-provision earnings 52,587 52,967 49,186 51,615 -0.6% great deal of its litigation concerns. We see the Loan loss provisions 5,585 24,971 12,552 11,437 27.0% greatest sources of potential earnings upside being Pre-tax income 47,610 28,255 36,634 40,178 -5.5% driven by higher loan growth and capital markets."
5474,433,9,"Upside case USD 160.00 Balance sheet $bn Average A more positive view on the stock would be Total assets 2,687 3,156 3,203 3,299 3,086 warranted from accelerating loan growth, higher Risk-weighted assets 1,516 1,754 1,780 1,833 1,721 capital markets activity and a more optimistic view on Non-performing loans $mn 4,080 9,713 23,124 25,436 15,588 the global economy. In that case, 2021 EPS could go Allowance for loan losses 13 34 30 28 26 to $9.40 which would warrant a $160 upside case on Loans 959.8 1,005.1 1,049.3 1,095.5 1,027.4 17x. Deposits 1,562 1,970 1,970 1,970 1,868 Tier 1 capital 214 220 227 233 224 Downside case USD 85.00 Tier 1 common capital 188 194 201 206 197 A more severe COVID-19 driven recession could put Shareholders equity 234 242 248 254 244 pressure on capital markets, as well as adversely Tangible common equity 188 196 202 207 198 impacting its asset quality metrics. In such a scenario, 12x a lower $7.10 2021E EPS should provide Loandeposit ratio % 52.4 54.3 56.7 59.2 55.6 support at $85. Valuation and leverage metrics Average UpsideDownside scenarios PE reported x 9.0 15.1 10.9 9.6 11.2 PBV tangible x 1.6 1.5 1.4 1.4 1.5 Dividend yield % 3.5 3.7 3.7 3.9 3.7 PPPE x 5.9 5.6 5.9 5.5 5.7 Tier 1 % 14.15 12.56 12.78 12.70 13.05 Tier 1 Common % 12.39 11.04 11.28 11.25 11.49 Tang assetstang equity x 14.0 15.9 15.6 15.7 15.3"
5475,433,10,"In response to the COVID-19 pandemic, JPM invoked resiliency plans in 1Q20 to allow its businesses to remain operational, utilizing disaster recovery sites and implementing alternative work arrangements globally, including work from home."
5476,433,11,"implemented strategies and procedures designed to help it respond to increased market volatility, client demand for credit and liquidity, distress in certain industriessectors and the ongoing impacts to consumers and businesses. In 2Q20, JPM continued its focus"
5477,433,12,"It continues to actively monitor the dynamic health and safety situations at local and regional levels, and plans remain flexible to adapt as these"
5478,433,13,"JPM has continued to support its clients and customers during the challenging conditions caused by the COVID-19 pandemic, including by providing liquidity. Since March, it has extended more than $350bn of new and renewed credit to its clients and"
5479,433,14,"customers, of which $300bn was in the wholesale businesses. It is participating in a number of U.S government facilities and programs including the Coronavirus Aid, Relief, and Economic Security Act CARES Act and the Small Business Administration"
5480,433,15,"At 2Q20, JPM had $28bn of loans under the PPP . In the consumer portfolio, through 2Q20, JPM has provided customer assistance to over 2mn accounts, including refunding over $83mn in fees and granting payment deferrals"
5481,433,16,"on over $79bn of loans and leases, of which $42bn was for third-party mortgage loans serviced. As of 2Q20 JPM had $28bn of retained loans that were still under payment deferral. In the wholesale portfolio, through 2Q20, JPM has provided client assistance to"
5482,433,17,"The majority of the client assistance was payment deferrals on $23bn of loans. As of 2Q20, there were $17bn of retained loans that were still under payment deferral."
5483,433,18,"Outlook: JPMs current outlook for the remainder of 2020 should be viewed against the backdrop of the global and U.S. economies, the COVID-19 pandemic, financial markets activity, the geopolitical environment, the competitive environment, client and customer activity levels, and regulatory and legislative developments in the U.S. and other countries where JPM does business. Each of these factors will affect the performance of JPM and its LOBs."
5484,433,19,"NII It expects full-year 2020 net interest income, on a managed basis, to be $56bn, market dependent."
5485,433,20,"Expenses JPM expects adjusted expense for the full-year 2020 to be $65bn. Credit Quality: Continued weakness in the macroeconomic environment driven by the impacts of the COVID-19 pandemic, resulted in an additional increase in the allowance for credit losses."
5486,433,21,"assistance and government stimulus efforts are effective could result in further impacts to credit quality metrics, including delinquencies, nonaccrual loans and charge-offs. On March 15, 2020, in response to the COVID-19 pandemic, JPM temporarily suspended share repurchases through 2Q20, and as such, there were no shares repurchased pursuant to the common equity repurchase program during 2Q20. In June 2020, the Fed directed all large bank holding companies, including JPM, to discontinue net share repurchases, at least through the end of 3Q20."
5487,433,22,"In March 2020, JPM began providing assistance to customers in response to the COVID-19 pandemic, predominantly in the form of payment deferrals."
5488,433,23,"Predominantly all accounts that requested payment assistance were less than 30 days past due at the time of enrollment. Although borrowers are not required to make payments while still under payment deferral, on 50% of accounts with payment"
5489,433,24,"assistance offered, borrowers have made at least one payment between March 2020 and June 30, 2020. At 2Q20, it had $28.3bn of consumer loans under payment deferral including $20.5bn of residential real estate, $3.4bn of auto and $4.4bn of"
5490,433,25,"Wholesale Assistance: In March 2020, JPM began providing assistance to clients in response to the COVID-19 pandemic, predominantly in the form of payment deferrals and covenant modifications. As of 2Q20, JPM had $17bn of retained loans still under"
5491,433,26,"payment deferral, almost all short-term, and included $8.8bn in Automotive that it proactively offered to performing auto dealer clients where the deferral period ended on June 30, 2020, and the majority of the clients returned to their original loan terms . JPM continues to monitor the credit risk associated with loans subject to deferrals throughout the deferral period and on an ongoing basis after the borrowers are required to resume making regularly scheduled payments. JPM initially elected to phase-in the January 1, 2020 day 1 CECL adoption impact to retained earnings of $2.7bn to CET1 capital, at 25% per year in each of 2020 to 2023. As part of their response to the impact of the COVID-19 pandemic, on March 31, 2020, the federal banking agencies issued an interim final rule that provided the"
5492,433,27,The interim final rule provides a uniform approach for estimating the effects of CECL
5493,433,28,"compared to the legacy incurred loss model during the first two years of the transition period the day 2 transition amount, whereby JPM may exclude from CET1 capital 25% of the change in the allowance for credit losses excluding allowances on PCD"
5494,433,29,"The cumulative day 2 transition amount as at December 31, 2021 that is not recognized in CET1 capital as well as the $2.7bn day 1 impact, will be phased into CET1 capital at 25% per year beginning January 1, 2022. JPM has elected to apply the CECL capital transition provisions, and accordingly, for the period ended 2Q20, the capital measures of exclude $6.5bn, which is the $2.7bn day 1 impact to retained earnings and 25% of the $15.7bn increase in the allowance for credit losses excluding allowances on PCD loans. Economic Assumptions: At 2Q20, its central case assumptions included a 10.9% unemployment rate at 4Q20, declining to 9.0% by 2Q21 and 7.7% by 4Q21. It assumed a 6.2% cumulative decline in GDP by 4Q20 relative to 4Q19, improving to a 4.0%"
5495,433,30,"In 2Q20, JPM placed significant weighting on its adverse scenarios, which incorporate more punitive macroeconomic factors than the central case assumptions above, resulting in weighted average U.S."
5496,433,31,"For example, compared its central scenario described, JPMs relative adverse scenario assumes a significantly elevated U.S. unemployment rate through 1H21, averaging 3.6% higher"
5497,433,32,"Money Market Mutual Fund Liquidity Facility: On March 18, 2020, the Federal Reserve established a facility, authorized through 3Q20, to enhance the liquidity and functioning of money markets. On July 28, 2020, the Federal Reserve announced that it was"
5498,433,33,"Under the MMLF, the FRBB makes"
5499,433,34,"Barclays JPMorgan Chase Co. nonrecourse advances to participating financial institutions to purchase certain types of assets from eligible money market mutual fund clients. These assets, which are reflected in other assets on the Firms Consolidated balance sheets, are pledged to the FRBB as"
5500,433,35,"On March 23, 2020, the federal banking agencies issued an interim final rule to neutralize the effects of purchasing assets through the program on risk-based and leverage-based capital ratios. As of 2Q20 JPM excluded assets purchased from money"
5501,433,36,"market mutual fund clients pursuant to nonrecourse advances provided under the MMLF in the amount of $3.8bn from its RWA and $7.8bn from adjusted average assets and total leverage exposure SCB: On March 4, 2020, the Federal Reserve issued the final rule introducing a stress capital buffer SCB framework for the Basel III Standardized approach that is designed to more closely integrate the results of the quantitative assessment in CCAR with the ongoing minimum capital requirements for BHCs under the U.S. Basel III rules."
5502,433,37,rule replaces the static 2.5% CET1 capital conservation buffer in the Standardized approach with a dynamic institution-specific SCB. The final rule does not apply to the Advanced approach capital requirements. The SCB requirement for BHCs will be
5503,433,38,"On June 29, 2020, JPM announced that it had completed the 2020 CCAR stress test process. Its indicative SCB requirement is 3.3% and the Federal"
5504,433,39,"Reserve will provide JPM with its final SCB requirement by August 31, 2020. The SCB requirement will become effective on October 1, 2020 and will remain in effect until September 30, 2021. The SCB will be integrated into JPMs ongoing Standardized"
5505,433,40,"On June 29, 2020, JPM announced that it had completed the 2020 Comprehensive Capital Analysis and Review CCAR stress test process."
5506,433,41,"Stress Capital Buffer SCB requirement is 3.3% and the Federal Reserve Board will provide JPM with its final SCB requirement by August 31, 2020. JPMs Board of Directors currently intends to maintain the quarterly common stock dividend of $0.90 per share for 3Q20. Additionally, in June 2020, the Federal Reserve directed all large bank holding companies, including JPM, to discontinue net share repurchases, at least through the end of 3Q20."
5507,433,42,"Brexit: JPM continues to execute on its Firmwide Brexit Implementation program and remains focused on the following key areas to ensure continuation of service to its EU clients: regulatory and legal entity readiness client readiness and business and operational readiness. JPMs Brexit-related planning in 2H20 will focus on the possibility that the U.K. will complete its departure from the EU without having agreed the terms of their future relationship, which is commonly referred to as hard Brexit, as the July 1, 2020 deadline for the U.K. to request an extension of the transition period has passed."
5508,433,43,"This will require completion of the relocation of certain front office roles from the U.K. to EU locations, and finalization of the migration of EU clients and certain positions to EU entities by the end of 2020. The COVID-19 pandemic has added incremental risk to its"
5509,433,44,"Brexit Implementation program due to the potential impact on its ability to execute changes such as relocation of employees given travel restrictions, or the ability of clients to be operationally ready to the extent that they have diverted resources during 2020 to address the effects of the pandemic. IBOR transition: On March 12, 2020, the FASB issued an accounting standards update providing optional expedients and exceptions for applying generally accepted accounting principles to contracts and hedge relationships affected by benchmark"
5510,433,45,"This update provides for various elective options, referred to as practical 4 August 2020 5"
5511,433,46,"Barclays JPMorgan Chase Co. expedients, that are intended to simplify the operational impact of applying U.S. GAAP to certain transactions. JPM expects to apply certain of the practical expedients relating to the IBOR transition in 2H20. JPM continues to monitor the transition relief being considered by the International Accounting Standards Board IASB and U.S. Treasury Department regarding accounting and tax implications of reference rate reform. JPM also continues to develop and implement plans to appropriately mitigate"
5512,433,47,"Legal RPL: Its estimate of reasonably possible losses in excess of already established reserves ranges up to $1.7bn at 2Q20, up $0.4bn from 1Q20. Country exposures: Its exposure to the UK totaled $58.7bn at 2Q20 $52.6bn at 1Q20. Other countries of size include Japan $41.0bn at 2Q20 vs. $47.2bn at 1Q20, France"
5513,433,48,"The bank also had $80.8bn in exposure to Germany at 2Q20, vs"
5514,433,49,"Criticized assets: The total criticized component of the portfolio, excluding loans held- for-sale and loans at fair value, was $39.4bn at 2Q20, up from $21.7bn at 1Q20 and included $35.1bn $19.0bn at 1Q20 criticized performing loans and $4.3bn $2.7bn at 1Q20 criticized non-performing loans. The increase was largely driven by downgrades in Consumer Retail and Oil Gas primarily due to impacts from the COVID-19"
5515,433,50,"Exposure to the oil and gas industries was $43.0bn at 2Q20 $42.8bn at 1Q20. As of 2Q20, 49% 52% at 1Q20 of the exposure was investment grade."
5516,433,51,"Unfunded commitments: JPM provides lending-related financial instruments e.g., commitments and guarantees to address the financing needs of its customers and"
5517,433,52,"At 2Q20, total lending-related commitments of $1,124bn $1,081bn at 1Q20 included $45bn $42bn at 1Q20 consumer ex. cards, $719bn $681bn at 1Q20 consumer credit cards, and $405bn $358bn at 1Q20 wholesale commitments. In 2Q20, JPM reclassified certain spend-based credit card reward costs from marketing expense to be a reduction of card income, with no effect on net income. Prior-period amounts have been revised to conform with the current presentation. Wholesale Payments: In 1Q20, JPM began reporting a Wholesale Payments business unit within CIB following a realignment of its wholesale payments businesses. The Wholesale Payments business comprises: Merchant Services, which was realigned from"
5518,433,53,Trade Finance was previously reported in Lending in CIB.
5519,433,54,"The LCR rule requires JPM to maintain an amount of unencumbered HQLA that is sufficient to meet its estimated total net cash outflows over a prospective 30 calendar- day period of significant stress. For 2Q20, JPMs average LCR was 117%, compared with an average of 114% for 1Q20. JPMs average LCR increased during 2Q20,"
5520,433,55,"JPMs average LCR may fluctuate from period to period, due to changes in its HQLA and estimated net cash outflows as a result of ongoing business activity."
5521,433,56,"Capital ratios : JPMs fully phased-in CET1 under the Basel III Advanced Approach was 13.2% at 2Q20 12.3% at 1Q20, standardized approaches CET1 was 12.4% 11.5% at 1Q20. JPMs BHC supplementary leverage ratio SLR was 6.8% at 2Q20 6.0% at 1Q20 and JPMorgan Chase Bank N.A.s SLR was 7.9% 6.6% at 1Q20. As 2Q20, the SLR reflects the temporary exclusions of U.S. Treasury securities and deposits at Federal Reserve Banks, as required by the Federal Reserves interim final rule"
5522,433,57,"JPMs SLR excluding the temporary relief was 5.7%. The Federal Reserves TLAC rule requires the top-tier U.S. GSIB holding companies, including JPM, to maintain minimum levels of external TLAC and eligible LTD. At 2Q20, it had $407.1bn $387.4bn at 1Q20 of total eligible TLAC and long term"
5523,433,58,"debt and its TLAC ratio was 26.4% 24.2% at 1Q20 above the minimum requirement of 23%. Additionally, effective March 26, 2020, the Federal Reserve, in response to the COVID-19 pandemic, reduced reserve requirements to zero percent, which increased JPMorgan Chase Bank, N.A.s HQLA by $25bn. Broker subs: JPMs principal U.S. broker-dealer subsidiary is J.P. Morgan Securities. At 2Q20, JPMorgan Securities net capital was $27.7bn $17.3bn at 1Q20, exceeding the minimum requirement of $5.5bn $5.9bn at 1Q20."
5524,433,59,"J.P. Morgan Securities plc is a wholly-owned subsidiary of JPMorgan Chase Bank, N.A. and has authority to engage in banking, investment banking and broker-dealer activities. J.P. Morgan Securities plc is jointly regulated by the U.K. Prudential Regulation Authority PRA and Financial Conduct Authority FCA. The Bank of England requires, on a"
5525,433,60,"transitional basis, that U.K. banks, including U.K. regulated subsidiaries of overseas groups, maintain a minimum requirement for own funds and eligible liabilities MREL. As of 2Q20, J.P. Morgan Securities plc was compliant with the requirements of the"
5526,433,61,"At 2Q20, J.P. Morgan Securities plc had estimated total capital of $55.2bn $53.7bn at 1Q20, its estimated CET1 capital ratio was 17.6% 16.6% at 1Q20 and its estimated Total capital ratio was 22.5% 21.3% at 1Q20."
5527,433,62,"capital ratios exceeded the minimum standards of 4.5% and 8.0%, respectively. HQLA and other liquidity sources: As of 2Q20, HQLA high-quality liquid assets was estimated to be $556bn $426bn cash, $225bn securities, compared with $548bn at 1Q20. As of 2Q20, in addition to HQLA reported above, JPM has $606bn $432bn at"
5528,433,63,"This includes HQLA-eligible securities forming part of the excess liquidity at JPMorgan Chase Bank, N.A. that is not transferable"
5529,433,64,"Furthermore, JPM maintains borrowing capacity at various Federal Home Loan Banks FHLBs, the Federal Reserve Bank discount window and various other central banks as a result of collateral pledged by JPM to such banks."
5530,433,65,"Although available, JPM does not view the borrowing capacity at the Federal Reserve Bank discount window and the various other central banks as a primary source of liquidity. As of 2Q20, JPMs remaining borrowing capacity at various FHLBs and the"
5531,433,66,Federal Reserve Bank discount window was $281bn $317bn at 1Q20. This remaining borrowing capacity excludes the benefit of securities included above in HQLA
5532,433,67,"JPMs sensitivity to rates is primarily a result of assets repricing at a faster rate than deposits. JPM did not provide an estimate for a 100bp decrease in rates compared to a $2.0bn decline in pre-tax income at 4Q19. Based upon current and implied market rates as of 2Q20, scenarios reflecting lower rates could result in negative interest rates. The U.S. has never experienced an interest rate environment where the Federal Reserve"
5533,433,68,"In a negative rate environment, the modeling assumptions used for certain assets and liabilities require additional management judgment."
5534,433,69,analysis is not material to JPM. Net unrealized AFS securities gains were $9.5bn $5.8bn gain at 1Q20 at 2Q20. Net unrealized HTM securities gains were $3.2bn $2.3bn gain at 4Q19 at 2Q20.
5535,433,70,"During 1Q20, JPM transferred $26.1bn of U.S. GSE and government agency MBS from AFS to HTM for capital management purposes."
5536,433,71,"AOCI included pretax unrealized gains of $1.0bn on the securities at the date of transfer. JPMs total VaR measure using a 95% confidence level averaged $130mn in 2Q20 $59mn in 1Q20 ranging from $106mn to $163mn $27-$164mn in 1Q20. JPMs average Total VaR diversification benefit was $13mn or 9% of the sum in 2Q20 $12mn or 17% of the sum in 1Q20. Average total VaR increased $71mn in 2Q20, as compared with the prior quarter. This increase was driven by the substantial increase in volatility in the one-year historical"
5537,433,72,The most significant impacts were reflected in the fixed income and commodities risk types.
5538,433,73,"Effective January 1, 2020, JPM refined the scope of VaR to exclude positions related to the risk management of interest rate exposure from changes in its own credit spread on fair value option elected liabilities, and included these positions in other sensitivity-based measures. This change was made to more appropriately align the risk from changes in JPMs own credit spread on fair value option elected liabilities in a single market risk"
5539,433,74,"In the absence of this refinement, the average Total VaR for 2Q20 would have been lower by $8mn. In 2Q20, JPM observed 2 VaR band break and posted gains on 38 of the 65 trading days in the quarter. Derivative receivables, net of cash collateral and giving effect to legally enforceable master netting agreements, was $74.846bn at 2Q20 $81.6bn at 1Q20. Its mix was 49% 45% at 1Q20 interest rates, 17% 23% at 1Q20 FX, 20% 16% at 1Q20 equity, 12% 14% at 1Q20 commodity and 2% 1% at 1Q20 credit derivatives."
5540,433,75,"securities and other cash collateral held against derivative receivables totaled $21.5bn compared to $26.2bn at 1Q20 primarily U.S. government and agency securities and other G7 government bonds, putting total net exposure at $53.3bn $55.5bn at 1Q20."
5541,433,76,The weighted-average prepayment speed assumption to determine the $3.1bn fair value of its MSRs at 2Q20 was a CPR of 19.08% 19.12% at 1Q20. A 10% adverse change would reduce its MSR by $207mn $206mn at 1Q20.
5542,433,77,The impact of a 100bp adverse change would decrease it by $100mn $103mn at 1Q20.
5543,433,78,"Residential mortgage: At 2Q20, JPMs residential mortgage portfolio included $23.2bn $22.8bn at 1Q20, of interest-only loans. These loans have an interest-only payment period generally followed by an adjustable-rate or fixed-rate fully amortizing payment period to maturity and are typically originated as higher-balance loans to higher-income"
5544,433,79,Performance of this portfolio for 2Q20 was in line with the performance of the broader residential mortgage portfolio for the same period same at 1Q20.
5545,433,80,"Effective January 1, 2020, JPM adopted the CECL accounting guidance."
5546,433,81,"resulted in a change in the accounting for PCI loans, which are considered purchased credit deteriorated PCD loans under CECL. The residential real estate portfolio decreased from 1Q20 primarily reflecting loan paydowns and loan sales in Home Lending, largely offset by originations of prime mortgage loans that have been retained on the balance sheet. Net recoveries for 2Q20 were lower when compared with the same period in the prior year as the current quarter included losses associated with the purchased credit deteriorated portfolio as a result of"
5547,433,82,The carrying value of home equity lines of credit outstanding was $26.5bn at 2Q20. This amount included $9.9bn of HELOCs that have recast from interest-only to fully amortizing payments or have been modified and $8.7bn of interest-only balloon
5548,433,83,"HELOCs, which primarily mature after 2030. JPM manages the risk of HELOCs during their revolving period by closing or reducing the undrawn line to the extent permitted by law when borrowers are exhibiting a material deterioration in their credit risk profile. At 2Q20, the total Treasury and CIO investment securities portfolio was $556.7bn $397.9bn at 1Q20 the average credit rating of the securities comprising the Treasury and CIO investment securities portfolio was AA AA at 1Q20 based upon external ratings where available and where not available, based primarily upon internal ratings that correspond to ratings as defined by SP and Moodys."
5549,433,84,"Corporate Investment Bank compensation expense as a percentage of total net revenue was 24% in 2Q20 compared with 29% in 2Q19. Firmwide headcount was 256,710 FTEs at 1Q20 , compared to 256,720 at 1Q20 and 254,983 at 2Q19. During 2Q20, JPM transferred $12.5bn $2.6bn in 2Q19 of securities to agency"
5550,433,85,"At 2Q20, JPM did not consolidate any agency re-securitization VIEs or any JPM- sponsored private-label resecuritization VIEs. It held $4.2bn $3.2bn at 1Q20 of interests in nonconsolidated agency re-securitization entities."
5551,433,86,"In connection with JPMs mortgage loan sale and securitization activities with GSEs, JPM has made representations and warranties that the loans sold meet certain requirements, 4 August 2020 9"
5552,433,87,"Barclays JPMorgan Chase Co. and that may require JPM to repurchase the mortgage loans andor indemnify the loan purchaser if such representations and warranties are breached by JPM. The amount of a recognized mortgage repurchase liability on JPMs balance sheet was $85mn, up from $84mn at 1Q20."
5553,433,88,This framework requires that managements estimate of credit losses over the instruments remaining expected life and considers expected future changes in macroeconomic conditions.
5554,433,89,"guidance for AFS securities to incorporate an allowance, which will allow for reversals of credit impairments in the event that the credit of an issuer improves."
5555,433,90,Requires recognition of an impairment loss when the estimated fair value of a reporting unit falls below its carrying value. Eliminates the requirement that an impairment loss be recognized only if the estimated implied fair
5556,433,91,value of the goodwill is below its carrying value. No impact upon adoption as the guidance is to be applied prospectively.
5557,433,92,"Provides optional expedients and exceptions to current accounting guidance when financial instruments, hedging"
5558,433,93,"relationships, and other transactions are amended due to reference rate reform."
5559,433,94,Provides a one-time election to transfer securities out of the held-to-maturity classification if certain criteria are met. JPM expects to apply certain of the practical
5560,433,95,"As of 2Q20, JPM and its subsidiaries and affiliates are defendants, putative defendants or respondents in numerous legal proceedings, including private, civil litigations and regulatorygovernment investigations. JPM believes the estimate of the aggregate range of reasonably possible losses, in excess of reserves established, for its legal proceedings is from $0 to $1.7bn at 4 August 2020 10"
5561,433,96,"Still, for certain cases, JPM does not believe that an estimate can currently be made, as of 2Q20."
5562,433,97,Litigation expense: JPMs legal expense was $118mn in 2Q20 and $69mn in 2Q19. There is no assurance that JPMs litigation reserves will not need to be adjusted in the
5563,433,98,"Indias Enforcement Directorate ED is investigating JPMorgan India Private Limited in connection with investments made in 2010 and 2012 by two offshore funds formerly managed by JPM entities into residential housing projects developed by the Amrapali Group Amrapali. In 2017, numerous creditors filed civil claims against Amrapali"
5564,433,99,The home buyers petitions have been overseen by the Supreme Court of India since 2017 pursuant to its jurisdiction over public interest litigation.
5565,433,100,"2019, the Supreme Court of India issued an order making preliminary findings that Amrapali and other parties, including unspecified JPM entities and the offshore funds that had invested in the projects, violated certain currency control and money laundering provisions, and ordering the ED to conduct a further inquiry under Indias Prevention of Money Laundering Act PMLA and Foreign Exchange Management Act FEMA. In May 2020, the Enforcement Directorate issued a provisional attachment"
5566,433,101,"In June 2020, the funds were transferred to an account held by the Supreme Court of India."
5567,433,102,JPM is responding to and cooperating with the investigation.
5568,433,103,"JPM operated an escrow and depository account for the Federal Government of Nigeria FGN and two major international oil companies. The account held $1.1bn in connection with a dispute among the clients over rights to an oil field. Following the settlement of the dispute, JPM paid out the monies in the account in 2011 and 2013 in"
5569,433,104,"In November 2017, the Federal Republic of Nigeria FRN commenced a claim in the English High Court for $875mn in payments made out of the accounts."
5570,433,105,"FGN, alleges that the payments were instructed as part of a complex fraud not involving JPM, but that JPM was or should have been on notice that the payments may be fraudulent. JPM applied for summary judgment and was unsuccessful."
5571,433,106,ongoing and no trial date has been set.
5572,433,107,"JPM previously reported settlements with certain government authorities relating to its foreign exchange FX sales and trading activities and controls related to those activities. Among those resolutions, in May 2015, JPM pleaded guilty to a single violation of federal antitrust law. In January 2017, JPM was sentenced, with judgment entered"
5573,433,108,"The term of probation has concluded, with JPM remaining in good standing throughout the probation period. The Department of Labor has granted JPM a five-year exemption of disqualification that"
5574,433,109,"allows JPM and its affiliates to continue to rely on the Qualified Professional Asset Manager exemption under the Employee Retirement Income Security Act ERISA until January 2023. JPM will need to reapply in due course for a further exemption to cover the remainder of the ten-year disqualification period. A South Africa Competition Commission matter is the remaining FX-related governmental inquiry, and is currently pending before the South Africa Competition Tribunal."
5575,433,110,"In August 2018, the United States District Court for the Southern District of New York granted final approval to JPMs settlement of a consolidated class action brought by U.S.-based plaintiffs, which principally alleged violations of federal antitrust laws based on an alleged conspiracy to manipulate foreign exchange rates and also sought damages on behalf of persons who transacted in FX futures and options on futures. Certain members of the settlement class filed requests to the Court to be excluded from"
5576,433,111,"the class, and certain of them filed a complaint against JPM and a number of other foreign exchange dealers in November 2018. A number of these actions remain pending. Further, putative class actions have been filed against JPM and a number of"
5577,433,112,other foreign exchange dealers on behalf of certain consumers who purchased foreign currencies at allegedly inflated rates and purported indirect purchasers of FX instruments these actions also remain pending in the District Court.
5578,433,113,JPM and 11 other defendants agreed in principle to settle the class action filed by purported indirect purchasers for a total of $10mn. That settlement remains subject to negotiation of final documentation and court approval.
5579,433,114,"individual and putative class actions based on similar alleged underlying conduct have been filed outside the U.S., including in the U.K., Israel and Australia."
5580,433,115,"Groups of merchants and retail associations have filed a series of class action complaints alleging that Visa and MasterCard, as well as certain banks, conspired to set the price of credit and debit card interchange fees, enacted respective rules in violation of antitrust laws. In 2012, he parties initially settled the cases for a cash payment, a"
5581,433,116,"In 2017, after the approval of that settlement was reversed on appeal, the"
5582,433,117,"case was remanded to the District Court for further proceedings consistent with the appellate decision. The original class action was divided into two separate actions, one seeking primarily monetary relief and the other seeking primarily injunctive relief."
5583,433,118,"parties to the class action seeking monetary relief finalized an agreement which amends and supersedes the prior settlement agreement. Pursuant to this settlement, the defendants collectively contributed an additional $900mn to the $5.3bn previously"
5584,433,119,"In December 2019, the amended agreement was approved by the District Court. Certain merchants filed notices of appeal of the District Courts approval order, and those appeals are pending."
5585,433,120,"percentage of merchants that opted out of the amended class settlement, $700mn has been returned to the defendants from the settlement escrow in accordance with the settlement agreement. The class action seeking primarily injunctive relief continues"
5586,433,121,"In addition, certain merchants have filed individual actions raising similar allegations against Visa and Mastercard, as well as against JPM and other banks, and some of those actions remain pending. JPM has responded to inquiries from various governmental agencies and entities around the world relating primarily to the British Bankers Associations London Interbank Offered Rate LIBOR for various currencies and the European Banking Federations Euro Interbank Offered Rate EURIBOR. The Swiss Competition Commissions investigation relating to EURIBOR, to which JPM and other banks are subject, continues."
5587,433,122,"In December 2016, the EC issued a decision against JPM and other banks finding an infringement of European antitrust rules relating to EURIBOR . JPM has filed an appeal with the European General Court and that appeal is pending."
5588,433,123,"In addition, JPM has been named as a defendant along with other banks in a series of individual and putative class actions related to benchmarks, including U.S. dollar LIBOR during the period that it was administered by the BBA and, in a separate consolidated putative class action, during the period that it was administered by ICE Benchmark Administration. These actions have been filed, or consolidated for pre-trial purposes, in the United States District Court for the Southern District of New York."
5589,433,124,"plaintiffs make varying allegations that in various periods, starting in 2000 or later, defendants either individually or collectively manipulated various benchmark rates by submitting rates that were artificially low or high. Plaintiffs allege that they transacted in"
5590,433,125,"loans, derivatives or other financial instruments whose values are affected by changes in these rates and assert a variety of claims including antitrust claims seeking treble damages. In actions related to U.S. dollar LIBOR during the period that it was administered by the BBA, JPM has resolved certain of these actions and other is various stages of litigation. The District Court dismissed certain claims, including antitrust claims brought by some plaintiffs whom the District Court found did not have standing to assert such claims,"
5591,433,126,The plaintiffs whose antitrust claims were dismissed for lack of standing have filed an appeal.
5592,433,127,District Court granted class certification of antitrust claims related to bonds and interest rate swaps sold directly by the defendants and denied class certification motions filed by other plaintiffs.
5593,433,128,"U.S. dollar LIBOR was administered by ICE Benchmark Administration, the District Court granted defendants motion to dismiss plaintiffs complaint, and the plaintiffs have appealed. JPMs settlements of putative class actions related to Swiss franc LIBOR, the Singapore Interbank Offered Rate, the Singapore Swap Offer Rate and the Australian Bank Bill Swap Reference Rate, and certain of the putative class actions related to U.S. dollar LIBOR remain subject to court approval."
5594,433,129,"related to SIBOR and Swiss franc LIBOR, the District Court concluded that the Court lacked subject matter jurisdiction, and plaintiffs appeals of those decisions are pending."
5595,433,130,"Various authorities, including the Department of Justices Criminal Division, are conducting investigations relating to trading practices in the precious metals markets and related conduct. JPM is responding to related requests concerning similar trading- practices issues in markets for other financial instruments, such as U.S. Treasuries. It continues to cooperate with these investigations and is currently engaged in discussions with various regulators about resolving their respective investigations."
5596,433,131,"assurance that such discussions will result in settlements. Several putative class action complaints have been filed in the United States District Court for the Southern District of New York against JPM and certain former employees, alleging a precious metals futures"
5597,433,132,Some of the complaints also allege unjust enrichment and deceptive acts or practices under the General Business Law of the State of New York.
5598,433,133,"putative class actions in February 2019, and the consolidated action is stayed through May 2021. In addition, several putative class actions have been filed in the United States District Courts for the Northern District of Illinois and Southern District of"
5599,433,134,"New York against JPM, alleging manipulation of U.S. Treasuries futures and options, and bringing claims under the Commodity Exchange Act. Some of the complaints also allege unjust enrichment. A motion is pending before the United States Judicial"
5600,433,135,JPM is also a defendant in a consolidated action filed in the United States 4 August 2020 13
5601,433,136,"Since 2012, the French criminal authorities have been investigating a series of transactions entered into by senior managers of Wendel Investissement Wendel during the period from 2004 through 2007 to restructure their shareholdings in Wendel. JPMorgan Chase Bank, N.A., Paris branch provided financing for the transactions to a number of managers of Wendel in 2007. JPM has cooperated with the investigation. The investigating judges issued an ordonnance de renvoi in November 2016, referring"
5602,433,137,"In January 2018, the Paris Court of Appeal issued a decision cancelling the mise en examen of JPMorgan Chase Bank, N.A."
5603,433,138,"Cassation, Frances highest court, ruled that a mise en examen is a prerequisite for an ordonnance de renvoi and in January 2020 ordered the annulment of the ordonnance de renvoi referring JPMorgan Chase Bank, N.A. to the French tribunal correctionnel."
5604,433,139,"In addition, a number of the managers have commenced civil proceedings against JPMorgan Chase Bank, N.A. The claims are separate, involve different allegations and are at various stages of proceedings."
5979,468,1,"We are initiating on Apple AAPL with an Overweight rating and December 2019 price target of $272, implying 23% upside from current levels. While Apples leadership position in the premium smartphone market is well understood by investors, we still see considerable upside to the stock from current levels led by a combination of: 1 faster-than-expected transformation to a services business 2 stronger-than- expected priceincreases in the core iPhone business 3 underappreciated position for continued robust growth in the installed base 4 continuous innovation disrupting new end-markets 5 boost to earnings growth from a normal courseof sharerepurchases and 6 optionality available from theuse ofa strong balance sheet for either outsized sharerepurchases or MA."
5980,468,2,"The mix of Services revenue rose from 8% in FY12 to 13% in FY17, and is forecast to furtherincrease to 20% by FY21E. We believe the transformation to services, led by growth in both installed devices and service revenue per device, is tracking better thaninvestor expectation, including achieving revenue target of $48bnby FY20E ahead of schedule."
5981,468,3,"While investors have been overly concerned about the modest growth in device sales JPMe FY17-21E CAGR of 1%, we believe the robust high-single-digitgrowth in the installed base, which is a key contributor to Services revenuegrowth,has been underappreciated."
5982,468,4,"Capital deployment provides option value to investors. Apple has a target to be net cash neutral long-term and the availability to deploy up to $291mn cash on hand free cash flow by FY21E or 30% of the market cap through a combination of dividends, share repurchases, and MA provides enormous option value to investors in terms of potential upside to earnings."
5983,468,5,"MA opportunitiesto prioritize large installed base. Apples interest in entering new end-markets is likely to be evaluated based on the opportunity to offer services on a large installed base. Certain end-markets in our view could be of interest, including gaming services, automotive services,and smart speakers."
5984,468,6,"We base our valuation on a blended target PE multiple of 17.5x, led by a SOTP approach, which leads us to arrive at our Dec-19 price targetof $272."
5985,468,8,The authors wish to thankJoseph Kaplan for his contribution to this report.
5986,468,9,"Transforming from a hardware company to a services company faster than investors had expected, which isdriving financial and valuation upside Apple hashistorically been regarded as an IT Hardware company tied to a short product refresh cycle of the iPhone in an extremely competitive smartphone industry. More recently, investors have been proved wrong on the pace of Apples transformation to a services company, with revenues in the Services reporting segment increasing from 8% of total in FY12to an estimated 20% of total in FY21E. The Services opportunity is currently derived primarily from App Store purchases and there are multiple emerging drivers, such asApple Music and Apple Pay, which should continue to drive strong growth. We forecast 23% revenue CAGR for Services including comfortably hitting the FY20E Services revenuetargetof $48bn with modestly better than company-wide margins to be accretive to profit growth, and accompanied by higher visibility to revenue and earnings, which we believe warrants a higher earnings multiple relative to the core hardware business."
5987,468,10,"Apple Music and Apple Pay levered to megatrends of streaming music and digital currency, which areemerging growth areas for Services Apple Music and Apple Pay are key additions to the Apple ecosystem levered to consumer behavior megatrends in the form of the shift from downloading to streaming musicand the increasing adoptionof mobile payments. We expect Apples subscription-based Music service to reach 100mnMAUs by FY20E through increasing penetration of a target market estimated by J.P. Morgan Internet analyst, Doug Anmuth , to total 2.7bnusers,thusremaining the second largestmusic streamingservice globally after Spotify. We forecastannual revenuesto grow at a 41% CAGR to$16bnby FY21E. Separately, Apple Pay is gaining traction with the installed base and already leads competitive product offerings on Samsung or other Android platforms. We forecast $2.2bnin revenues from Apple Pay by FY21E with a 48% CAGR,led by the broader industry trend of strong growth in use of mobile payments and increase in NFC-enabled merchants."
5988,468,11,"Apple to expand mediaoffering to consumers with the additionof video, newspaper, and magazine content We expect Appleto expand its media offering beyond music by adding videoand print media content, resulting inan all-encompassing Media subscription. We expect Apple to ramp up its investments in video content steadily starting with $1bnin 2018. We expect a steady increase in investments in video content, given Apples focus on differentiation through content rather than encouragement ofcord-cutting. However, the level of investments is unlikely to reach Netflixs $8bnand Amazons $5bnover our forecast window FY21E. We expect Apple to combine the video and print media offering through acquisition of Texture to offer a packaged subscription at $14.99month relative to $9.99 for Apple Music anddrive Apple Music subscribers to upgrade to the packaged subscription, while at the same time growing the subscriber base at a rapid pace. We estimate Apples incremental media offerings beyond Music to drive an incremental $2.8bnof revenues by 2025."
5989,468,12,"Missing the forest for the trees: Concerns about iPhone volumes have driven investors to overlook the robust growth in the installed base In addition to the increase in service revenue opportunityper device, growth in the installed base of Apple devices is the other primary contributor to thegrowth in new"
5990,468,13,"While investors have been concerned about the modest growth in iPhone volumes, Apple has still been able to drive double-digit increases in the installed base through a combination of 1 new subscribers 2 incremental consumer switching to iOS and 3 replacement units from existing iOS users making it to the secondary market we estimate Apple has a 50% share of the secondary market relative to 15% of new smartphone market. We estimate atotal installed base of 1.4bndevices in 2017 1bniPhones rising to 1.9bnby 2021or a 7% CAGR."
5991,468,14,"Pricing power, driven in part by differentiation on technology, will continue to surprise investors on the upside Investors have been pleasantly surprised by the limited price elasticity exhibited by customers, which includes the increase in iPhone volumes despite a 3% pricing CAGR over the last tenyears and a higher increase in retail price in certain countries due to roll-off of carrier subsidies. Consumers have been willing to pay higher ASPs, due to a combination of: 1 stickiness of the iOS platform including smartphonesand accessories like watches through technology differentiation 2 increasing use of financing to pay in installmentsand3 push-out of spend on laptops and tablets. Our analysis reveals that Apple has an exceptional track record of success with the top-of-the-line smartphone marketed each year and with larger screen size smartphones generally priced at a premium, relative toApplesprimary competitor in the high-end smartphone category, Samsung. The latest generation of iPhones launched on September 12, with base prices ranging from $1,099 at the high-end to $749 at the low-end,is set to continue to drive ASPshigher."
5992,468,15,"Apple to drive differentiation of the ecosystem through technology leadership Apples portfolio strategy of focusing on design of three iPhone models each year allows it more bandwidth for resources to drive technology leadership and quality assurance, which are crucial in maintaining price premium over competitive products and driving a longer life-cycle of the product which supports installed base growth. Apple is already comfortably ahead of competition in relation tofacial recognition modules. JPM Asia Technology analyst, Narci Chang , expects world facing 3D Sensing to be adopted on iPhones starting in 2019 see report, again comfortably ahead of competition. Similarly, optimism around foldable smartphones has increased in recent months we expect Apple to be a fast follower with adoption starting in 2021 see report if it finds theform factor gaining traction with customers. Apples technology leadership drives both new customers joining the iOS installed base an estimatedone-third of annual demand and replacement demand led by upgrades from existing customers roughly two-thirds."
5993,468,16,"Acceleration in revenue growth to be a catalyst for investor sentiment buybacks to boost earnings growth further We expect a 10% revenue CAGR between FY17 and FY21, accelerating from the 8% CAGR over the last fiveyears, led by a combination of high-single-digit revenue growth in iPhones and double-digit revenue growth in Services and Other Products revenues. The acceleration in revenue growth should drive investor attention to the change in the drivers of revenue growth from being primarily led by iPhone revenues historically, to a balance between iPhone, Services, and Other Product revenues over our forecast window. We expect the 10% revenue CAGR to translate into a 17% earnings CAGR over the forecast window FY21E, through deployment of capital in share buybacks on a continual basis."
5994,468,17,"Enormous capital deployment opportunity provides optionality The firms target of being net cash neutral in the long-run relative to the net cash position of $129bnat end of F3Q18 and strong free cash flow generated annually average of $54bnannually over last fiveyears provides an enormous opportunity for capital deployment. However, we believe medium-term upside to our base case estimates based on buybacks largely in line with free cash flow is likely from large buybacks or acquisitions. For example, we estimate annual buybacks of $100bncan help Apple can reach close to a cash neutral position by FY21E, with accretion of $2.25 to our FY21E EPS. On the downside, however, our base case forecasts embed largelyflat operating margins, and we estimate the proposed tariffs,if implemented,could be a modest headwind of 50bpson operating margins medium- term and moderate our earnings growth forecasts."
5995,468,18,"Expect MA to focus on Services opportunities and large installed base Video Gaming, Automotive,and Smart Speakers could be potential opportunities While Apple has historically acquired hardware companies, it has largely been to bring certain technologies in-house and have the ability to further develop them. We expect bolt-on acquisitions of hardware companies to continue as the firm continues to evaluate technology differentiation for future generation of products. However, recent acquisitions of Texture, and Shazam, are more typical of acquisitions we would expect Apple to focus on moving forward to further enhance the Services offering to its existing installed base. Additionally, we do not rule out Apple looking at other end-markets with a combination of a large installed base and associated opportunity to deploy services. We believemobile video gaming and the automotive end-market could be of interest in this regard, in addition to potential interest in the smart speaker end-market given lackluster performance of the HomePod todate."
5996,468,19,"Stronger track record of profitability than other technology leaders yet trading at only market multiples makes it attractive to both value and growth investors Interestingly, with annual revenues of $230bn, Apple is ahead of other technology leaders, including Amazon, Alphabet, Facebook, and Netflix all covered by JPM Internet analyst Doug Anmuth . In greater contrast, Apples $61bnin operating profit compares to $26bnfor Alphabet, $20bnfor Facebook, $4bnforAmazon, and $0.8bn for Netflix. Additionally, the firm has a historical track record of much stronger earnings growth than the SP 500 index,of which it is the largest constituent at 5% weight. However, AAPL shares still trade at 16.6x NTM PE, modestly below the market multiple and well below trading multiples of other technology leaders. We expect the combination of double-digit earnings growth and a trading multiple in line with the market to screen very attractively for both value and growth investors although AAPL ispart of only the SP 500 growth index."
5997,468,20,"We rate Apple shares Overweight with solid 23% upside potential to our December 2019 price targetof $272 We rate AAPL shares Overweight given our favorable outlook on iPhone and Services revenues relative to investor expectations, catalysts toaccelerate revenue growth, and upside risk to our base forecast for 18% earnings CAGR. We expect increasing appreciation of acceleration in growth, along with greater visibility into earnings and cash flow with increasing mix of Services,to drive a modest re-rating, from NTM trading multiple of 16.6x to a 17.5x blended PE, which we arrive at a based on a SOTP methodology using 14.0x PE for iPhones, 11.0x for Mac and iPad devices, 26.0xfor Services, 25.0x for Apple Watch, and 16.0x for Other Products. We see 23% upside to our December 2019 price targetof $272."
5998,468,21,"Industry Downside Risks Deceleration or contraction in the handset and smartphone market could be faster than expected Economic conditions or shifting consumer demand could cause greater-than- expected deceleration or contraction in the handset and smartphone markets. This would negatively impact Apples prospects for growth, and the shares may fail to achieveour target price as a result."
5999,468,22,"Increase in competitive pressures in international markets Apple is increasingly participating in internationalmarkets, such as China and India, where local players, which are better situated, could leverage their position and pull on levers such as pricing to make the market more competitive. In addition,tariffs enactedby local governments may further hurt Apples ability to effectively compete in international markets."
6000,468,23,"Company-Specific Downside Risks Investment in new business strategies and acquisitionscould be fruitless Apple has historically invested in new business strategies and acquisitions. As such, success on these investments has low visibility at this time and could lead to greater- than-expected liabilities andexpense. Additionally, new investments could have a negative impact on current operations by distracting management."
6001,468,24,"Key man risk around departure of chief executive officer While risks related to departure of management executives is considerably lower relative to in the past, we believe the execution on strategic priorities under CEO Tim Cooks leadership does still present modest risk to the share price, although we see a strong group of executives to support business performance without disruptions."
6002,468,25,"Litigation with Qualcomm could drive unexpected liabilities As part of risk mitigation from the ongoing litigation with Qualcomm, Apple has provisioned what management believes could be worst-case payments to Qualcomm in the event of an adverse judgement. However, less favorable outcomes with greater damages awarded to Qualcomm could be a liability for Apple beyond the provisions, and drive downside to our price target."
6003,468,26,"Forecast Services to grow to one-fifth of revenues by FY21E Investors have been pleasantly surprised on the pace of transformation to Services, particularly given the size of the hardware business with 215mnsmartphone units sold annually. However, with strong double-digit growth 18% CAGR over the last five years, Apple has more than doubled the FY12 revenue of $13bnby FY17 $30bn. We forecast a modestly stronger 23% CAGR through FY21E, including comfortably achieving its target of doubling the FY16 revenue of $24bnby FY20E JPMe $56bn. Growth will be drivenboth by increase in the installed base from 1.4bndevices in FY17 to 1.9bnby FY21E at a 7% CAGR, and an increase in service revenue per installed device at a 16% CAGR."
6004,468,27,"Apple Music to account for $30bnby 2025, led by strong subscriber growth Apples Music service, based on monthly subscriptions, is second only to Spotify globally and we see adequate room for growth for both players in a market where consumers are switching to streaming services relative to download purchases. Streaming revenues for the industry have grown at a 59% CAGR since 2012 and we expect the same to continue withApple Music gaining further penetration of the estimated by J.P. Morgan Internet analyst, Doug Anmuth TAM globally of 2.7bn users relative to its current subscriber base of 50mn. We expect Apple to reach 106mnsubscribers by FY20 and 262mnby FY25, accounting for an estimated $30bn of revenues by FY25."
6005,468,28,"Media services, including original video, to be the next big driver for Apple News reports see link indicate that Apple is looking to invest around $1bninto original video programming initially to drive exclusive content and we expect investments to steadily ramp further over time. However, investments willremain lower than Netflixs $8bnand Amazons $5bnlevels through our forecast window FY21E,primarily as Apple is looking to add exclusive content to the media platform rather than position itself as an alternative to cable,Netflix or Amazon Prime. Additionally, we expect Apple to add print media subscriptions, building on the recent acquisition of Texture to further enhance the services offering. We believe Appleis likely to look to consolidate the media services by tying together existing Music services and original video and print media. We expect the Apple Media subscription to be priced at a premium to the existing Music subscription we assume pricing of $14.99 for individual subscriptions vs. $9.99 for Music and $19.99 for family subscriptions vs. $14.99 for Music. We also expect 35% of Apple Music subscribers to upgrade to the all-encompassing Media service by FY25E, and account for an incremental $3bnof revenue in FY25E."
6006,468,29,"Apple Pay leveraged to growth in mobile payments globally We see Apple Pay as a key component in the Services portfolio which is positioned for significant growth in the coming years with the increasing adoption of mobile payments globally. eMarketer forecasts global mobile payment users amounted to 721mnin 2017and are expected to expand at a13% CAGR to greater than 1bn globally in 2020. In consumer surveys, Apple Pay has had stand-out feedback with materially better adoption withininstalled base of devices relative to other competing platforms on Android devices, including those of primary premium smartphone competitor, Samsung. We expect Apple Pay revenues to rise at a 38% CAGR through FY25 to $6bn."
6007,468,30,"Investors have been concerned relative to modest volume growth in iPhone in the backdrop of plateauing smartphone volumes iPhone volumes rose quickly from 11mnunits in the first year after the first iPhone launch FY08 to peak at 231mnunits in FY15, before moderating to FY17 volumes of 217mn. The combination of Apples current three-fourths market share in the premium smartphone market and expectations for flat volumes for the handset and smartphone market have raised concerns relative to maturity of the smartphone market and Apples position in it, leading to limited opportunities for volume growth. We acknowledge the modest volume opportunity for iPhones, particularly when every generationof smartphones is accompanied by price increases, and forecast 1% volume CAGR through FY21E."
6008,468,31,"However, we believe investors are missing the forest for the trees: Installed base demonstrating robust growth feeding into strong Services growth While investors have been focused on iPhone volumes sold annually in the primary market, the driver fueling the transformation to Services has been the expansion in the installed base which has demonstrated double-digit growth to date. Going forward, growth in the installed base is likely to moderate to a high-single-digit pace, but still implying growth of roughly 100mnunits in the installed base of devices every year relative to flat volumes in the primary market. The high-single-digit expansion in the installed base is led by new consumers switching to the iOS platform, new subscribers, and a high portion of replacement units makingtheir way to the secondary market where we estimate iPhones have a 50% market share relative to 15%market share of the new smartphone market."
6009,468,32,"Apple has continued to drive higher prices to grow revenues despite benign growth in iPhone volumes see acceleration in pricing over the forecast window Blended ASPs for iPhones have increased at a 3% CAGR since 2007 with an even higher increase in retail prices in certain geographies where carrier subsidies rolled off after 2010. Despite the increase in prices, iPhone volumes have not shown any significant signs of decline and investors have been pleasantly surprised by the limited price elasticity exhibited by consumers. Banking on the limited price elasticity demonstrated by consumers, Apple pivotedto a more aggressive pricing strategy with the launch of the iPhone Xat a base price of $999 in 2017,which has put the firm on track for a high-teen percentage increase in pricing for FY18E.The latest generation of iPhones released on September 12 this year now has the top-end product with a base price $1,099 and the low-end product with a base price of $749, setting up the firm for another year of strong price increase, by our estimates."
6010,468,33,"Better track record of driving the premium pricing strategy relative to peers Our analysis shows Apple has a better track record relative to competition with driving consumer adoption of the top-end phone in its portfolio. For example,iPhone X has accounted for one-third of total iPhone shipments to date and Applestop-end iPhones accounted for 14%-38% of total shipments over the last sixquarters, which compared to a range of 3%-24% for Samsung. Similarly, Apple has a solid track record with larger screen size phones marketed popularly as Plus Size models with shipments of these premium models accounting for an increasing portion of total shipments, roughly in line with Samsungs track record with a much broader set of smartphone models offered in larger screen sizes."
6011,468,34,"Pricing strategy is sustainable as consumers are willing to pay more for smartphones,which are dis-intermediating other IT hardware spend We believe the pricing strategy is sustainable and expect limited price elasticity from consumers led by: 1 stickiness of the iOS platform with the combination of the iPhone and accessories,including watches 2 smartphone capabilities increasing and substituting demand for laptops and tablets, pushing out the replacement cycle led consumer spending on these devices 3 consumers spending an increasing amount of time on a smartphone and 4 consumers increasingly using financing to convert the high retail prices into affordable monthly payments."
6012,468,35,"Pricing strategy to drive change incomposition of iPhone revenue growth, with surprises led by pricing strength We forecast solid growth in iPhone revenue from iPhone sales, despite heightened investor concerns around both volumes and pricing. We expect growth in revenues from iPhone sales to moderate from 12% CAGR over the last fiveyears to a 9% CAGR for FY17-FY21E, but still surprise on the upside relative to investor expectationsled by a greater contribution from price increases."
6013,468,36,"Target of neutral net cash position long-term provides optionality to investors Apple ended F3Q18 with $244bnof cash on the balance sheet and with debt of $115bn, leading to a net cash position of $129bn. Additionally, the firm has generated on average free cash flow of $54bnover the last fiveyears. Apple has not put a timeline to its net cash neutral target, but the availability ofupto $291bnor 30% of the market cap to deploy over FY19E-21E through a combination of dividends, share repurchases, and MA provides enormous option value to investors in terms of upside to earnings."
6014,468,37,"Embed increasedshare repurchases and dividend in our base case forecasts, partly drivingour above consensus forecast for FY20 and FY21 Apple has returned roughly $300bnof cash to shareholders since 2012 through the end of F3Q18,which is roughly 30% of its current market capital, and we expect there is another roughly $300bnto deploy over the next threeyears. While we dont expect Apple to reach its net cash neutral position by end of FY21E, we expect share buybacks to accelerate to a $75bnannual pace similar to 2018E rather than the slower pace of around $30-$35bnduring FY15-17in part driving our above consensus forecast for FY20E and FY21E. Additionally, we are modeling a steady increase in dividends from $2.40share in FY17 to $3.42share in FY21E, amounting to $42bnof dividends over the next three years."
6015,468,38,"Acceleration in share repurchases to drive 6% accretion to our already above consensus FY20 and FY21 earnings estimates Despite our above consensus modeled pace of buybacks in FY20 and FY21, we still expect Apple to have a net cash position of $60bnby end of FY21E and generating over $64bnof free cash annually. We see upside to our already above consensus forecasts if management decides to aggressively pursue their target foraneutral cash position. We estimate a pace of buybacks close to $100bnannually would drive the company to a cashneutral position by end of FY21E, and imply upside of $2.25 to our already above consensus FY21E EPS forecast."
6016,468,39,Balance between share purchase acceleration and MA is likely as Apple invests to build the Services platform and maintain leadership in technology We believe it is more realistic to assume a balance between an acceleration of share repurchases beyond what is already in our base case estimates and spend on acquisitions as the drivers of earnings upside relative to our estimates.
6017,468,40,"Apple has historically only engaged in bolt-on acquisitionsexpect focus to be on subscription-based service opportunities in the coming years Apple has a history of making multiple bolt-on acquisitions everyyear, whichhas largelybeen focused on bringing any hardware technologythatthe company expects to be crucial in driving competitive differentiationin-house and better managingits development towards commercialization. As shown in Table 1, a lot of applications in use on iPhones today can be associated with technology acquisitions in the past, for example,facial recognition using 3D sensing and speech recognition for Siri. However, as we look at the transformation of the business to Services at a rapid pace, we expect a greater bias towards acquiring subscription-based software businesses that can be integrated into the Services segment, and we believe the recent acquisitions of Shazam and Texture are typical examples of what investors should expect going forward."
6018,468,41,"Relative to transformational MA driving access to new end-markets, we expect criteria to include large installed base and services opportunity We believe with increasing focus on Services revenues, particularly in the form of subscriptions, Apples interest in entering new end-markets is likely to be evaluated based on the opportunity for Apple to offer services leveraging the iOS platform on a large installed base."
6019,468,42,"Video gaming companies: The video gaming industry generates about $125bnin revenues, including roughly one-third on smartphones, making it an attractive industry for smartphone manufacturers in terms of vertical integration, particularly given recent investments in augmented reality. Apples focus on services will be highly complemented by video games, which are taking time and monetization share from other forms of entertainment. JPM Media analyst, Alexia Quadrani , believes the increasing global reach, improving technology, shift to higher-margin digital revenues, and increasingly social environments are fueling greater player engagement and spending. Software game sales are becoming increasingly digital in the US 31% of total sales in 2010 to 74% in 2016 which is likely to coincide with the increasing computing capabilities and larger screen sizes on smartphones to drive consumer gaming habits increasingly to mobile devices. We see opportunity for smartphone-basedgaming to increase from current levels of one-third of gaming revenues to around 40% of the industry by 2020, led by a double-digit annual growth rate."
6020,468,43,"Automotive services: Numerous press reports have in the past indicated Apples interest in the automotive end-market, including developing an autonomous vehicle. We think Apples interest in the automotive end-market is reasonable given the large installed base roughly 1.4bnvehicles globally and the ability to deliver services to drivers and passengers. We see the automotive OEM business"
6021,468,44,"Though,we would not rule out acquisitions of:"
6022,468,45,"Apple has already developed the CarPlay software to get access to the automotive end-market, but we believe owning the complete infotainment product would allow Apple to deliver the same high-quality experience that it hasbeen able to offer consumers on other devices like the iPhone."
6023,468,46,"Smart Speakers: We acknowledge that Apple already has a HomePod product, which was first released in early 2018. Based on our discussion with the company, we believe Apple wants to position the HomePod as a high-quality speaker with some intelligence features, relative to: 1 Google Assistant, which is geared to intelligence leveraging the companys leadership in search functions and 2 Amazon Alexa, which is geared towards promoting Amazons portfolio of features, including driving purchases in the Amazon marketplace. We believe this leaves room for Apple to position another product with greater intelligence features and with a different form factor, potentially leveraging an acquisition similar to its purchase of Beats to enter the headphone category."
6024,468,47,"Apple has already disrupted the fitness-wearables market Apples launch of AppleWatch was relatively late when compared to early movers in the fitness-driven wearables market,including Garmin, Fitbit and Nike. However, despite being late to the market, Apple Watch managed to disrupt some of the existing players, particularly single-activity tracking devices, as wellasexpand the addressable market for the wearables market. While most early entrants into the wearables market were seen as functional products targeting the fitness enthusiast, we believe Apple managed to expand the addressable market with a utility product, which went beyond the niche segment of fitness enthusiasts."
6025,468,48,"Now set to addresshealth-wearablesmarket, further expanding the target demographic to drive higherpenetration We believe with the launch of features like heart rate monitoring and electro cardio grams ECGs inthe latest generation of Apple Watches Series 4, Apple is now making a bigger push into health-based wearables, expanding the target market beyond the typical age demographic interested in fitness wearables. For example,the target age demographicin the USnow includes an additional 136mnpeople in the age group of 50 years and above, relative to the existing target market of 182mnin the age group below 50 years for fitness-based wearables."
6026,468,49,"Move into preventive healthcare to provideawider TAM than diagnostics We believe the preventive healthcare market is an even more attractive market than diagnostics. With its entry into health-based wearables Apple is able to target a much wider population relative to the targeted individuals in the diagnostic phase following symptom identification. For example, relative to the occurrence of AFib Atrial Fibrilation,which the Series 4 watch can help identify, the number of people impacted in the US rangesfrom 2.7mnto 6.1mnand the company will be involved in the diagnostic phase with products from specialized companies like iRythm covered by JPM Medical Supplies Devices analyst Robbie Marcus .This compares to 182mnTAM for those aged50 or more who are likely to adopt the Apple Watch for preventive measures and symptom identification for AFib."
6027,468,50,"Revenue acceleration likely to be a catalyst to increase investor focuson Services transformation We believe investors have largely ignored the transformation of the business towards Services. However, looking forward, we see a catalyst in the acceleration in revenue growth to a forecasted 10% CAGR from the 8% CAGR in the last five years, with further likely upside to our estimates from: 1 stronger increase in Services revenue per device 2 stronger than expected pricing on iPhones 3 and stronger than currently modeled growth in the Apple Watch after a major refresh with the Series 4. Boosted by an aggressive capital deployment program with repurchases totaling a forecasted $294bnfor FY18E-FY21E, we expect a 17% earnings CAGR leading to our above consensus EPS forecasts."
6028,468,51,"Shift in composition of growth to a greater balance of Services, more than offsetting moderation in iPhone revenue growth As shown in Figure 12and Figure 13, historically revenue growth for the company has been primarily driven by iPhone sales,but we expect more balanced growth led by iPhone sales, Services, and Other Products in the medium-term."
6029,468,52,"Apple shares have traded at a discount to the SP 500 multiple, despite stronger revenue and earnings growth We find it largely unwarranted that AAPL shares have traded at a modest discount to the average SP 500 multiple over the last few years despite a stronger historical track record in revenue and earnings growth, as well as stronger outlook. As shown in Figure 14, Apple shares still trade only roughly in line to at a modest discount to the SP 500, despite a stronger revenue outlook and earnings growth outlook relative to the average company in the SP 500."
6030,468,53,"Premium to recent year average multiple warranted on return to innovation We believe the recent year discount on Apples trading multiple relative to the SP 500 multiple has largely been driven by the perception that opportunities for innovative product launches into new markets have moderated since the large success of the iPhone. However, we believe Apple has now returned to demonstrating its innovation prowess, although now disrupting end-markets like wearables, health, and gaming, rather than disrupting existing hardware like it did with iPhones."
6031,468,54,"We believe a modest re-rating is warranted based on our SOTP analysis Wearrive at a blended multiple of 17.8x for the combination of Apples products and services we anticipate in our forecast and expect a modest re-rating from current NTM trading multiple of 16.6x, led by a 14.0x multiple on the iPhone in line with Nokias multiple during its leadership in feature phonesand 26.0x on Services in line with hardline and luxury goods retailers with similar loyalty-driven recurring purchases from customers."
6032,468,55,Should AAPL shares be valued in line with consumer staples?
6033,468,56,"It appears there has been an increasing narrative that AAPL should be evaluated in comparison to earnings multiples for consumer staples companies, such as Household and PersonalCare products with high degree of repeat purchases by consumers. We acknowledge the repeat purchase cycle for consumers in relation to the iPhone and Services group, which together currently account for 77% of total company revenues however,the iPad, Mac, and Other products have more unpredictable replacement cycles. In addition, while the average 21x PE multiple for Household and Personal Care HPC companies can be thought of as the high-end of potential re-ratingfor AAPL shares, we think investors should consider a discount to the average HPC multiple to account for the ability of consumers to push out smartphone purchases during a downturn in addition to trading down to less expensive variants, with only the latter likely for HPC products."
6034,468,57,"Comparison with other technology leaders is normaland we find Apple well positioned relative to balance of valuation multiple against earnings outlook Interestingly, with annual revenues of $230bn, Apple is ahead of other technology leaders, including Amazon, Alphabet, Facebook, and Netflix all covered by JPM Internet analyst Doug Anmuth . In greater contrast, Apples $61bnin operating profit compares to $26bnfor Alphabet, $20bnfor Facebook, $4bnforAmazon, and $0.8bn for Netflix, showcasing a much stronger track record of generating profits than other technology leaders. While revenue and earnings growth rates for AAPL are expected to be a little less than half of the group average of Alphabet, Amazon, Facebook, and Netflix, so is the earnings multiple of 16.0x relative to the group average of 42.2x. As a result,we find AAPL shares screening well forboth growth and value investors relative to techleaders when looking at earnings multiple for every point of earnings growth, with PEG ratio ex-cash of 0.8x relative to the group average of 1.0x."
6035,468,58,"Currently proposed tariffsonly impact accessories Apple recently sent a letter to the US Trade Representative, Robert Lighthizer, detailing a list of products that will be impacted from the currently proposed $200bn of tariffs on imports from China. The list initially included products from the Other Products segment, which has total revenues of an estimated $26bn in FY19E, but was later updated to exclude Apple Watch which we estimate accountsfor almost half of the segment revenues. We estimate Other Products excluding Apple Watch has gross margins closer to 20%. iPhones are also currently outside the purview of the proposed tariffs."
6036,468,59,"We see limited impact as Apple is likely to take pricing to offset the pressures We believe it is relatively easier for Apple to raise prices on accessories relative to taking price increases on the iPhone. We expect relatively minimal price elasticity for accessory products and expect Apple to likely raise prices to cover entirely the tariffs. As shown in Table 7below, we expect the 25% tariff to translate into a price increase of 15% if Apple decides to pass the entire impact of the tariff to consumers."
6037,468,60,"Headwind of up to 50bps in the worst case if Apple decides not to raise prices As shown in Scenario 3in the table above, we estimate a headwind of up to 50 bps to total company margins if Apple decides to take a conservative approach to prices and absorb the impact, which in our view is unlikely given the even lower degree of price elasticity on accessories."
6038,468,61,"No tariff impact on iPhone currently however, we would not expect a change in sourcing strategy even with a 25% tariff Although the iPhone is not the purview of currently proposed tariffs, the greater risk to Apple would be from any potential developments relative to tariffs on the iPhone, which accounts for 60% of total company revenues. However, our analysis shows that even if a 25% tariff were to be imposed, it would still make economic sense for Apple to continue with the current manufacturing footprint relative to moving the assembly to the United States. Over the long-run, we would expect Apple to move assembly operations for the iPhone done by Pegatron, Honhai, and Wistron to other countries with relatively cheaper labor cost relative to the United States and not"
6039,468,62,"See labor cost still driving enough arbitrage to keep existing manufacturing footprint rather than move to the United States As shown inTable 8, we estimate moving the assembly operations to the United States for the iPhone X would increase the cost to Apple from $522 to $643 assuming only 50% of components are manufactured in China, relative to an estimated cost of $653 if Apple decided to pay a 25% tariff on the assembled product. In our view, the lack of any major advantage of moving assembly operations back to the United States limits the likelihood of any investment in the US as a consequence of the tariffs."
6040,468,63,"Price increase of 13% required to absorb impact of tariff As shown in Table 9, we estimate a price increase of around 13% would be required to absorb the impact of a 25% tariff, keeping margin dollars for all players in the supply chain constant."
6041,468,64,"Worst case headwinds of 300 bps to gross margins if Apple does not price for the tariff However, if Apple were to be willing to absorb all the tariff and not raise prices, we estimate a 300 bps headwind to margins."
6042,468,65,"Prices increases to cover part of the tariff impact more likely 10% retail price increase would mitigate gross margin headwind to less than 100 bps As shown in Table 11, if Apple were to take a 10% price increase on the iPhone citing punitive tariffs, it would reduce the estimated headwind from any potential tariffs to less than 100 bps on gross margin."
6043,468,66,"Innovation has enabled the company to drive a 8% revenue CAGR over the last five years Apples innovation in new and existing product categories, including smartphones, tablets, and watches has helped drive robust revenue growth for the firm over the last few years. Looking over the last five years, the firm has posted revenue CAGR of 8% between FY12 and FY17, although as shown in Figure 15, FY17 revenues are largely in line with FY15 revenues following a levelling out of the growth driver in the form of iPhone revenues. As shown in Figure 16, relative to the revenue growth of $73bnfrom FY12to FY17 for the firm, three-fourths has been driven by iPhones, and 20% by Services, with Mac and Other Products contributing a minority, while iPad has been a modest headwind."
6044,468,67,"We expect low-double-digit revenue growth, led by iPhone, Services, and Apple Watch As shown in Table 13, we believe the medium-term revenue growth for the company will track in the low-double-digit range, led by a combination of: 1 high-single-digit revenue growth in iPhones, largely driven through priceASP increases 2 double- digit revenue growth in Services, led by growth in both the installed base as well as revenueper unit from the installed base and 3 double-digit revenue growth in Other Products, the combination of which is likely to be partly offset bydeclinesin iPads andMac devices."
6045,468,68,"Despite similar growth expectations relative to history, the composition of growth is likely to be materially different Relative to the $73bnof revenue growth over the five-year period starting in FY12, we expect even greater revenue growth of $111bnover our four-year forecast window FY17-FY21E. However, as shown in the comparison in Figure 17and Figure 18, while iPhone sales accounted for three-fourths of the revenue growth in the last fiveyears, we expect the growth in the next fouryears to be more balanced, although iPhones will continueto be the leading contributor to growth. As shown in Figure 18, we expect growth drivers to shift to Services and Other Products accessories in addition to the growth in iPhone revenues."
6046,468,69,"Despite continued volume concerns from investors, we expect revenue growth, although now led by pricing As shown in Figure 19, we forecast growth in revenue from iPhone sales, despite heightened investor concerns around both volumes and pricing. However, we do expect growth in revenues from iPhone sales to moderate from 12% CAGR over the last fiveyears to 9% CAGR for FY17-FY21E."
6047,468,70,"However, mix of volume and ASP drivers for revenue growth to change relative to historical trends While we do expect continued revenue growth from iPhone sales, we expect the composition of growth drivers to be more heavily weighted to pricing relative to volumes. As shown in the comparison in Figure 20and Figure 21, we expect the drivers of revenue growth to shift from being weighted to volume growth in the last five years to being weighted to ASP growth over the next fouryears."
6048,468,71,"Services to be second largest revenue growth driver and to more than double FY16 revenues by FY20E We expect Services to turn out to be the second largest revenue growth driver for the company over the medium-term and expect it to comfortably meet the firms target of $48bnin revenues by FY20. As shown in Figure 22, we expect Services revenue growth to accelerate and rise at a 23% CAGR over our forecast window. Helped by the strong pace of growth, by our estimates, Services revenue should reach $56bnby FY20E, relative to Apples target of $48bn. The forecast growth in Services revenue is led by both growth in the installed base and rise in Services revenue per device in the installed base."
6049,468,72,"Installed base growth to outpace growth in new devices Services revenue allows Apple to leverage its installed base of devices with consumers relative to annual revenues from device sales being levered to new units sales and being more cyclical around success of certain product launches in certain years. As shown in Figure 23, we expect the installed base of all devices, estimated to be around 1.4bndevices at FY18E end, will continue to increase ata high-single- digit pace to 1.9bndevices by FY21E. However, we believe primary portion of Services revenues will be levered to the installed base of iPhone devices with customers being able to use the same subscription across all their devices. As shown in Figure 23, we estimate the installed base of iPhones including those with second owners will be roughly 1bndevices at the end of FY18E, progressing to 1.45bnat FY21E end, implying high-single-digitincreases. Net, we expect the high-single- digit pace of increase in the installed base to outpace the modest declinefor legacy devices, including iPhones, iPads, and Mac devices, positioning the Services group for stronger growth relative to new devices."
6050,468,73,"Also expect growth in revenue per installed base device, led by growth in Music, App Store, Apple Care, and Apple Pay penetration As shown inFigure 25, we expect a continuedstrong pace of increase in Services revenue per device in the installed base, from a variety of growth drivers including increasing penetration of Apple Music within the installed base, increase in adoption as well as revenue per transaction for Apple Pay, continued growth in App Store revenues from increasing pace of application activity by third-party developers, and penetration of Apple Care as the preferred support and repair coverage for new device sales relative to third-party coverage."
6051,468,74,"Other Products, including Apple Watch, to be third primary driver of medium- term revenue growth The Other Products segment comprises various products, primary among which is the Apple Watch. Additionally, Apple has seen good success with launch of accessory products like Airpods and with the acquisition of Beats. While we expect growth in revenues ofthe Other Products segment to be driven by multiple products, we believe the primary driver will be sales of Apple Watch, which is already the leading smart watch globally."
6052,468,75,"Gross margins have moderated on a combination of headwinds including memory costs and currency While Applesgross margins have improved substantially from the 29.0% in FY06, prior to the launch of the iPhone, they have been range bound around the 38%-40% level for the last three years. Additionally, as shown in Figure 27, gross margins in recent years are lower than the peak gross margin of 43.9% in FY12, led we believe by a combination of the following: 1 increase in memory costs 2 currency headwinds 3 increasing exposure to accessory sales at lower margins, partly offset by growth in Services revenue."
6053,468,76,"Expect gross margins to be range boundon increasing mix of Services revenue offset by increasing mix of lower margin accessory sales Table 14below shows our forecast for gross margin by product. We estimate iPhone sales, and Services to be accretive to corporate gross margins, while sales of iPad, Mac devices, and Other Products excluding the Apple Watch are dilutive to gross margins. Apple does not disclose margin by product."
6054,468,77,"Figure 28shows our gross margin forecasts, which we expect to remain largely range bound between 38% and 39%, on the confluence of tailwinds from increasing mix of Services revenues, which we estimateto be at higher-than-corporate margins and increasing mix for revenues from sales of accessory products excluding Apple Watch, which we estimate to be at lower margins relative to corporate margins."
6055,468,78,"Despite stable gross margins, we forecast moderation in operating margins with the company likely to prioritize growth in Services opportunities We expect to see a higher pace of investments from Apple towards driving the existing services revenue opportunities and create new opportunities. While there is ample headroom for growth in current Services opportunities, including growth in penetration of Apple Music and Apple Pay, we believe more investments are likely to drive original content in both Apple Musicand video content."
6056,468,79,"Earnings growth to accelerate led by capital deployment While we expect modest acceleration in revenue growth relative to the pace over the last fiveyears, we expect a stronger earnings acceleration led by an accelerated pace of share repurchases. As shown in Figure 30, we expect the pace of earnings growth to accelerate to a 17% CAGR for FY17-FY21E, relative to 8% earnings CAGR between FY12 and FY17."
6057,468,80,"Largest capital return program for any US company, pace of repurchases accelerated since tax reform After already returning $275bnof capital to shareholders through repurchases and dividends since 2012, Apple announced a $100bnbuyback program in May of 2018. In addition to the$100bnbuyback program, Apple has an existing dividend through which Apple has already promised to return around $14bnannually, the combination of which makes it the largest capital return program for any US company. The pace of repurchases accelerated earlier this year on the back favorable tax reform. We expect Apple to buyback$74bnof stock in FY18E and $70bnof FY19E, to exhaust the $100bnprogram announced in mid-FY18, before accelerating to a pace of around $75bnannually. This compares to repurchases of $165bnbetween FY13 and FY17 fiveyears, at an average pace of $33bnyear."
6058,468,81,"Large repurchases are enabled by attractive free cash flow Apples large repurchase activity is facilitated by attractive free cash flow generation, which we currentlyforecast to be in the range of $65bn-$69bnannually in the coming years. As shown in Figure 32, despite a very large repurchase and dividend program, Apple has continued to add cash to the balance sheet helped by free cash flow exceeding the capital returns in most years."
6059,468,82,"We rate Apple shares Overweight with a December 2019 price target of $272, implying 23% upside from current levels."
6060,468,83,"Overweight We rate shares of Apple Overweight given our favorable outlook for continued growth in iPhone revenues led by price, combined with significant growth opportunities for its Services segment which is levered to growth in the installed base as well opportunity to increase Services revenue per device in the installed base."
6061,468,84,"We value Apple shares using a blended multiple, which values Apples various product segments at different multiples We believe a blended multiple is most appropriate for Apple, which as discussed is expected to see a shift in the composition of growth drivers from hardware sales to services sales. While growth in Services revenues isexpected to be one of the primary drivers of the revenue growth for the company through FY21, it still only accountsfor 20% of total company revenues by the end of our forecast window FY21. We expect the growth in Services revenue to drive accelerationin revenue growth for the total company beyond our forecast window, as it becomes a greater portion of total company revenues."
6062,468,85,Our SOTP approach implies a blended 17.5x PE multiple is appropriate We estimate earnings per share contributions from the various product segments and arrive at our price target by assigning PE multiple appropriate for the earnings growth outlook for each segment.
6063,468,86,"iPhone: We use a 14.0x PE multiple for our iPhone earnings estimate in calendar 2020, in line with the multiple that industry leader in the early 2000s, Nokia, traded at from 2005to 2010 when the firm had a leadership position in feature phones."
6064,468,87,"iPad devices : PE multiple of 11.0x, in line with the multiple we assign for Mac devices as growth opportunities are limited for both notebooks as well as tablets. Additionally, we believe increasing consumption of content on smartphones is likely to substitute purchases of laptopsnotebooks as well as tablets in the future."
6065,468,88,"Services: PE multiple of 26.0x on the Services segment, in line with the average trading multiple for a peer group of luxuryretail companies Costco, Este Lauder and Home Depot, which are leaders in their respective markets and derive a stickiness for product sales through customer loyalty either in the form of membership programs or brand value. We believe the subscription nature of ApplesServices segment, with high visibility of revenue and earnings, warrants it beingvalued in line with the leading luxuryretail companies. As shown in Table 15, the average NTM for the peer group is 26.6x."
6066,468,89,"Apple Watch: PE multiple of 25.0x, roughly in line with the 26.0x target multiple we use for the Services group, on account of the materially higher room for growth relative to Apples legacy hardware products like iPhone, iPad, and Mac."
6067,468,90,"Other Products: PE multipleof 16.0x, at a modest premium to the legacy hardware devices like iPhone, iPad, and Mac on account of higher growth opportunities. However, the 16.0x multiple is at a discount to the 25.0x multiple we use to value Apple Watch on account of lower margins for accessory sales in a more competitive market."
6068,468,91,Our 17.5x blended PE multiple leads us to December 2019 price targetof $272 We arrive at our December 2019 price target of $272using a blended 17.5x PE multiple and our 2020E calendar EPS of $16.19.
6069,468,92,"Apple shares have traded at a discount to an appropriate earnings multiple As shown in Figure 39, shares of Apple havetraded at an average of 15.3x PE since beginning of 2008and an average multiple of 13.5x since 2014, both of which are at a discount to what we believe is an appropriate multiple for Apple shares."
6070,468,93,"Apple shares have traded at a discount to the SP 500 multiple, despite stronger revenue and earnings growth As shown in Figure 40, Apple shares still trade at a modestdiscountto the SP 500, despite a stronger revenue outlook and earnings growth outlook relative to the average company in the SP 500."
6071,468,94,"PE and FCF yield continue to be attractive despite a trillion dollar valuation Despite a trillion dollars or more in market value, AAPL shares trade at inexpensive levels in term of both PE multiple and FCF yield. As shown Figure 41, AAPLs FCF yield is an attractive 6%, while as shown in Figure 42the NTM PE multiple of 16.6x is roughly in line with the average of communication peers and the SP 500 despite a demonstrated track record in innovation and leadership with a strategy to maximize profits rather than chase volume share."
6072,468,95,"Apple designs and sells mobile communication devices, media devices, personal computers, smart watches, and home audio systemsmediums through which content isdelivered to consumers. While the content is not necessarily owned by Apple, the devices that Apple sells are the mediums through which consumers are increasingly consumingcontent. Appleshardware devices include the iPhone, iPad, Mac, AppleTV, and Apple Watch."
6073,468,96,"In addition to hardware devices, Apple controls the portal through which digital contentis delivered to the devices, including through iTunes Store and Apple Music music, App Store applications, iBooks Store books,andTV App Store TV content. The above portals are collectively referred to as Services."
6074,468,97,"In the fiscal year ended 2017September year-end, Apple hadrevenues of $229bn, with a majority accounted for by iPhones62%. Revenue contributions from iPhones were followed by Services 13% of total, Mac 11%, iPad 8%, and Other products 6%, which comprisesdevices such as the Apple Watch as well as accessories."
6075,468,98,"Apple shares are listed on the NASDAQ ticker: AAPL and are marked as the first public company to reach a trillion dollars in market value on August 2, 2018."
6076,468,99,"Tim Cook has been serving as the CEO since August 2011, prior to which he was the Chief Operating Officer and was responsible for worldwide sales and operations. Prior to joining Apple, he was Vice President of Corporate Materials for Compaq and responsible for procurement, and also spent 12 years with IBM in various roles prior to Compaq."
6077,468,100,"Senior Vice President of Retail: Angela Ahrendts is responsible for strategy, real estate and development and operations of Apples physical stores, which remain key to Apples differentiated customer experience. Prior to joining Apple in 2014, Angela Ahrendtswas CEO of luxury goods retailerBurberry."
6078,468,101,"Senior Vice President Internet Software and Services: Eddy Cue is responsible for Apples content services, including iTunes Store, Apple Music, Apple Pay, Maps, Search Ads, iCloud services, and productivity and creativity apps. Eddy is also responsible for Apples worldwide video programming. Eddy joined Apple in 1989 and has since been instrumental in creating much of the current Services portfolio."
6079,468,102,Senior Vice President Software Engineering: Craig Federighi is responsible for the development of iOS and macOS. His prior experiences include NeXT acquired by Apple in 1996 and Ariba software company acquired by SAP.
6080,468,103,"Chief Design Officer: Jonathan Ive is responsible for all design at Apple including look and feel of hardware, user interface, packaging, etc.,and has been leading the team since 1996."
6081,468,104,"Luca Maestri joined Apple in 2013. Prior to joining Apple, Luca Maestri was CFO at Xerox and prior to that at Nokia Siemens Networks. He began his career with General Motors."
6082,468,105,"Senior Vice President Hardware Engineering: Dan Riccio leads the Mac, iPhone, iPad, and iPod engineering teams."
6083,468,106,"Philip W. Schiller is a frequent presenter at Apples annual product event and is a member of the Executive Team. Chiller joined Apple in 1997 and helped in creation of Mac, digital music, and iPhone and App Store."
6084,468,107,"Senior Vice President: Johny Srouji has been responsible in driving innovation in silicon and custom hardware technologies, including the application processors, display silicon and batteries. Johny joined Apple in 2008 to lead development of A4, the first Apple-designed system on chip."
6085,468,108,"Jeff Williams oversees supply chain, service and support, and development of Apple Watch. Jeff Williams has been COO since 2010."
6086,468,109,Senior Vice President and General Counsel: Katherine Adams joined in 2017 to oversee all legal matters.
6087,468,110,"Mature penetration of mobile handsets globally makes it one of the most attractive markets The increasing adoption of mobile handsets globally, including both smartphones and feature phones, has driven the market to 2.0bnunits in 2017 from 1.1bnin 2007, representing a 6% CAGR over the last ten-year period. The significant increase means that roughly every fourth individual globally buys a mobile handset each year. Additionally, the installed base globally for mobile handsets is estimated to be roughly 7.4bn, which means that almost every individual globally owns one. The high penetrationandvolume opportunity makesit a very attractive market for new entrants."
6088,468,111,"Thedisruption ofthe feature phone market by smartphones While the global handset industry demonstrated a strong CAGR of 6% over the last tenyears, within the industry we saw significant disruption led by smartphones marginalizing feature phones to the low-end of the market. As shown in Figure 45, roughly 512mnfeature phones are sold annually relative to 1.5bnsmartphones currently, making smartphones the primary segment within the mobile handset industry. This is relative to 90% of the total mobile handset industry comprising feature phones in 2007."
6089,468,112,"Samsung and Apple disrupted the mobile handset industry as new entrants Apple was one of the disrupters in the mobile handset industry with the launch of its smartphone, the iPhone, in 2007. Despite being a premium offering priced at $499, relative to the majority of feature phones available in the market at that time, the iPhone managed to gain share quickly. Other manufacturers, including Samsung, had already been dabbling with the idea of smartphones by then, starting with the Samsung SPH-I300 launched in 2001. However, the market for smartphones received a boost from the launch of the iPhone by Apple and subsequent launches by Samsung, including the Samsung Galaxy in 2009. Nokia, the large incumbent player globally in feature phones, did not focus on keeping up with the changing consumer preference towards smartphones and quickly lost out on its strong position in the market. As shown in Figure 46, Nokia had 49% global market share in 2007 with Apple and Samsung accounting foronly 3% and 2% market share, respectively. Since then, the market has changed dramatically with only two of the top eight companies from 2007 still remaining today. As shown in Figure 47, Samsung and Apple were ranked 1 and 2 in 2017, respectively. At the same time, it is worth noting that the Smartphone market has become more fragmented, with the top three companies now accounting foronly 48% of total shipments, which compares to 65% in 2007."
6090,468,113,"Emerging countriesaccount for the majority of smartphone shipments With smartphones largely accessible to most demographics today,given the wide range of price points at which they are offered to consumers, population has a strong correlation to thesize of the smartphonemarketin any particular country. As shown in Figure 48, China accountedfor 30% of the smartphone shipments in 2017, followed by the US 12%and India 8%. Additionally, as shown in Figure 49, Emerging countries accountedfor 76% of smartphoneshipments in 2017, while Developed countries accountedfor 24%."
6091,468,114,"Emerging countries account for an even greater portion of the installed base As illustrated in Figure 50, despite consumers in Developed countries being early adopters of smartphones, Developed countries only accounted for 20% of the smartphone installed base in 2017, which compares to 24% of smartphone revenues. We believe the higher churn rate and the shorter life-cycle of smartphones for consumers in Developed countries compared to consumers in Emerging countries drives the higher revenue contribution relative to the size of the installed base."
6092,468,115,"Revenue opportunityby countryis more balanced given averagesellingprices DespiteEmerging countries representing the larger volume opportunity , the revenue opportunity is more balanced given the variancein averageselling price for smartphones in different countries."
6093,468,116,"Smartphones to continue displacingfeature phones and increase penetration Whilethe penetration of mobile handsets is high on aglobal level,we continue to see further growth opportunities for smartphones driven by thedisplacementof feature phones, particularly in underserved Emergingcountries dominated by feature phones. As shown in Figure 53, smartphone penetration standsat 60 per 100 people, which compares to almost complete mobile handset penetrationglobally."
6094,468,117,"Smartphone penetration lagging in key countries As shown inFigure 54, out of the top tencountries by smartphone installed base, the United States and Germany rank the highest in smartphonepenetration with a per capita installed base of 97 per 100 people. Meanwhile, smartphone penetration remains low in certain key countries, including China with 81 per 100 peopleand India with28 per 100 people. However,mobile handset penetration in both China and India are likely higher with a substantial portion of the population still using feature phones, representing a significant growth opportunity for smartphones."
6095,468,118,"Significant growth opportunity from increasing smartphone penetration We expect smartphone penetration to increase relative to feature phones over time. As illustrated in Figure 55, an increase in smartphone penetration to the levels displayed by the United States and Germany would imply a significant volume opportunityof more than 1bnunits for theremaining countries."
6096,468,119,"Developed countriesremain attractive onhigher smartphone churn rates With a high penetration of smartphonesin Developed countries, the growth in the installed base is likely to be closely tied to populationgrowth, in contrast to Emerging countrieswhere the smartphone installed base is likely outstrip population growth. However, as shown in Figure 56, population growth in Developed countries is expectedto be modestly positive, driving our expectations for modest growth for the smartphone market in Developed countries."
6097,468,120,"Growth opportunity in Emerging countriesis greater than in Developed countries, but more likely in the low-tier price segments The growth drivers for the smartphone industry are greater in Emerging countries relative to the Developed countries, and thus we expect stronger growth over the medium-term in the Emerging countries. However, with an increasing portion of the growth coming from Emerging countries, the OEMs with products positioned atthe low-tier and at the low end of the mid-tier smartphone marketare more likely to benefit relative to the OEMs with products focused on the premium smartphone market, which includes Apple."
6098,468,121,"Smartphonesexpected to growlow-single digitsover the medium-term As illustrated in Figure 57, we expect Smartphone unit shipments to grow 1.9%per yearfrom 1,444mnin 2017 to 1,531mnin 2020, led by growth inEmerging countries."
6099,468,122,"Emerging countries driving growth over the medium-term As shown in Figure 58, we forecast roughly 90% of the unit growth for the smartphone industry over the next three years to be attributable to Emerging countries, with Developed countriesaccountingfor the remaining 10%. As illustrated inFigure 59, we forecast the Middle East and Africa to account for 31% of the growth, followed by India accounting for 26%, rest of Asia Pacific largely Emerging Asia accountingfor 18%, and Central Eastern Europe accountingfor 13%. North America and Western Europe are expected to account for only 7% and 4% of the three-year growth, respectively."
6100,468,123,"Appledoesnot participate in the low-tier smartphone market As illustrated in Figure 60, the low-tier smartphone market $150unitor less, which represented560mnunits shipments in 2017 40% of total, is highly fragmented as the top five companies only account for 48% of shipments. Samsung with its broad range of smartphone models maintains a leading position in the low-tier market, followed by newer entrants, such as Xiaomi, Huawei, ZTEandLG."
6101,468,124,"Apple has a small share in the mid-tier smartphone market The mid-tiersmartphonemarket, defined to be in the price range of $151-$600, accounts for roughly 45% of the global market. Apple accounts for 8% of the market with its product offering, including iPhone SE, iPhone 6S, iPhone 6S Plus,iPhone 6, andiPhone 5S."
6102,468,125,"Apple has a large share of the premium smartphone market The premium smartphone market, defined as more than $600, accounts for roughly 15% of the global market. Apple is by far the largest player as it accounts for almost three-fourths of the market, followed by Samsung. Together, Apple and Samsung account for 97% of the premium smartphone market. Apples product offering in this premium price range includes the iPhone XS Max, iPhone XS, iPhone XR, iPhone X, iPhone 8, iPhone 8 Plus, iPhone 7, and iPhone 7 Plus, which compete with Samsungs Galaxy Note 9, Galaxy S9, Galaxy S9 Plus, Galaxy Note 8,Galaxy"
6103,468,126,"Apple has a 15% global marketshare, ledbyits premium product offering Apple is estimated to have a global market share of 15% through a combination of modest share in the mid-tier marketand solid share in the premium market. As shown in Figure 63, Apple has no presence in the low-tier market,which accounts for 40% of total shipments. However, Apple has a modest share in the mid-tier market, which accounts for 45% of total shipments, and has three-fourths of the share in the premium market, which accounts for 15% of total shipments."
6104,468,127,"Apple has a strong market share position in Developed countries As shown in Figure 64, Apples market shareof smartphone shipmentsstood at 36% in Developed countries in 2017, compared to only 10% in Emerging countries. Additionally, Apples market share of smartphone shipments has moderated slightly over the last three years in both Developed and Emerging countries."
6105,468,128,"Driving revenue growththrough average selling price increases While Apples limited market share in Emerging countries is an opportunity, we have not seen any appreciable change in strategy, which would allow it to better leverage the forecasted growth for smartphone shipments in Emerging countries. However, Apple has successfully explored a premium pricing strategy to drive revenue growth through consistent increases in prices. As shown in Figure 65, the average selling price of an iPhone has increased 36% since 2007, or 3% per annum, which has recently supported revenue growth as unit shipments have started to plateau."
6106,468,129,"Consumers experience even greater priceincreases onroll-off of subsidies As illustratedin Figure 66, the price to consumersfor iPhonesin certain countries has increased at an even greater pace relative to the 3% CAGR reported by Apple. Specifically, following the initial launch of the iPhone, telecom service carriers sold iPhoneswith a heavy subsidy to make itmore palatablefor consumersin an effort to grow their respectivesubscriber bases. Carrier subsidies, which were quite prevalent historically in the US, limited the price paid by iPhone consumersfrom 2008 to 2013. Followingthat period,carriers moved away from subsidies and instead began offering consumers monthly installment programs to drive device ownershipand replacement."
6107,468,130,"Apples premium smartphone customers demonstrate low price elasticity As shown in Figure 67and Figure 68, iPhone shipments continued to increase despite the roll-off of carrier subsidies starting in 2013. Whileinvestors are concerned about the price elasticity of consumers given Apples pricing strategy, the increase in iPhone shipments long-term indicates to us that investor concerns appear unfounded and the customer demographic targeted by Apple demonstrates very low price elasticity."
6108,468,131,"Success of pricingstrategy demonstrated withadoption of premium smartphone While there is seasonality relative to demand, Figure 69demonstrates that Applestop-end smartphonein any particular period hasbeen successful in capturing a significant portion of consumersin each quarterfollowing its initial release, which has resulted in the increase in Applesblended average selling price. Despite investor concerns relative to demand for premium smartphones, consumers have not shied away from purchasingApplestop-end smartphone."
6109,468,132,"Demand for the latest generation smartphone remains very high Despite Apple increasing the price for every generation of iPhone, consumers have shown a strong preference for the latest generationof phones, which largely reflects preference for incremental features that Apple introduces with each new model. As illustrated in Figure 70, the latest generation of iPhone, which is usually introduced in September of each year, has become the primary contributor to unit shipments for the next four quarters, despite the availability of the previousgeneration for a reduced price. In our view, this demonstrates the premium pricing Apple is able to drive through consumer preference for features introduced on the latest generation of the iPhone."
6110,468,133,"Success of Plus models also contributing to success in pricing strategy Until 2017, the Plus models were the top-end smartphone in Apples portfolio. As shown in Figure 71, Plus models increased as a mix of iPhone shipments as Apple successfully drove a significant proportion of customers to upgrade to the larger screen size for a premium price. Despite the launch of the iPhone Xas Apples top- end smartphone in 4Q17, it only modestly cannibalized the mix of the Plus models, which are still sold at a premium to the corresponding base model with a 4.7 inch screen. For example, the Plus and the Xmodel, both at a premium to the base iPhone model with a 4.7 inch display, accounted for 48% of the mix in 2Q18 26% iPhone Plus 22% iPhone X, which compares to the Plus model accounting for 38% of mix in 1Q17."
6111,468,134,"Expanding the portfolio with more product offerings in recent generations Starting with the launch of the iPhone in 2007, Apple focused its energy on delivering one quality product every year, following up on the first iPhone launch in 2007 with the launch of iPhone 3G in 2008, iPhone 3GS in 2009, iPhone 4 in 2010, iPhone 4S in 2011, and iPhone 5 in 2012. Starting in 2013, Apple moved to a two- product strategy with the launch of the 5C and 5S, followed by the launch of the 6 and 6 Plus in 2014, and 6S and 6S Plus in 2015. Apple has now moved to a three- product strategy with the launch of the iPhone 7, iPhone 7 Plus, and the iPhone SE in 2016, followed by the launch of the iPhone 8, iPhone 8 Plus, and iPhone X in 2017, and the launch of iPhone XS, iPhone XS Max, and iPhone XR in 2018."
6112,468,135,"Expanding the portfolio, widening the price points By expanding the iPhone model lineup with every generation from one in 2007-12 to three in 2016, Apple is able to offer consumers a wider range of choices in terms of device capabilities, screen dimensions, as well as price points. Maxis $350 starting prices, relative to $100 in 2014 and 2015 when Apple launched two products in each generation."
6113,468,136,"Apple to deliverthe best consumer experience on a small number of models Despite Apple modestly broadening its portfolio over time,we believe itwill continue to focus on delivering a solid consumer experience through a small number of models, rather than pursue a broad portfolio similar to competition. We believe the focus on a smallernumber of models allows Apple to drive higher volume leverage across its portfolio as well as focus marketing spend on fewer products, driving the optimum outcome in relation to both gross margin and operating margins."
6114,468,137,"Fewer models and premium pricing drive best-in-class productmargins We believe the combination of the premium pricing strategy as well as the focus of both RD and marketing spend acrossfewer modelscontributes to Apples stronger margins on iPhones relative to competitors. As shown in Figure 74, Apple delivers stronger margins than any of its competitors in the smartphone industry. Admittedly, some of the companies mentioned below have business interests outside of smartphones, but we estimate Apple has a leadership in margins forsmartphones on a stand-alone basis relative to any competitive products. The higher operating margins are a function of: 1 higher gross margin led byafocus on premium smartphones 2 pricing power with the customer demographic purchasing premium smartphones and 3 lower operating costs, which is a function offocusing on developing 2-3 stand-out smartphone models during a year,allowing for better leverage of costs over greater volumes per phone model."
6115,468,138,"iPhone X: Top-end phone contributing one-third of total shipments to date As shown in Figure 75, despite increasing the price of the top-end iPhone offered from 2016 to 2017 by around $200 25% yy, demand was much stronger than most investors would have expected. Specifically, iPhoneX accounted for 30% of the mix of total iPhone shipments to date, which demonstrates that Apples strategy of launching top-end smartphones with a competitively superior feature set has been successful."
6116,468,139,"Success of top-end strategy stands out relative to primary competitor Samsung Apples strategy tofocus on the top-end smartphone stands out relative to its primary competitor, Samsung. Samsung has a broader portfolio of devices with a wider range of price points, including some smartphones that are comparable in price to Apples top-end phones in certain generations. While we acknowledge the difference in strategies between Apple and Samsung may make a comparison difficult, we think it is important to highlight that as shown in Figure 77, Samsungs top-end smartphone has only reached 20% of total shipments."
6117,468,140,"Apples top-end smartphone contributing an even greater percentage of revenue As shown in Figure 78, not only is the iPhone Xalready contributing one-third of Apples unit shipments, it is also contributing an even greater percentage of the company revenuesroughly 40% to date."
6118,468,141,"Samsungs top-end smartphoneshave contributed a lower portion of revenues While it might not be the most appropriate to compare Samsungs Galaxy S8 Plus and Galaxy S9 Plus to Apples iPhone X, given different portfolio strategies, we believe the comparison can provide insights into the ability to drive towards a very rich mix and maximize margins. As shown in Figure 79, Samsungs top-end smartphone has historically contributed around 17% of revenue relative to the iPhone Xs 40%."
6119,468,142,"Success for Apple and Samsung has been fairly similar with Plus sized models Larger screen sizes have been a driver of higher ASPs as well for smartphone manufacturers, with both Apple and Samsung choosing to label the larger screen size models as Plus and charging roughly $0-$100 premium relative to the base model. When we focus on shipments of smartphones with screen sizes larger than 5.5 inches for both Apple and Samsung, we find that both have had similar success in driving an increasing mix of shipments from larger screen sizes at a premium ASP. However, the roughly similar contribution of mix from Samsung is driven by a higher number of smartphone models relative to Apple."
6120,468,143,"Samsung is slowly increasing ASPs, but remains well behind Apple While Samsung might have some top-end smartphones at comparable prices to Apples, the average ASP for the Samsung portfolio remains well short of Apples. On a year-to-date basis, the average selling price for Apples iPhones are $823 per IDC, which compares to Samsungs$340. Over the last ten years, Apple has increased average ASP by roughly $202 per IDC relative to Samsungs $135. While this might indicate more opportunity for Samsung with high-end smartphones, we think it also indicates that Apple has been more willing to push the pricing barrier in conjunction with delivering technology feature setsthat are at least in linewith, if not better than,the best phones in the market."
6121,468,144,"Volumes for both OEMs have started to plateau Apple and Samsung have captured most of the market share in premium smartphone market. Volumes for both OEMs have started to plateau in recent years, which is likely driven by the maturing penetrationof smartphones in Developed countries."
6122,468,145,"Samsung is following Apples premium pricing strategy Samsung had historically preferred to price its top-end smartphone at a modest discount to Apple in a bid to cannibalize revenue from Apple. More recently, particularly with the recent launch of the Galaxy Note 9, Samsung is now looking to price smartphones in line with or at a premium to Apple. The pricing likely reflects a change in strategy and expectation around price elasticity from Samsung."
6123,468,146,"Smartphones substituting tablets and laptops consumers willing to attribute higher share of wallet to smartphone purchase from savings on other devices One of the primary reasons we believe consumers have been willing to pay an increasing amount for smartphones is the increasing convergence of capabilities of a smartphone with those of a tablet and other personal computing devices, including laptops. The increase in hardware capabilities has not been the sole driver the increasing delivery of web-based content through applications customized for smartphones to keep up with changing consumer preference towards mobility has driven a convergence of the use cases for smartphones relative to other personal computing devices. As shown in Table 18, while the mobile handset industry is still registering modest growth, the marketsfor personal laptopsdesktops and tablets are both declining. With smartphones substituting usage of laptopsdesktopsand tablets, we believe consumersarewilling to attribute incremental share of wallet to the smartphone, driving limited price elasticity relative to expectations."
6124,468,147,"Consumers are increasingly spending more time on a smartphone We believe consumers are spending an increasing amount of time on a smartphone instead of other devices, including tablets, which saw a rapid increase in usage in the early part of this decade. The willingness from consumers to pay an increasing amount for the smartphone has stemmed from their desire tohave a richer experience on the device on which they are spending an increasing amount of time. For example, one of the primary drivers for large screen sizes, or Plus sized models, was that consumers were increasingly consuming content on their smartphones and wanted larger screen sizes to make it more convenient to readview, which in turn increased the opportunity for OEMs to raise pricing."
6125,468,148,"Financing has a lot of headroom to allow pricing to increase Developed countries, including the US, are seeing a modest headwind on the replacement cycle for smartphones led by the discontinuation of subsidies by the carriers to facilitate consumer purchases. However, the headwind is largely being offset by the increasing penetration of financing plans to make the purchases more affordable. According to research published by Kantar, 47% of smartphones sold in the US are linked to installment plans, including 51% of iPhonesand 46% of Androiddevices."
6126,468,149,"Limited product positioning for leverage to growth in Emerging countries Since its launch in 2007, Apple has primarily focused on the premium smartphone market. However,Apple began designingproduct focused on Emerging countriesin 2013, including withthe 5C and the SE. However, product introductions targeting the Emerging countrieshave been infrequent, as we believe Apple continues to prioritize Developed countriesto drive growthas"
6127,468,150,"Apple has limited products targeting Emerging countries Apple has not focused on consistently launching specific products targeting Emerging countries. Apples product strategy has involved positioning the prior years smartphone modelsas the primary product in most of the Emerging countries, at a significantly lower price than the current generation of smartphones. The strategy of pushing the prior years smartphonesin certain Emerging countries allows the pricing to be more affordable by the target demographic. Additionally, with a year of cost reduction opportunities explored on the prior years smartphones, Apple can deliver solid margins despite participating in a more price competitive market."
6128,468,151,"Apples strategy in Emerging countries offers numerous benefits to financials long-term We believe Apples strategy in Emerging countries, in contrast to competitive priority of developing specific products, has several benefits for financials, including: Pricing of the primary model in Emerging countries is more affordable for consumers. With the launch of iPhones every year, the price of the prior years model is trimmed and offers a better price point."
6129,468,152,"With leverage of existing products, Apple avoids new RD investments to develop specific products for Emerging countries."
6130,468,153,"Thefirm has a year of learnings from product manufacturing to drive savings, leading to better gross margins on the smartphone model."
6131,468,154,"With average life cycle of a smartphone in North America close to 2.3 years, the positioning of an older smartphone product inEmerging markets allows the company to fully leverage the RD in developing a product for a longer duration, allowingfor better operating margins than competition."
6132,468,155,"Positioning products in Emerging countries,which already have been launched in Developed countries the prior year, creates an aspirational value attached tothe product by the consumer requiring, in our view, limited incremental marketing spend relative to stand-alone products positioned for the Emerging countries."
6133,468,156,"While the combination of the above does not allow for strong volume opportunity, as Apples smartphone usually remains at the high-end compared to competitive offerings, it does optimize the profitability, in our view."
6134,468,157,"Increasing wealth in Emerging countries to drive iPhone adoption Apples pricing strategy allows for the price of the primary iPhone positioned in an Emerging market to remain more stable than in the Developed markets. While the price of the prior years model is still at the high-endof consumer spending on smartphones in Emerging markets, we expect more and more consumers to enter the target demographic for Apple with increasing wealth of consumer in Emerging countries. As shown in Figure 83and Figure 84, the average selling prices of a premium smartphone in China and India are expected to increase at a robust pace, but lower than the rise in GDP per capita which we treat as a proxy for changes in disposable income in the region."
6135,468,158,"Ratio of Smartphone ASP to GDPCapita to decline, leading to an increase in target demographic over time As shown in Figure 85, average premium smartphone ASP as % of GDP per capita in 2016 was 2.35% and 3.45% in China and India, respectively, and is expected to decline through 2022 to 1.76% and 2.33%, respectively. The decline expected over the next few years demonstrates that the increasing wealth in Emerging countries will likely push incremental consumers into Apples target demographic."
6136,468,159,"Apple is more levered to growth in Developed countries As shown in Figure 86and Figure 87below, iPhone shipments to Developed countries account for roughly 48% of total iPhone shipments relative to 24% for the industry."
6137,468,160,"Emerging countries a key opportunity for Apple, but we dont see realization of this opportunity in the near-term Relative to Apples position globally with iPhones and the 15% market share it has, the opportunity is greater in Emerging countries where Apple only has a modest 8% share relative to the 30% market share it has in Developed countries."
6138,468,161,"China is the single largest country in terms of smartphone shipments Accounting for roughly 30% of total smartphone shipments globally, China is currently the single largest country in terms of smartphones sold and installed base. As shown in Figure 89, China accounted for roughly 7% of global shipments back in 2008 before a period of exceptional growth between 2010 and 2012 driving Chinas leadership position in the global smartphone market by units."
6139,468,162,"China also leads relative to smartphone revenue, despite a lower ASP As shown in Figure 90, despite an ASP in China lower than in Developed countries, including North America and Western Europe, the total revenue opportunity is greater in China."
6140,468,163,"Apples iPhone sales in China appear to have peaked As shown in Figure 91, iPhone shipments to the Greater China region peaked in 2015 with the delivery of 58mndevices. Since 2015, Apples shipments to the region have declined yy."
6141,468,164,"iPhone sales to China have been declining in recent years As shown in Figure 92, iPhone sales in China increased at a phenomenal rate in 2011 and 2012 as well as 2014 and 2015. However, more recently in 2016 and 2017, iPhone sales in China have declined significantly."
6142,468,165,"Mobile handset sales in China have also been declining in recent years The decline in iPhone sales in China, although much greater in magnitude, is not entirelyinconsistentwith industry trends. Mobile handset shipments in China have increasedstrongly over the last decade. As shown in Figure 93, mobile handset shipments doubled from 251mnunits in 2008 to 501mnunits in 2016, growing at a 9%CAGR. However, the industry has shown signs of weakness intermittently, including yy declines in the latest full year."
6143,468,166,"Strong growth years in China have also been accompanied by years of declines As shown in Figure 94, the Chinese market has seen strong growth in mobile handset shipments, although years of strong growth like in 2009, 2010, 2013, and 2014, have also been accompanied by years of declines in 2011, 2015, and 2017."
6144,468,167,"iPhone revenue trends in China have improved despite unit trends Despite the yy declines in iPhone shipments in 2017, iPhone shipments returned to growth in calendar 3Q17 F4Q17 and were up double digitsin mainland China. While iPhone unit sales in 1H2018 are estimated to be still down -4% yy in China, the launch of the iPhone Xhas improved momentum relative to revenue growth with four consecutive quarters of double-digit growth in revenue leading up to 3Q18. Despite being a premium smartphone, the iPhone Xhas been successful in featuring in the top few mobile handsets sold in the country on a consistent basis since its launch."
6145,468,168,"India represents another underserved market with solid growth potential Despite accounting for around one-fifthof the global population, India only accounts for 12% of the global mobile handset shipments and only about 8% of global smartphone shipments, led by lower than average penetration."
6146,468,169,"iPhone shipments have increased steadily, although remain small in India As shown in Figure 96, iPhone shipments in India have increased steadily over the last few years. However, despite the increase, Apple has only a 2% market share of the roughly 122mnsmartphones shipped into the market."
6147,468,170,"Apple is expanding its presence in India to build momentum in the country Applebelieves it is still in the early stages of building its presence in India, including setting up a channel and working on plans relative to owning retail stores in the country. Additionally, the company has invested in building a local supply chain for its smartphones, which is important to meet local regulations and reduce the average selling price to consumers by avoiding tariffs. Further, with the mobile infrastructure in the country improving, led by recent investments from Reliance Jio and Bharti Airtel, Apple feels more confident relative to the replacement cycle driving towards higher-capability smartphones."
6148,468,171,"Estimate installed base of roughly 1bniPhones globally in 2018 As shown in Table 19, we estimate that the installed base of iPhones globally with their first owners is roughly 915mnunits in 2018. However, a portion of the iPhones sold annually to existing iPhone owners addsto the installed base with secondary owners, which also contributes to the installed base. Including devices sold to secondary owners, we estimate the total installed base is close to 1.1bndevices. We estimate the growth in the installed base has been inthe double-digit percentages over the last few years. While we estimate the growth in the installed base will moderate to high-single-digit percentages in the coming years, the growth in the absolute number of devices should remain close to 0.1bnannually."
6149,468,172,"Mac shipments have plateaued and volumes are likely to remain range bound As shown in Figure 97, Mac shipments rose strongly in the last decade to reach 18mnunits globallyin 2011.However, since then we believe a variety of headwinds have limited growth for Mac shipments including: 1limited growth in laptop shipments in Developed countries 2 premium pricing for Mac limiting addressable markets 3 shift of content consumption from traditional devices like laptops to smartphones, which has elongated the replacement cycle for laptops."
6150,468,173,"Apples shipments are more aligned to international markets As shown in Figure 98, Apples Mac devices, which have less than 10% share of the laptop market, have a greater exposure to international markets when compared to industry levels. The US accounts for 60% of global volumes for Apple, while for the industry the US accounts for 80% of global volumes."
6151,468,174,"Laptop industry volumes peaked in 2011 Despite the different geographical exposure relative to the industry, the peak in Mac shipments was relatively similar to that for the industry. As shown in Figure 99, laptop industry volumes rose from 59mnin 1995 to 360mnin 2011. However, since then industry volumes have been on a consistent decline and reached 255mnunits in the latest full year."
6152,468,175,"Laptop industry volumes have declined at a single-to double-digit pace As shown in Figure 100, the industry demonstrated strong growth for most of the late 90s and2000s, except for a couple of years during the dotcom bust."
6153,468,176,"Apple has gained modest share, although market leaders have not changed As shown in Figure 101and Figure 102, Apples laptop market share has increased from 3% in 2000 to 7% in 2017. While market share for the competitive set of companies has changed a bit over the last 17 years, the leaders in the laptop market are unchanged HP, Lenovo, and Dell."
6154,468,177,"Apple market share gains have stalled over the last few years Apple gained a modest amount of market share in the industry since the early 2000s. However, Apples market share peaked at 8% in 2015 and has since moderated to 7%."
6155,468,178,"Apples recent product launches have reinvigorated revenue growth While unit growth for Apples laptops has plateaued over the last few years, Apple continues to report record revenue quarters for Mac laptops, including in FY17 with $25.9bnof revenue in the September quarter F4Q17 Apple has looked to differentiate its product offering on the basis of capabilities, driving an increasing number of consumers to switch. Apple estimates that in the most recent quarters, 60% of Mac purchases were driven by newbuyers as well as switching customers, including 90% of Mac purchases in China. Most importantly, the growth in Mac purchases has contributed to double-digit growth in the installed base of Mac laptops."
6156,468,179,"Product launches have provided a boost to ASPs As shown in Figure 104, the recent product refresh, which included increased capabilities with the MacBook Pro and the iMac, has led to an increase in ASPs for Apples Maclaptopsin 2017 and 2018 on a year-to-date basis. As a point of reference, the year-to-date ASP of $1,572 for Apples Maclaptops is almost 2x the industrys ASP of$713."
6157,468,180,"Expect PC shipments to stabilize in coming years We believe volumes of personal computing devices will stabilize in coming years. J.P. Morgan Technology analyst Gokul Hariharan forecasts volume declineof -0.2% yy in both 2019E, and 2020E, following greater magnitude of declines in the last few years Global PC and Server Forecasts PCs staying flattish in 2018, Servers growing at 9% led by hyperscale."
6158,468,181,"Forecast Mac shipments to decline modestly, implying market share losses We expect Apple to launch more entry-level Macs in the coming years to broaden the portfolio and target a large demographic. At the same time, we expect Apple to expand capabilities at the high-end of the portfolio to target gaming demand where priceelasticity is limited. However, despite these changes in the portfolio, we expect Apple to give up modest amount of market share, which in turn should drive unit decline on a yy basis in the backdrop of a largely flat market. Led by the rebound in revenue growth in 2017, following MacBook Pro refreshes, we expect Apples focus to remain largely on high-end devices to drive revenue growth even in the absence of unit growth."
6159,468,182,"iPad successfully created the tablet market Apple launched the first iPad in April 2010, creating the tablet market, which immediately gained significant popularity with consumers. The popularity of the iPad led competitors to quickly follow Apple into the tablet market, which resulted in moderationof Apples market share however,Apple still remains the largest player in the category it created. As shown in Figure 105, Apple started with almost 100% share of the tablet market with the launch of the iPad in 2Q2010. Apples market share moderated over time to as low as 20% by 3Q 2015, prior to the launch of the iPad Pro, which has driven a recovery in market share."
6160,468,183,"Despite the moderation in share, Apple is still the leader in the tablet market As shown in Figure 106, despite the moderation of Apples share in the tablet market, as a result of a fast-follower strategy by competition, the firm still has the leading share in the tablet market and almost 2x the share of its nearest competitor, Samsung."
6161,468,184,"iPad geographic sales largely in line with the industry As shown in Figure 107and Figure 108, iPad sales by geography are weighted towards the US and APAC region, largely in line with the industry."
6162,468,185,"iPad as well as tablet industry volumes have slowed down As shown in Figure 109and Figure 110, iPadvolumes peaked in 2013 and have declined since, before finally stabilizing in 2017. The trend in iPad volumes is similar to that for the industry, despite the industry decline starting in 2014."
6163,468,186,"Starting in late 2017, iPad units and revenues have rebounded We believe Apples latest refresh of the iPad line-up in 2017, including positioning the iPad for the education sector as well as pushing for greater enterprise adoption, has helped drive a recovery in both units and revenue. In calendar 2Q18, Apple reported the fifth consecutive quarter of iPad revenue growth, including share gains in China, rest of APAC, and the US, where it has roughly 60% share of the tablet market. Additionally, Apple believes half of the iPad purchases in the quarter were for new tablet customers as well as those switching from competitors, which has further added to the installed base of devices."
6164,468,187,"iPad ASPs have declined on the launch of lower-price versions As shown in Figure 111, iPad ASPs havedeclined since introduction in 2010. The launch of additional lower-price versions, including iPad mini, likely drove the ASP moderation."
6165,468,188,"Despite ASP moderation, Apple has increased its premium to the industry While ASPsfor tablets in the industry have been declining in conjunction with the decline in ASP for iPads, Apple has been able to expand its premium relative to the industry by holding off in competing with the less feature-rich and lower-ASP products introduced by competition. As shown in Figure 112, iPad has been able to expand the premium relative to the industry from 110% in 2010 and 127% in 2011 to 186% in 2016, 176% in 2017, and 153% in 2018."
6166,468,189,"Apple has quickly established itself as a leader in the smart watch market The first Apple Watch was released on April 24, 2015 and has since gained in popularity to become the leading smart watch sold globally. As shown in Figure 59, Apple now has 15% share of the global wearables market, followed by Xiaomi 14%, Fitbit 13% and Garmin 5%."
6167,468,190,"The smart watch market accounts for roughly half of the wearables market While we have seen a lot of new competition come into the already intensely competitive wearables market, capabilities are not uniform across smart watches, which are only a partof the overall wearables market. We estimate smart watches account for roughly 50% of the overall wearables market. The US smart watch market is estimated to be about 13mnunits relative to the US wearables market of 30mnunits."
6168,468,191,"Apple Watch shipments gained momentum in 2017 after taking a pause in 2016 As shown in Figure 114, Apple Watch shipments took a pause after a hugely successful first year in which the companysshare rose to 21% of the wearables market. Subsequently, Apple Watch shipments increased more than 50% yy in 2017. Apple has disclosed that Apple Watch shipments continued to report strong growth in early 2018, including a mid-40% growth rate in the latest quarter."
6169,468,192,"Within the wearables market, IDC forecasts the market for smart watches to expand at a 22% CAGR, from 33mnunits in 2017 to 89mnunits in 2022. We see upside to these already bullish third-party estimates for unit growth in the smart watch market, led by the introduction of additional capabilities in smart watches driven by new digital content and lifestyle tracking features. Additionally, we are in the early stages of 3G4G capabilities being incorporated into smart watches, which will provide additional flexibility to consumers and should drive a replacement cycle for earlier generation smart watches."
6170,468,193,North American smart watch market expected to grow at a 19% CAGR The USmarket for smart watches is estimatedto account for 14mnof the 115mn market. IDC estimates that the US smart watch market will rise at a 19% CAGR through 2022. The strong growth overall for shipments in the US is likely to be accompanied by a moderation in average ASPs as new entrants try to capture market share through less expensive product offerings.
6171,468,194,"Apple Watch penetration into iPhone installed base still relatively modest Apple Watch is in almost all circumstances a purchase for a consumer who owns an iPhone. We see the Apple Watch appealing to all iPhone users, including secondary owners, as an excellent alternative to traditional watches given increasing features like the pedometer, heart rate monitor, andnotification of calls and messages. We estimate that the sale of roughly 14K Apple Watches in FY17 implies only a 1.4% penetration of the iPhone installed base. We expect the increasing penetration of Apple Watch sales with iPhone users to continue to drive strong growth in Apple Watch units, making unit growth more sustainable than investors may expect."
6172,468,195,"Theoretically a TAM opportunity of $385bn Even if Apples installed base of iPhones were to plateau today, we estimate Apple theoretically could still target a revenue opportunity of $385bnwith the Apple Watch if penetration were to reach closer to 100%. Realistically, the penetration of Apple Watches in the iPhone installed base will be lower and should ramp up steadily over time. We expect to see penetration increase in line with gains in the last two years see Figure 117, which we believe will result in continued growth for Apple Watch see Figure 118."
6173,468,196,"Estimate total installed base of roughly 1.4bndevices globally and growing at a mid-to high-single-digit pace As shown in Table 19, we estimate that the installed base of iPhones, iPads, Mac devices, and Apple Watches is 1.4bn, which we expect to grow at a high- single-digit ratethrough our forecast window."
6174,468,197,"Key observationsfrom our installed base calculations: iPhones are three-fourths of the total installed base, driving increased focus to continue to grow the iPhone installed base."
6175,468,198,"Switchers to iOS devices and replacement demand are key to driving growth in installed base. With variations in replacement demand likely to be modest at best through the years, the primary driver of installed base growth should rest onthe ability to get consumers to switch to iOS."
6176,468,199,"As shown in Table 24, if Apple fails to get incremental consumers to switch, replacement demand and new subscriber demand are unlikely to expand enough to offset the shortfall, driving a decline in iPhone unit sales."
6177,468,200,"As shown in Table 24, decline in iPhone unit sales should lead to only a modest single-digit increase in the installed base, restricting opportunities to drive both replacement-led demand and Services revenue growth in the long-run. Apples strategy to focus on developing the best products, even though at a premium price, is to drive incremental consumers to switch to the iOS platform, which is key for growth."
6178,468,201,"Amazon and Google captured the market early on Apple launched its smart speaker, the HomePod, in early 2018, almost three years after Amazons launch of its smart speaker, Alexa, in November 2014, and more than a year after Google announced the launch of the Google Assistant in November 2016. Not only has Apple lost the first-mover advantage in this market, it has also cededthe installed base to Amazon and Google, which is likely to see a longer life cycle relative to either the iPhone or the Apple Watch. As shown in Figure 119, Amazon has 62% share of the smart speaker market, followed by Google at 31%, and other players being fairly small."
6179,468,202,"US is the primary market for smart speakers currently we expect improving network infrastructure to facilitate growth in international markets IDC estimates that a total of 43.9mnsmart speakers were sold globally in 2017. Of the 43.9mnunits sold, IDC estimates that 76% or 33.5mnunits were shipped in the US. We believe improvement in network infrastructure in international markets will facilitate stronger adoption of smart speakersin other regions."
6180,468,203,"Current installed base implies minor penetration of homes In the US, smart speaker sales rose from 14mnunits in 2016 to 34mnunits in 2017, more than doubling within a year. While significant, the overall penetration of homes remains fairly modest. An average of one speaker per home would imply a 25% penetration rate of the 136mnhouseholds in the US. However, we believe thereal penetration is potentially much lower at around half that number with an average household owning two devices instead of one. Undoubtedly, penetration of smart speakers remains fairly low in international markets."
6181,468,204,"We expect Apple to further refine the hardware for the HomePod Apple historically has differentiated its products through superior design and aesthetics in addition to the capabilities of the product itself. However, we believe the HomePod, despite being late to the market relative to Amazonand Google, has failed to appeal to consumers in design and aesthetics. We expect Apple to refine the product further in coming generations."
6182,468,205,"Apple Music can be the driver for HomePod sales While the integration of HomePod with Apple Music could drive growth for Apple Music subscriptions longer-term, we expect Apple Music will drive HomePod sales near-term. Specifically, we expect Apple to look to integrate HomePod and Apple Music into a packaged offering in the near-term as the company looks to leverage the success of the Apple Music platform, which boasts 50% of the market share in streaming subscriptions with 43mnmonthly active users in the US."
6183,468,206,"Despite HomePods lackluster start, we do not rule out Apples ability to innovate While the HomePod has not been a success for Apple to date, we do not rule out Apples ability to innovate in terms of product and strategy to drive adoption. While admittedly HomePod has lagged competitors in the smart speaker market, Apple has successfully entered the smart watch market and wireless headphone market over the last few years and is well on its way to establishing itself as the leader in both. For example, the Airpods wireless earbuds have seen significant success in relatively short time after their launch in December 2016 and now have 2% share of the total headphone market including earphonesorganically, and closer to 27% when including Beats, which Apple acquired in 2014."
6184,468,207,"Servicesto be a $68bnbusiness segment by FY21 Apple has inarguably increased its focus on Services in the last few years. The Services segment comprises revenues from the App Store, iTunes, Apple Music, and Apple Care. As shown in Figure 121, Services accounted for only 8% of total company revenues in FY12, increasing to 13% in FY17. With Apple on track to easily exceed its target of doubling Services revenuesof $24bnin FY16 by FY20E, we believe Services will account for around 20% of total company revenues in FY21E."
6185,468,208,"Services growth has accelerated in recent years As shown in Figure 122, Services revenues have accelerated from $19bnin FY15 10% yy, to $24bnin FY16 20% yy,and to $30bnin FY17 26% yy."
6186,468,209,"Apple is benefiting from growth in theinstalled base and revenue per device We believe the strong growth in Services revenue is being fueled by the combination of growth in the installed base as well as the service revenue derived from each device. As shown Figure 123, we estimate that the installed base of iOS devices including secondary users increased from 1.16bnin FY15, to 1.30bnin FY16,and"
6187,468,210,"Additionally, average revenue per device in the installed base also increased from $17in FY15, to $18 in FY16, and to $21in FY17."
6188,468,211,"Expect revenue per device to increase, led by Apple Care and Apple Music We expect revenue per device in the installed base to continue to increase in conjunction with a growing installed base. As shown in Figure 124, we forecast Service revenue per device to continue to increase at a 16% CAGR from $21 in FY17 to $38in FY21. We expect the primary driver of the increase to be the higher adoption of Apple Care services across the portfolio and across greater number of points in the indirect channel for Apple and Apple Music."
6189,468,212,"Forecast 23% CAGR in Services revenues from FY17 to FY21 As shown in Figure 125, we forecast Services revenues to rise at a 23%CAGR to $68bnin FY21Efrom $30bnin FY17."
6190,468,213,"App Store and Apple Care account for a primary portion of Services revenues Apple does not disclose the mix of its $22bnin Services revenue. We estimate the mix ofServices revenue is weightedtowards purchasesin theApp Store as well as purchasesof Apple Care. However, in additionto continued growth in App Store revenues, we expect to see additional drivers in the form of Apple Music and Apple Pay. The next section takes a deeper dive into these two relatively new services ."
6191,468,214,"Formidable addition to the Apple ecosystem Apple Music, which launched in June of 2015, is an ad-free music streaming service that boasts a collection of 50mnsongs. Apple offers Apple Music initially as a three- month free trial, after which consumers have the option to choose from various monthly subscriptions at different price points, which fluctuates from country to country. For example, customers can choose between a Student subscription at $4.99month, an Individual subscription at $9.99month, and a Family subscription at $14.99monthe.g.,access for up to six people in the US. Apple Music is available in 100 countries worldwide and, more importantly, on all Apple devices including CarPlay as well as non-Apple PCs, Android devices, and Sonos devices through iTunes or various app stores."
6192,468,215,"Changing consumer preferences have led tothe rise of streaming music The music industry has seen a fundamental change over the last decade. The era of downloading music to a device and revenue models dependent on downloads has been replaced to a large extent by music as a service in the form of monthly subscriptions to users. The number of people who pay to stream music has grown at a 54% CAGR since 2012,culminating in an estimated 176 million people globally who stream music. This rise in steaming music has disrupted the traditional incumbents in the music industry and driven a change in business models for most music companies in order to survive. Additionally, it has led to an increased incentive for music distributors like Apple and Spotify to engage with musicians, producers, and music labels to create exclusive relationships to differentiate their streaming services relative to competition."
6193,468,216,"Streaming music drives growth in the music industry as a whole The music industry had been struggling and revenues were declining drastically led by illegal downloads and unwillingness of consumers to pay for individual downloads. As shown inFigure 127,IFPI, a not-for-profit international organization registered in Switzerland and representing the recording industry,estimates that worldwide revenues for the recorded music industry declined from $20bnin 2000 to aslow as $14bnby 2014 representing the challenges faced by the music industry in the early 2000s. However, with increasing adoption of streaming, the industry started to see an increase in total revenues and has nowreached an estimated $19bnin 2018."
6194,468,217,"While streaming services have had a strong pace of growth starting from 2014, the contribution of non-streaming services to overall revenues has declined rapidly. Streaming revenues are expected to continue to grow at a brisk pace offsetting the decline in alternate means of music distribution."
6195,468,218,"Streaming growing at a solid pace and taking over the primary role from downloads Taking a closer look at Digital Music revenues, we see the increase in streaming revenues complementing the decline in revenues through downloads. As shown in Figure 129, streaming overtook contribution from downloads to total industry revenues in 2015, and streaming has continued to post strong growth since then."
6196,468,219,"Adoption of streaming music continues to increase The easier access to music provided to consumers through streaming services has led to consumers spending more time consuming music content. In the United States, for example, consumers were listening to approximately 23 hours of music per week in 2015, which increased to 32 hours per week in 2017."
6197,468,220,popularity of streaming services to continue to engage consumers further on their platforms.
6198,468,221,"Smartphones are the most popularway to streammusicmaking Music a great addition to the Apple Services platform Smartphones have become the primary device of choice for consumers when it comes to streaming music. While only 50% of consumers were using the smartphone for streaming music in 2015, by the end of 2017 the percentage had increased to 90%.The tie-in of streaming music on the smartphone makes Apple Music a great addition to the Apple Services portfolio."
6199,468,222,"Apple Music MAUs have grown at 75% CAGR through mid-2018 Apple Music was launched in the summer of 2015 and gained 10mn paid subscribers by the end of that year in just six months. Most recently, Apple announcedthat Apple Music had surpassed 50mn monthly active users MAUs. We estimate that Apple can end FY18E with roughly 54mnusers and continue to drive solid growth in MAUs to more than double the subscriber base by end of FY21E."
6200,468,223,"Apple Musics growth is impressive, but Spotify still holds the streaming crown Spotifyrecentlyannounced that it had surpassed 180mn MAUs, with 83mnof those users paying for the premium service. The difference of 180mn Spotify MAUs versus Apple Musics 50mnappears daunting, but one must consider that Apple Music does not offer a free ad-supported version of its service, so the true comparison has to be between Spotifys 83mn MAUs and Apples 50mnMAUs. While Spotify as a service can monetize the free subscriber base for advertisement revenues, Apple continues to prioritize user experience for paying consumers. As shown in Figure 133, Spotify has been growing users rapidly as well and currently is the leader in the streaming market."
6201,468,224,"Spotify and Apple Music are significantly ahead of competition outside of China The key players in the streaming market include Google Pay Music, Amazon Music, and Pandora in addition to Spotify and Apple Music. Tencent has a near monopoly in Asia however,excluding Tencent the other big five streaming services appear to have around 165mnusers as of mid-2018."
6202,468,225,"Globally Spotify is the leader however,domestically Apple is roughly at par While globally Spotify is the leader in streaming services, the user base is much more balanced in the US led by the tie-in of the smartphone to the choice of a subscription service and the high share for Apple in the US smartphone market. We estimate that Apple has roughly half of its subscriber base in the US, i.e.,around 21mnusers, which compares to Spotifys American user base of around 22mn. Additionally, with higher growth for Apple in the US relative to Spotify, we estimate Apple can soon surpass Spotifys domestic user base."
6203,468,226,"JPM estimates TAM of 2.7bnusers for Apple Music relative to 50mn subscribers currently Based on an analysis of householdspending in 118 countries where Apple Music currently operates, JPM Internet analyst Doug Anmuth estimates that total user TAM for Apple Musics paid service is around 2.7bn. The analysis is based on an"
6204,468,227,evaluation of household spending in 56 markets where Apple Music operates without the presence of Spotify and JPM estimatesthat the subscription service can reach approximately 1.5bn subscribers in those markets. Adding to this the 62 countries in which Apple Music and Spotify both operate brings in another 1.2bn potential consumers. This leads to a total TAM of 2.7bn subscribers in 118 countries.
6205,468,228,"Apple is positioned to address a large TAM with localized pricing In the countries where Apple Music is available, our JPM Internet team observes that Apple Music is an affordable service, making up only 1% of household expenditures. The service is most expensive in Europe, at approximately $11.09month on average for anindividual plan. This is especially striking when compared to regions such as South America and Africa where the individual subscription is offered for $4.20month on average. In the U.S, Apple Music is $9.99month for the individual plan and $14.99monthfor the family plan up to six users. According to the 2017 IFPI Consumer Insight report, roughly 22% of streaming plans are family plans."
6206,468,229,"Apple Music sees higher conversion rate of trial subscribers into paying subscribers Apples growth is assisted by the three-month free trial, which is the companys primary way of gaining new paying MAUs. Unlike Spotify, Apple Music does not offer a free ad-supported version of the product so reliance on the teaser free trial is vital to new consumer onboarding. One year after Apple Musics launch in mid- 2015, Apple Music had a total of 33mn subscribers, with only 17mn paid subscribers, representing roughly 50%conversion rate. Now, three years after launch in 2018, Apple Music has 50mnsubscribers in total, with 40mn of them paying subscribers, representing an increase of the conversion rate to 80%."
6207,468,230,"Apple Musics retention rate nears Netflix levels of loyalty Netflix, like Apple Music, does not have an ad-supported subscription,but rather a similar one-month free trial system to attract and retain new consumers. While Netflix has different business priorities, focusing more on original content generation and is in the video streaming industry, it is still an interesting comparison to make due to their similar free trial and no free ad-supported model. We believe Netflix has enjoyed 90% retention post free trial, something that Apple Music is trending towards."
6208,468,231,"Apple Music subscribers to account for a larger percentage of Apple device owners We believe one of the drivers of growth for Apple Music will be the increase in penetration of subscribers in the installed base, in addition to benefits from the incremental increase in the installed base on an annual basis. We expect the tight coupling of the iPhone,the Apple Watch, and the HomePod with the Apple Music subscription will enable growth in subscriptions for Apple Music within existing installed base of devices. We estimate the penetration of Apple Music is quite low and in the low-single-digit range at this time. We expect growth in subscribers for Apple Music to be driven by an increase in penetration for Apple Music subscriptions within the installed base and with existing Apple users."
6209,468,232,"Apple Music also well positioned to gain penetration into streaming TAM with its leadership position in the industry, along with Spotify Based on our estimate for a total addressable market of 2.7bnsubscribers in FY18 for Apple Music, we conclude that Apple Music currently serves only 1.7% of the total TAM. However, given Spotifysand Apples strong positioning in streaming services, we believe Apple Music is well positioned to increase penetration of the total addressable market and drive strong revenue growth. As shown in Figure 141, we estimate in 2018 Apple Music only has 1.7% of the total addressable market for subscribers, which we forecast will rise to 3.7% in 2020."
6210,468,233,"Strong relationship with artists and music labels part of Apple Musics long- term strategy It is crucial to have a good working relationship with existing music labels and artists to ensure availability of quality content on the platform, but also in some cases use the relationships to create exclusivity for content and drive differentiation for the platform relative to competition. Apple is at an advantage over Spotify as it has the financial abilityto deploy significantly moreresources towardsimproving the companys product. Spotify pays approximately 71.7% of revenue to labels and publishers while Apple pays closer to 73%. Additionally, Apple pays 62% more to"
6211,468,234,"While near-term margins could be lower on the higher payout, we believe it is likely to be a driver towards long-term differentiation."
6212,468,235,"Estimate $32bnin revenues by FY25 As shown inTable 25, we estimate thatApple Music will account for $32bnof revenues by FY25. Our key assumptions in the model include:"
6213,468,236,"Family subscriptions and Individual subscriptions account for roughly 22% and 78%, respectively."
6214,468,237,"Apple Music potentially opens up the opportunity for introduction of original content in the future In a 2017 Bloomberg interview Jimmy Iovine, one of the heads of Apple Music, expressed that Apple could potentially include original video content into the music streaming service. More recent comments by Apple executives have indicated that the firm is investing heavily in delivering original content, although it has not disclosed any details. As shown in Figure 143, video already accounts for 55% of streaming. We believe video streaming and original content are going to be next big steps for Apple Music in differentiating itself relative to competition."
6215,468,238,"Apple Pay set to leveragethe move to digital money Apple Pay, which was launched in October of 2014, is a mobile payment and digital wallet service that allows consumers to make secure payments in stores, apps, and websitesas well as send and receive money via Apple Messages or Siri. In addition, Apple Pay includes the Wallet app, which stores the Apple Pay Cash card digital money, credit cards, debit cards, as well as other items, such as boarding passes, tickets, and reward cards. The Wallet app supports most major credit cards and debit cards around the world. Apple Pay is available on most Apple devices, including the iPhone, iPad, Mac and Apple Watch, that have some combination of at least two user identifications or two-factor authentication e.g.,passcode, PIN, Touch ID or Face ID. Apple Pay incorporates near field communication NFC in order to enable wireless payments via point-of-salesystems. Utilizing this technology, Apple Pay supports contactless in-person payments via the iPhoneand Apple Watch, which is generally faster than average card transactions. Importantly, Apple does not store card numbers on the device itself or on any of its servers. Instead,Apple Pay uses a device-specific number and uniquetransaction code thus,consumerscard numbers are never shared by Apple with merchants."
6216,468,239,"Credit and debit card purchase volume growth a positive trend for Apple Pay As illustrated in Figure 144, JPM Paymentsanalyst Tien-tsin Huang expects the aggregate credit and debit card purchase volume for Visa and Mastercard to grow 10% from $11trn in 2017 to $15trn in 2020, which is a positive trend for Apple Pay, as credit card transactions of Apple device owners are increasingly being done through Apple Pay. Importantly, creditand debitcard transactions only accounted for 23% of GDP, which is estimated to be closer to 30% in 2020, implying a significant growth opportunity for Apple Pay going forward."
6217,468,240,"Growing usage of mobile payments by consumers As seen in Figure 145, mobile payment users rose 36% yy to 721mnin 2017 and are expected to continue to increase at an 13% CAGR through 2020. Importantly, that growth rate is even higher for smartphone mobile payment users. Specifically, smartphone mobile payment users rose 67% yy to roughly 240mnin 2017 and are expected to expand at a 19% CAGR through 2020."
6218,468,241,"Mobile payment market growth is expected to accelerate As illustrated in Figure 146, the mobile payment market rose 34% yy to $803mnin 2017, which only accounted for 2% of GDP. However, the mobile payment market is forecasted to grow 34% per annum to $2bnin 2020."
6219,468,242,"Growing installed base of NFCterminals supports Apple Pay growth Near field communication NFC is the process by which consumers use digital wallets to purchase items at point-of-salePOSterminals in merchantlocations. Recently, NFC has seen a massive rate of adoption,particularly in the US whereover two-thirds of merchants havean NFC-capable POS terminal, which we believe is key to growing mobile payments. As seen in Figure 147, the installed base of NFC-ready POS terminals stood at 55mnin 2017 and is expected to grow 16% per year to 112mnin 2022, which we think is being supported by Visasand Mastercards recent mandatesthat all POS terminals be NFC enabled by 2020."
6220,468,243,"Apple Pay also entering the P2P payment market with Apple Pay Cash Peer-to-Peer P2P payment has also seen a rise in consumer adoption given its ability to transfer money from one person to another person in a relatively seamless manner, unlike traditional methods that require the use of the banking system. Apple Pay Cash, launched in December of 2017, allows users to transfer and receive money, via Apple Messenger or Siri, free of charge when using a debit card and includes a 3% charge when using a credit card. Additionally, after receiving money, users can store the money in their Apple Pay Cash card, which is stored in the Wallet app. To that end, we think the strong adoption of P2P payments is most evident by Venmos owned by PayPal recent success as seen in Figure 148. Specifically, Venmos purchase volumes have increased at a 115% CAGR since 2015."
6221,468,244,"Apple Pay participating in e-commerce growth through Macs as well In 2017, Apple introduced the MacBook touch bar, which allows users to seamlessly check out of merchant websites with the Apple Touch-ID. As illustrated in Figure 149, PCs remainthe dominant form factor for e-commerce in the US as they accounted for 77% of the total. In addition, PC e-commerce grew 11% per annum from $322bnin 2013 to $486bnin 2017."
6222,468,245,We forecast revenues of $6bn by 2025E led by double-digit increases in Apple Pay users amongst the large installed base of Appledevices and an increase in the average value of mobile transactions over time.
6223,468,246,"Apple introduced new iPhones LCD iPhone XR and OLED iPhones XSXS Max and Apple Watch Series 4 at an event on September 12. The specs are largely in line with our forecast from October 2017and market expectations, whereas the starting price is slightly above market expectation LCD iPhone price starting $749, instead of $699.Key spec changesupgrades include:"
6224,468,247,"Display: 6.1 LCD for iPhone XR and 5.86.5 OLED for iPhone XSXS Max, all with edge-to-edge display. Memory: DRAM is upgraded from 2GB iPhone 8 and 3GB 8 PlusX to 3GB iPhone XR and 4GB iPhone XSXS Max for NAND, the highest spec is migrated to 512GB."
6225,468,248,Camera: Both OLED models carry dual cameras and dual-OIS LCD model has continued with single camera.
6226,468,249,"Touch: LCD iPhone XR has adopted out-cell X-Y touch but has removed 3D touch. Dual-sim: All models will support dual-sim Nano-SIM and e-SIM, with iPhone XS Max and iPhone XR in China supporting two physical SIMs due to unavailability of e-SIM."
6227,468,250,"Casings: iPhone XR colors now include Yellow, White, Coral, Black, Blue, and Red."
6228,468,251,All models adopt a powerful receiver similar to iPhone X. Waterproof: iPhone XSXS Max are upgraded to IP68 rating waterproof.
6229,468,252,"Apple Watch sees a strong upgrade units likely to keep surprising Apple Watch units have been growing 40% yoy, after the launch of the LTE- enabled Apple Watch. The Series 4 launch also is a strong upgrade in the product line-up, with 30% larger screen size and broader price coverage. We believe this is positive for Quanta main EMSand ASE SiP module."
6230,468,253,"iPhone XS and iPhone XS Max are available from Sep 21 in 33 countries with prices from $999 and$1099 respectively, which is in line with expectations, similar to iPhone X last year. iPhone XR will start pre-orders from Oct 19 and shipping from Oct 26 in 59 countries with price from $749, similar to our preview but a tad more expensive than market consensus at $699. The available timing for LCD iPhone is also later than expected and one month behind the OLED iPhones."
6231,468,254,"Given the higher entry price range and the lingering trade tariff uncertainties, we believe flat YY comp would be a challenging goal to achieve. We already witness some Asia iPhone suppliers revisingdown outlook, likely driven by muted initial volumesfor iPhone XS. However, we do not expect order cut on iPhone XR before the phone is on the market in late October. Weexpect negative sentiment across the Apple names whereas iPhone XSXS Max plays including Largan dual-lens, Alps dual-OIS, LG Innotek dual-camera, AAC acoustic component, Samsung OLED, and Honhai casing and assembly may see largerswing in the next month."
6232,468,255,The Apple Supply China Index has underperformed the Bloomberg APAC Tech Index by over the past month. Wethink the Street expectations are fairly low but Apple supply chain stocks are likely to staymuted for the next few monthsunless any positive data flow.
6233,468,256,"However, we believe the market focus byyear end will shift to 2019 iPhone, which may see the most significant design change and upgrade in rear camera. We believe chances for both OLED iPhone models to incorporate Triple Camera plusTime-of- flight ToF 3D sensing in 2019 are high, and the LCD model willlikely be upgraded to dual camera from single. The key beneficiaries in Asia would be Win Semi , LG Innotek, and Largan. We are also positive on TSMC, AAC, Chipbond, Catcher, Flexium and Pegatron in Asia."
8923,664,1,"OVERWEIGHT Stock Rating Unchanged POSITIVE Industry View Unchanged USD 43.00 Price Target 2020 Outlook: 1 NII: quarterly NII to decline in 1H20, and to rise modestly in 2H20 2 Unchanged Credit: quarterly NCOs of $1bn, provision modestly above NCOs 3 Tax rate: 18%."
8924,664,2,Unrealized AFS debt gains Tickers BAC were $2.3bn at 4Q19 $3.1bn gain at 3Q19. BAC remains asset sensitive with the
8925,664,3,"Still, it highlighted the Market Cap USD mn 306791 potential adverse impact of protracted period of lower interest rates, or a move to Shares Outstanding mn 8836.15 negative interest rates in its Risk Factors disclosures. Wk Avg Daily Volume mn 51.0 Asset quality: Commercial reservable criticized utilized exposure was $11.5bn -$0.3bn Dividend Yield % 2.07 vs. 3Q19, with 90% secured at 4Q19 90% at 3Q19. Price Performance Exchange-NYSE 52 Week range USD 35.72-26.21 Legalmortgage: Combined legal and mortgage RW RPL was $0 to $1.6bn in excess"
8926,664,4,Its mortgage RW reserve was unchanged $1.8bn at 4Q19. It settled mortgage appraisal litigation accrued at 4Q19.
8927,664,5,"Preferred stock: On Jan 24, BAC issued $1.1bn of Series MM preferred stock and on Jan 27, 2020, it fully redeemed $1.1bn of Series Y preferred stocks. On Feb 19, BAC had 8,728,530,308 shares outstanding -1.2% vs. 4Q19."
8928,664,6,"At 4Q19, net DTA was $6.4bn $10.7bn at 4Q18 including $2.0bn valuation allowance $1.6bn valuation allowance at 4Q18. Unrecognized Tax Benefits UTB balance was $1.2bn at 4Q19 $2.2bn at 4Q18."
8929,664,7,"Brian Morton, CFA 1 Barclays Capital Inc. andor one of its affiliates does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the BCI, US firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision."
8930,664,9,"We believe the substantial improvements BAC has made in its consumer bank Pre-provision earnings 39,331 38,867 41,241 43,008 3.0% and the benefits of recent technology investments are Loan loss provisions 3,590 5,057 5,698 6,527 22.0% not yet fully appreciated by investors. We also expect Pre-tax income 32,754 33,234 34,594 35,532 2.8% further market share gains in wholesale. Our price Net income adj 25,998 25,706 26,987 27,756 2.2% target is $43 and implies 13.0x our 2021 EPS estimate of $3.30. Balance sheet $bn Average Total assets 2,434 2,478 2,555 2,634 2,525 Upside case USD 50.00 Risk-weighted assets 1,495 1,522 1,554 1,586 1,539 Significantly improving economic environment, Non-performing loans $mn 3,797 3,225 3,064 2,911 3,249 resulting in a much stronger capital markets Allowance for loan losses 9 13 14 14 13 backdrop, could drive 2021 EPS higher to $3.70. In Loans 983.4 1,020.8 1,061.7 1,114.7 1,045.2 this scenario, we could see a $50 upside case 13.5x Deposits 1,435 1,468 1,529 1,594 1,506 EPS of $3.70. Tier 1 capital 188 175 176 178 180 Tier 1 common capital 167 154 155 156 158 Downside case USD 20.00 Shareholders equity 241 234 235 237 237 If the economy were to experience significant Tangible common equity 172 164 165 167 167 deterioration, impacting both domestic and international markets, we could envision a scenario Loandeposit ratio % 69.4 69.6 69.5 70.0 69.6 where BAC shares trade down to 1x 2020E tangible book value, or $20 per share. Valuation and leverage metrics Average PE reported x 12.6 11.6 10.5 9.8 11.1 UpsideDownside scenarios PBV tangible x 1.8 1.7 1.6 1.5 1.7 Dividend yield % 1.9 2.2 2.8 3.1 2.5 PPPE x 8.3 7.7 6.9 6.3 7.3 Tier 1 % 12.61 11.53 11.35 11.21 11.68 Tier 1 Common % 11.15 10.10 9.95 9.84 10.26 Tang assetstang equity x 13.8 14.7 15.0 15.3 14.7"
8931,664,10,"Barclays Bank of America Net interest income: Assuming a stable economic and interest rate environment compared to December 31, 2019, BAC expects quarterly net interest income in 1Q20 and 2Q20 to be lower compared to the 4Q19 driven by the impact of rates and one fewer day of interest accruals. Quarterly net interest income is expected to rise modestly in 2H20 due to one additional day of interest accruals and expected loan and deposit growth."
8932,664,11,"Tax rate : BAC expects the effective tax rate for the 2020 to be approximately 18%, absent unusual items."
8933,664,12,"Credit costs: Assuming a stable economic environment in 2020 compared to the end of 2019, BAC expects net charge-offs of approximately $1bn per quarter in 2020 $959mn in 4Q19."
8934,664,13,"allowance for credit losses, BAC expects the provision for credit losses to be modestly higher than net charge-offs in 2020, assuming no change in the current economic outlook and estimates of loan growth, including product mix. Upon adoption of the standard on January 1, 2020, BAC recorded a $3.3bn, or 32%, increase to the allowance for credit losses. After adjusting for deferred taxes and other adoption effects, a $2.4bn decrease was recorded in retained earnings through a cumulative-effect adjustment. Its adoption of the CECL standard resulted in a decrease"
8935,664,14,"to the CET1 capital ratio of 17bps, which will be phased in evenly, or approximately 4bps per year, at the beginning of each year from January 1, 2020 through January 1, 2023 in accordance with transition provisions issued by the U.S. banking regulators. Risk of negative rates: In the U.S. and abroad, uncertainties surrounding fiscal and monetary policies present economic challenges. Actions taken by the Fed, including changes in its target funds rate and balance sheet management, and other central banks are beyond BACs control and difficult to predict and can affect interest rates and the"
8936,664,15,"A continued protracted period of lower interest rates, or a move to negative interest rates in the U.S., could result in lower revenue, and maintain or increase"
8937,664,16,"pressure on net-interest income, which may adversely affect BACs results of operations. Diluted shares: For 4Q19, 62mn average dilutive potential common shares associated with the Series L preferred stock were not included in the diluted share count because the result would have been antidilutive under the if-converted method. Deferred compensation: At 4Q19, there was an estimated $1.6bn of total unrecognized compensation cost related to certain share based compensation awards that is expected to be recognized over a period of up to four years, with a weighted-average period of 2.2"
8938,664,17,In 2019 the amount of cash paid to settle equity-based awards for all equity compensation plans was $84mn $1.3bn in 2018.
8939,664,18,"Legal Mortgage RPL: For such matters, where an estimate of the range of possible loss is possible, as well as for representations and warranties exposures, management currently estimates the aggregate range of reasonably possible loss for these exposures $0 to $1.6bn $0 to $1.8bn at 3Q19 in excess of the accrued liability, if any, at 4Q19."
8940,664,19,"On January 21, 2020, the parties agreed to resolve the litigation for an amount that is not material to BAC, and which was fully accrued as of 4Q19. The agreement is subject to court approval."
8941,664,21,"certain certificate-holders in the trusts agreed to settle the respective matters in amounts not material to BAC, subject to acceptance by USB. The litigations have been stayed pending finalization of the settlements"
8942,664,22,"Mortgage repurchase reserve: Its liability for representations and warranties i.e. reserve was $1.8bn at 4Q19 $1.8bn at 3Q19. Government authorities in the U.S. and various international jurisdictions continue to conduct investigations of, to make inquiries of, and to pursue proceedings against, BAC"
8943,664,23,"BAC is cooperating with these inquiries and investigations, and responding to the proceedings. At 4Q19, net notional credit default protection purchased in its credit derivatives portfolio to hedge it funded and unfunded exposures for which it elected the fair value option, as well as certain other credit exposures, was $3.3bn $3.9bn at 3Q19. Forward commitments: At 4Q19, BAC had commitments to purchase loans e.g., residential mortgage and commercial real estate of $86mn $135mn at 3Q19, and commitments to purchase commercial loans of $1.1bn $329mn at 3Q19, which upon settlement will be included in loans or LHFS. At 4Q19, BAC had commitments to"
8944,664,24,"purchase commodities, primarily liquefied natural gas of $830mn $976mn at 3Q19, which upon settlement will be included in trading account assets. At 4Q19, BAC had commitments to enter into resale and forward-dated resale and securities borrowing"
8945,664,25,These commitments expire primarily within the next 12 months.
8946,664,26,This commitment extends through November 2022 and can be terminated with 12-months prior notice.
8947,664,27,"activity is performed by a joint venture, formed in 2009, in which BAC owns a 49% ownership interest. The joint venture is accounted for as an equity method investment. BAC gave notice on July 29, 2019 to the joint venture partner of the termination of the"
8948,664,28,"joint venture upon the conclusion of its current term, after which BAC expects to pursue its own merchant services strategy. In addition, BAC and the joint venture partner have an agreement to provide uninterrupted delivery of products and services to the joint"
8949,664,29,"As a result of the above actions, BAC incurred a non-cash, pretax impairment charge of $2.1bn included in other general operating expense in 3Q19. As stated above, BAC expects to pursue its own merchant"
8950,664,30,"services strategy, which is expected to begin in 3Q20. Under this strategy, BAC will begin to record the revenues and expenses from those operations in the Consolidated Statement of Income instead of recognizing its proportionate share of the joint ventures"
8951,664,31,"On January 31, 2020, the U.K. formally exited the European Union EU. Upon exit, a transition period began during which time the U.K. and the EU expect to negotiate a trade agreement and other terms associated with their future"
8952,664,32,"The transition period is scheduled to end on December 31, 2020. BAC conducts business in Europe, the Middle East and Africa primarily through its subsidiaries in the U.K., Ireland and France. While BAC has taken measures to minimize"
8953,664,33,"operational disruption and prepare for various potential outcomes of the U.K.s withdrawal from the EU, the preparedness of its counterparties and the relevant financial markets infrastructure remain outside its control."
8954,664,34,"BAC continues to assess potential risks, including operational, regulatory and legal risks. At 4Q19, its net exposure to the U.K. was"
8955,664,35,"Following the 2017 announcement by the U.K.s Financial Conduct Authority FCA that it will no longer persuade or require participating banks to submit rates for the London Interbank Offered Rate LIBOR after 2021, central"
8956,664,36,"banks and regulators around the world have commissioned working groups to find suitable replacements for Interbank Offered Rates IBOR, including LIBOR, and other benchmark rates and to implement financial benchmark reforms more generally."
8957,664,37,"future discontinuance of IBORs is a complex process that has resulted in significant uncertainty regarding the transition to suitable alternative reference rates ARRs and could cause disruptions in a variety of global financial markets, as well as adversely impact BACs business, operations and financial results. IBORs, including LIBOR, are used in many of BACs products and contracts, including mortgages, consumer, commercial and corporate loans, derivatives, floating-rate notes and other adjustable- rate products and financial instruments. The aggregate notional amount of these products and contracts is material to BACs business. As previously disclosed, to facilitate an orderly transition from IBORs and other benchmark rates to ARRs, BAC has"
8958,664,38,"As part of this initiative, BAC continues to identify, assess and monitor risks associated with the expected discontinuation or unavailability of LIBOR and other benchmarks and evaluate"
8959,664,39,and address documentation and contractual mechanics of outstanding IBOR-based products and contracts that mature after 2021 and new and potential future ARR-based products and contracts to achieve operational readiness.
8960,664,40,"BAC is also modifying its operational models, systems, procedures and internal infrastructure to transition to ARRs. In 2019, BAC launched capabilities to support issuance and trading in products indexed to the new Secured Overnight Financing Rate SOFR, which is the alternative benchmark rate to U.S. dollar LIBOR recommended by the Alternative"
8961,664,41,"Also, in 2019, BAC issued debt linked to SOFR, and BAC co-arranged one of the first credit facilities linked to SOFR and has implemented fallback provisions into certain new IBOR-based products"
8962,664,42,"BAC continues to monitor the development and usage of ARRs, including SOFR. Emerging markets: A number of economic conditions and geopolitical events have given rise to risk aversion in certain emerging markets."
8963,664,43,"trade tensions, BAC continues to closely monitor its exposures to tariff-sensitive regions and industries, particularly to countries that account for a large percentage of U.S. trade, 20 February 2020 5"
8964,664,44,"Headcount: At 4Q19, BAC had a headcount of approximately 208,000 209,000 at 3Q19 employees. Preferred stock: 1 On January 24, 2020, BAC issued 44,000 shares of 4.300% Fixed- to-Floating Rate Non-Cumulative Preferred Stock, Series MM for $1.1bn 2 Additionally, on January 27, 2020, BAC fully redeemed Series Y preferred stock for $1.1bn. Pension plan contribution: Other long-term liabilities include BACs contractual funding obligations related to the Non-U.S. Pension Plans and Nonqualified and Other Pension Plans together, the Plans. Obligations to the Plans are based on the current and projected obligations of the Plans, performance of the Plans assets, and any participant"
8965,664,45,"During 2019, BAC contributed $135mn $156mn in 2018, and BAC expects to make $128mn of contributions during 2020 ."
8966,664,46,"Other Pension Plans, and Postretirement Health and Life Plans in 2019 is $21mn, $92mn and $15mn, respectively. BAC does not expect to make a contribution to the Qualified Pension Plan in 2020. The IRS and other tax authorities in countries and states in which BAC has significant business operations examine tax returns periodically continuously in some jurisdictions."
8967,664,47,"2018 is expected to begin in 2020. Its California returns for , NYS and UK tax return for 2018 are in the process of field examination."
8968,664,48,Deferred taxes: Its net DTA was $6.4bn at 4Q19 $10.7bn at 4Q18 including $2.0bn valuation allowance $1.6bn valuation allowance at 4Q18. UTB: Its Unrecognized Tax Benefits UTB balance was $1.2bn at 4Q19 $2.2bn at
8969,664,49,"At 4Q19, the balance of BACs UTBs which would, if recognized, affect BACs effective tax rate was $814mn, $1.6bn at 4Q18. Included in the UTB balance are some items the recognition of which would not affect the effective tax rate, such as the tax"
8970,664,50,"effect of certain temporary differences, the portion of gross state UTBs that would be offset by the tax benefit of the associated federal deduction and the portion of gross non- U.S. UTBs that would be offset by tax reductions in other jurisdictions."
8971,664,51,"reasonably possible that the UTB balance may decrease by as much as $1.2bn during the next 12 months, since resolved items will be removed from the balance whether their resolution results in payment or recognition."
8972,664,52,"Total Loss-Absorbing Capacity Requirements: Effective January 1, 2019, BAC is subject to the Federal Reserves final rule requiring G-SIBs to maintain minimum levels of total loss-absorbing capacity TLAC and long-term debt. TLAC consists of BACs Tier 1 capital and eligible long-term debt issued directly by BAC. Eligible long-term debt for TLAC ratios is comprised of unsecured debt that has a remaining maturity of at least one year and satisfies additional requirements as prescribed in the TLAC final rule."
8973,664,53,"with the risk-based capital ratios and SLR, BAC is required to maintain TLAC ratios in excess of minimum requirements plus applicable buffers in order to avoid restrictions on 20 February 2020 6"
8974,664,54,"At 4Q19, BACs total eligible TLAC balance was $367.4bn $368.5bn at 3Q19. Its TLAC Percentage of risk- weighted assets ratio was 24.6% 24.8% at 3Q19 at 4Q19 vs. regulatory minimum"
8975,664,55,"of 22%, and Percentage of SLR leverage exposure was 12.5% 12.7% at 3Q19 vs. regulatory minimum of 9.5%. Its TLAC eligible long term debt totalled $171.3bn at 4Q19 $168.9bn at 3Q19, and its long term debt Percentage of risk-weighted assets"
8976,664,56,"TLAC ratio was 11.5% 11.4% at 3Q19 vs. regulatory minimum of 8.5% and the ratio of TLAC long term debt as percentage of SLR leverage exposure was 5.8% 5.8% at 3Q19 vs. regulatory minimum of 4.5%. Broker-dealer Regulatory Capital and Securities Regulation : BACs principal U.S. broker-dealer subsidiaries are BofA Securities, Inc. BofAS, Merrill Lynch Professional Clearing Corp. MLPCC and Merrill Lynch, Pierce, Fenner Smith Incorporated MLPFS. BofAS was formed as a result of the reorganization of MLPFS which was completed in May 2019. BACs principal European broker-dealer subsidiaries are Merrill Lynch International MLI and BofA Securities Europe SA BofASE. BofAS provides institutional services and is required to maintain tentative net capital in excess of $1.0bn and net capital in excess of the greater of $500mn or a certain percentage of its reserve requirement. BofAS is also required to hold a certain percentage of its risk-based margin in order to meet its CFTC minimum net capital requirement. At 4Q19, BofAS had tentative net capital of $12.5bn $13.3bn at 3Q19."
8977,664,57,BofAS also had regulatory net capital of $10.4bn $11.1bn at 3Q19 which exceeded the minimum requirement of $2.4bn $2.3bn at 3Q19 by $8.0bn. MLPCC is a fully-guaranteed subsidiary of BofAS and provides clearing and settlement services.
8978,664,58,"At 4Q19, MLPFS regulatory net capital was $4.1bn $3.3bn at 3Q19 which exceeded the minimum requirement of $102mn $104mn at 3Q19 by $4.0bn."
8979,664,59,"European broker-dealers are regulated by non-U.S. regulators. MLI, a U.K. investment firm, is regulated by the Prudential Regulation Authority and the Financial Conduct Authority, and is subject to certain regulatory capital requirements. At 4Q19, MLIs capital resources were $34.8bn $35.0bn at 3Q19, which exceeded the minimum Pillar"
8980,664,60,"BofASE, a French investment firm, is regulated by the Autorit de Contrle Prudentiel et de Rsolution and the Autorit des Marchs Financiers, and is subject to certain regulatory capital requirements."
8981,664,61,"BofASEs capital resources were $5.5bn $5.0bn at 3Q19 which exceeded the minimum Pillar 1 requirement of $1.3bn $1.3bn at 3Q19. Under the Basel 3 standardized approach, it estimated the common equity tier 1 capital ratio to be 11.2% at 4Q19 11.4% at 3Q19 with $166.8bn of common equity Tier 1 capital $169.2bn at 3Q19 and $1,493bn of risk-weighted assets $1,484bn at 3Q19. Under the Basel 3 advanced approach, it estimated the common equity tier 1 capital ratio to be 11.5% at 4Q19 11.7% at 3Q19 with $166.8bn of common equity Tier 1 capital $169.2bn at 3Q19 and $1,447bn of risk-weighted assets $1,440bn at 3Q19. BACs SLR was 6.4% at 4Q19 6.6% at 3Q19, which was above the 5.0% required minimum. Its average global liquidity sources were $576bn at 4Q19 $552bn at 3Q19 . The excess liquidity available to the parent company is held in cash and high-quality, liquid,"
8982,664,62,"Barclays Bank of America excess liquidity sources consisted of $454bn $426bn at 3Q19 in cash on deposit at the Federal Reserve and high-quality, liquid, unencumbered securities. Its brokerdealer subsidiaries excess liquidity sources consisted of $63bn $61bn at 3Q19 in cash and"
8983,664,63,"Its global liquidity sources are substantially the same in composition to what qualifies as High Quality Liquid Assets HQLA under the final U.S. Liquidity Coverage Ratio LCR rules. However, HQLA for purposes of calculating LCR is not reported at"
8984,664,64,"market value, but at a lower value that incorporates regulatory deductions and the exclusion of excess liquidity held at certain subsidiaries. The LCR is calculated as the amount of a financial institutions unencumbered HQLA relative to the estimated net"
8985,664,65,"cash outflows the institution could encounter over a 30-day period of significant liquidity stress, expressed as average. In 4Q19, BACs average consolidated HQLA, on a net basis, was $464bn $454mn at 3Q19 and the consolidated average LCR was"
8986,664,66,"BACs LCR will fluctuate due to normal business flows from customer activity. Stock issuance capacity: During 2019YTD, in connection with employee stock plans, BAC issued 91mn 83mn in 1H19 shares of its common stock and, to satisfy tax withholding obligations, repurchased 35mn 32mn in 1H19 shares of its common stock. At 4Q19, BAC had reserved 579mn 586mn at 3Q19 unissued shares of common stock for future issuances under employee stock plans, common stock"
8987,664,67,The capital conservation buffer and global systemically important bank surcharge were both 2.5% at 4Q19 and 2.5% at 3Q19. The countercyclical capital buffer for both periods was zero. The SLR minimum includes a leverage buffer of 2.0%.
8988,664,68,U.S. banking regulators issued a proposal for a Net Stable Funding Ratio NSFR requirement applicable to U.S. financial institutions following the Basel Committees final standard. The proposed U.S. NSFR would apply to BAC on a consolidated basis and to BACs insured depository institutions. While the final requirement remains pending and
8989,664,69,"is subject to change, if finalized as proposed, BAC expects to be in compliance within the regulatory timeline. The standard is intended to reduce funding risk over a longer time horizon. The NSFR is designed to provide an appropriate amount of stable funding,"
8990,664,70,"In 2019, U.S. banking regulators published a final rule outlining a standardized approach for counterparty credit risk, which updates the"
8991,664,71,"The final rule will be effective on April 1, 2020, with a mandatory compliance date of January 1, 2022. This rule could have a negative impact on BACs"
8992,664,72,"In 2018, the Federal Reserve issued a proposal to implement a stress capital buffer into its capital requirements, which may increase BACs regulatory capital requirements, if adopted. A significant component of regulatory capital ratios is calculating BACs risk-"
8993,664,73,"weighted assets and BACs leverage exposure, which may increase. The Basel Committee on Banking Supervision has also revised several key methodologies for measuring risk-weighted assets, including a standardized approach for credit risk,"
8994,664,74,U.S. banking regulators may update the U.S. Basel 3 rules to incorporate the Basel
8995,664,75,"On January 1, 2020, BAC adopted the new accounting standard that requires the measurement of the allowance for credit losses to be based on managements best estimate of lifetime expected credit losses inherent in BACs relevant financial assets."
8996,664,76,"adoption of the standard resulted in a decrease to the CET1 capital ratio of 17 bps, which will be phased in evenly, or approximately four bps per year, at the beginning of each year from January 1, 2020 through January 1, 2023 in accordance with transition provisions issued by the U.S. banking regulators. Capital Requirements for Swap Dealers: On December 10, 2019, the CFTC re-opened the comment period on its 2016 proposal to establish capital requirements for swap dealers and major swap participants that are not subject to existing U.S. prudential"
8997,664,77,"Under the proposal, applicable subsidiaries of BAC would be permitted to elect one of two approaches to compute their regulatory capital. The first approach is a bank-based capital approach which requires that firms maintain CET1 capital greater"
8998,664,78,The second approach is based on net liquid
8999,664,79,assets and requires that a firm maintain net capital greater than or equal to 8.0% of the margin as described above. The proposal also includes liquidity and reporting requirements.
9000,664,80,Single-Counterparty Credit Limits: The Federal Reserve established single- counterparty credit limits SCCL for BHCs with total consolidated assets of $250bn or more. The SCCL rule is designed to ensure that the maximum possible loss that a BHC could incur due to the default of a single counterparty or a group of connected
9001,664,81,"counterparties would not endanger the BHCs survival, thereby reducing the probability of future financial crises. Beginning January 1, 2020, G-SIBs must calculate SCCL on a daily basis by dividing the aggregate net credit exposure to a given counterparty by the"
9002,664,82,"G-SIBs Tier 1 capital, ensuring that exposures to other G-SIBs and nonbank financial institutions regulated by the Federal Reserve do not breach 15% of Tier 1 capital and exposures to most other counterparties do not breach 25% of Tier 1 capital."
9003,664,83,"exposures, including exposures to the U.S. government, U.S. government-sponsored entities and qualifying central counterparties, are exempt from the credit limits."
9004,664,84,"The ratings from Standard Poors Global Ratings SP for BAC and its subsidiaries did not change during 2019. The long-term and short-term debt ratings of BofAS and BofASE, which were initially rated by SP during 1Q19, also remained unchanged during the rest of 2019."
9005,664,85,"Moodys: On March 6, 2019, Moodys Investors Service Moodys upgraded the long- term and short-term ratings of BAC by one notch to A2P-1 from A3P-2 for senior debt, as well as the long-term ratings of its rated subsidiaries, including BANA, which the agency upgraded to Aa2 from Aa3 for senior debt. Moodys concurrently affirmed the short-term ratings of BACs rated subsidiaries, including BANA. Moodys cited BACs strengthening profitability, continued adherence to a conservative risk profile and stable capital ratios as rationale for the upgrade. The rating outlook for all long-term ratings is"
9006,664,86,"On June 12, 2019, Fitch Ratings Fitch completed its periodic review of the 12 large, complex securities trading and universal banks, including Bank of America Corporation. The agency affirmed the long-term and short-term senior debt ratings of"
9007,664,87,"Barclays Bank of America Designated Activity Company, which Fitch upgraded by one notch to AA-F1. The rating outlook for all long-term ratings is currently stable."
9008,664,88,"During 2019, the asset sensitivity of BACs balance sheet increased primarily due to decreases in interest rates. BAC continues to be asset sensitive to a parallel move in interest rates with the majority of that impact coming from the short end of the yield curve . Additionally, higher interest rates impact the fair value of debt securities and,"
9009,664,89,"accordingly, for debt securities classified as available for sale AFS, may adversely affect accumulated other comprehensive income OCI and thus capital levels under the Basel 3 capital rules."
9010,664,90,impact to Basel 3 capital is reduced over time by offsetting positive impacts to net interest income. Rate sensitivity: A 100bp instantaneous parallel increase in rates from the forward curve increases core net interest income by $4.2bn $4.6bn at 3Q19.
9011,664,91,instantaneous parallel decrease in rates from the forward curve decreases core net interest income by $6.5bn -$6.5bn at 3Q19. A 100bp instantaneous curve flattening from the forward market curve increase in short-term rates increases net interest
9012,664,92,"income by $2.6bn $2.7bn at 3Q19, while a 100bp instantaneous curve steepening increase in long-term rates, increases net interest income by $1.6bn $1.9bn at 3Q19. AFS debt securities portfolio totaled $245.6bn $244.9bn at 3Q19 at fair value, with net unrealized gain of $2.3bn net unrealized gain of $3.1bn at 3Q19. BAC had $38.7bn $49.5bn at 3Q19 of AFS debt securities in an unrealized loss position for 12 months or longer at 4Q19 with a loss of $298mn $466mn loss at 3Q19."
9013,664,93,"The residential mortgage portfolio made up the largest percentage of BACs consumer loan portfolio at 51% 50% at 3Q19 of consumer loans and leases at 4Q19. At 4Q19, approximately 50% 49% at 3Q19 of the residential mortgage portfolio is in Consumer Banking and approximately 36% 36% at 3Q19 is in GWIM."
9014,664,94,"the residential mortgage portfolio is in All Other and is comprised of originated loans, purchased loans used in BACs overall ALM activities, delinquent FHA loans repurchased pursuant to BACs servicing agreements with GNMA as well as loans repurchased related to BACs representations and warranties. At 4Q19, mortgage loans totaled $236.2bn $227.5bn at 3Q19. Of this portfolio, 2% 2% at 3Q19 has a refreshed LTV between 90-100%, 1% 1% at 3Q19 has a refreshed LTV over 100%, 3% 3% at 3Q19 has a FICO score below 620, and 4%"
9015,664,95,"4% at 3Q19 is from origination vintages. Of the $217.5bn $208.8bn at 3Q19 in total residential mortgage loans excluding fully insured loans, 26% 27% at 3Q19 were originated as interest-only. The outstanding balance of interest-only residential mortgage loans that have entered the amortization"
9016,664,96,"period was $7.4bn $7.9bn at 3Q19, or 13% at 4Q19 14% at 3Q19. Residential mortgage loans that have entered the amortization period generally have experienced a higher rate of early stage delinquencies and nonperforming status compared to the"
9017,664,97,"At 4Q19, $124mn or 2% $156mn, or 2% at 3Q19 of outstanding interest-only residential mortgages that had entered the amortization period were accruing past due 30 days or more compared to $1.3bn or 1%"
9018,664,98,"Barclays Bank of America 4Q19, $260mn or 4% $301mn, or 4% at 3Q19 of outstanding interest-only residential mortgage loans that had entered the amortization period were nonperforming, of which $108mn $97mn at 3Q19 were contractually current, compared to $1.5bn or 1% $1.6bn, or 1% at 3Q19 for the entire residential mortgage portfolio. Loans that have yet to enter the amortization period in its interest-only residential mortgage portfolio are primarily well-collateralized loans to its wealth management clients and have an"
9019,664,99,Approximately 94% 93% at 3Q19 of these loans that have yet to enter the amortization period will not be required to make a fully- amortizing payment until 2022 or later.
9020,664,100,"FHA loans: At 4Q19, the residential mortgage portfolio included $18.7bn $18.7bn at 3Q19 of outstanding fully-insured loans. At 4Q19, $11.2bn $11.7bn at 3Q19 had FHA insurance with the remainder protected by long-term standby agreements."
9021,664,101,"At 4Q19, the home equity portfolio made up 9% 9% at 3Q19 of the consumer portfolio and is comprised of home equity lines of credit HELOCs, home equity loans and reverse mortgages. At 4Q19, home equity loans totaled $40.2bn $44.3bn at 3Q19. Of this portfolio, 1% has a refreshed CLTV between 90-100% 2% at 3Q19, 2% had a CLTV over 100% 2% at 3Q19, 3% had a refreshed FICO below 620"
9022,664,102,"3% at 3Q19, and 18% was from 2006-07 origination vintages 19% at 3Q19. HELOCs: The outstanding balance of HELOCs that have entered the amortization period was $11.5bn $12.3bn at 3Q19 at 4Q19. The HELOCs that have entered the amortization period have experienced a higher percentage of early stage delinquencies"
9023,664,103,"At 4Q19, $149mn, or 1% $162mn, or 1% at 3Q19, of outstanding HELOCs that had entered the amortization period were accruing past due 30 days or more. In addition, at 4Q19, $472mn, or 4% $518mn, or 4% at 3Q19, were nonperforming."
9024,664,104,"At 4Q19, residential mortgage TDRs were $4.8bn $5.0bn at 3Q19, including $1.2bn $1.3bn at 3Q19 deemed collateral dependent and $2.1bn $2.1bn at 3Q19 fully insured loans. Home equity TDRs were $1.2bn $1.3bn, including $442mn $478bn at 3Q19 deemed collateral dependent."
9025,664,105,Commercial reservable criticized utilized exposure was $11.5bn compared to $11.8bn at 3Q19. 90% of commercial reservable criticized utilized exposure was secured at 4Q19 90% at 3Q19.
9026,664,106,"Derivative balances: Derivatives are entered into on behalf of customers, for trading or to support risk management activities. At 4Q19, total derivative assets were $40.5bn $45.1bn at 3Q19 net of $270.4bn $305.6bn at 3Q19 of legally enforceable master netting agreements and $33.9bn $40.7bn at 3Q19 of cash collateral."
9027,664,107,Cash Flow and Net Investment Hedges: Of the $400mn net loss after-tax on derivatives in accumulated OCI at 4Q19 $365mn after tax net loss at 3Q19 net losses in accumulated OCI of $68mn after tax $78mn after-tax in 3Q19 on derivative instruments that qualify as cash flow hedges are expected to be reclassified into earnings in the next 12 months . These net losses reclassified into earnings are expected to primarily reduce net interest income related to the respective hedged items.
9028,664,108,"OCI are recorded in personnel expense. For terminated cash flow hedges, the time period over which substantially all of the forecasted transactions are hedged is"
9029,664,109,"Certain of BACs derivative contracts contain credit risk-related contingent features, primarily in the form of ISDA master netting agreements and credit support documentation that enhance the creditworthiness of these instruments compared to other obligations of the respective counterparty with whom BAC has transacted. These contingent features may be for the"
9030,664,110,"At 4Q19, it held cash and securities collateral of $84.3bn $91.0bn at 3Q19 and posted"
9031,664,111,"cash and securities collateral of $69.1bn $73.6bn at 3Q19 in the normal course of business under derivative agreements, excluding cross-product margining agreements where clients are permitted to margin on a net basis for both derivative and secured financing arrangements . In connection with certain OTC derivative contracts and other trading agreements, BAC can be required to provide additional collateral or to terminate transactions with certain counterparties in the event of a"
9032,664,112,"At 4Q19, the amount of collateral, calculated based on the terms of the contracts, that BAC and certain subsidiaries could be required to post to counterparties but had not yet"
9033,664,113,"Some counterparties are currently able to unilaterally terminate certain contracts, or BAC or certain subsidiaries may be required to take other action such as"
9034,664,114,"At 4Q19 and 3Q19, the liability recorded for these derivative contracts was not significant."
9035,664,115,Mortgage repurchase reserve: The reserve for representations and warranties and corporate guarantees was $1.8bn at 4Q19 $1.8bn at 3Q19 and is included in accrued expenses and other liabilities on the Consolidated Balance Sheet and the related provision is included in other income in the Consolidated Statement of Income.
9036,664,116,"representations and warranties reserve represents BACs best estimate of probable incurred losses, is based on BACs experience in previous negotiations, and is subject to judgment, a variety of assumptions, and known or unknown uncertainties."
9037,664,117,"representations and warranties losses may occur in excess of the amounts recorded for these exposures however, BAC does not expect such amounts to be material to BACs financial condition and liquidity."
9038,664,118,"At 4Q19, BAC had $10.7bn $14.4bn at 4Q18 of unresolved repurchase claims, net of duplicate"
9039,664,119,claims and excluding claims where the statute of limitations has expired without litigation being commenced. The balance for 2019 also includes $1.6bn of repurchase claims related to a single monoline insurer and is the subject of
9040,664,120,"Bank-owned Life Insurance Book Value Protection: BAC sells products that offer book value protection to insurance carriers who offer group life insurance policies to corporations, primarily banks."
9041,664,121,"which are recorded as derivatives totaled $7.3bn $7.2bn at 3Q19. At 4Q19, BACs maximum exposure related to these guarantees totaled $1.1bn $1.1bn at 3Q19, with estimated maturity dates between 2033 and 2039."
9042,664,122,"Merchant Services: In accordance with credit and debit card association rules, BAC sponsors merchant processing servicers that process credit and debit card transactions 20 February 2020 12"
9043,664,123,"If the merchant processor fails to meet its obligation to reimburse the cardholder for disputed transactions, then BAC could be held liable. In 2019, the sponsored entities processed and settled $916.6bn $874.3bn in 2018 of"
9044,664,124,"At 4Q19, the maximum potential exposure for sponsored transactions totaled $384.2bn $375.7bn at 3Q19. However, BAC believes that the maximum potential exposure is not"
9045,664,125,"A significant portion of BACs merchant processing activity is performed by a joint venture formed in 2009, in which"
9046,664,126,"BAC holds a 49% ownership interest . The carrying value of the investment was $640mn at 4Q19 $652mn at 3Q19. The joint venture is accounted for as an equity method investment and reported in All Other. On July 29, 2019, BAC gave notice to the"
9047,664,127,"As a result, BAC incurred a non-cash, pretax impairment charge in 2019 of $2.1bn, included in other general operating expense."
9048,664,128,"Other Guarantees: BAC has entered into additional guarantee agreements and commitments, including sold risk participation swaps, liquidity facilities, lease-end obligation agreements, partial credit guarantees on certain leases, real estate joint venture guarantees, divested business commitments and sold put options that require gross settlement. The maximum potential future payment under these agreements was approximately $8.7bn at 4Q19 $8.1bn 3Q19. The estimated maturity dates of these obligations extend up to 2049. BAC has made no material payments under these"
9049,664,129,"During 2019, BAC recognized a loss of $210mn in other income under its indemnity obligation in connection with the 2017 sale of its non-U.S. consumer credit card business payment protection insurance."
9050,664,130,"During 2019, positive trading-related revenue was recorded for 98% 98% in 2018 of the trading days, of which 80% 79% in 2018 were daily trading gains of over $25mn and the largest loss was $35mn."
9051,664,131,"trading portfolio in 2019 was $38mn range of $28mn-$56mn, compared to $38mn in 2018 range of $26mn-$57mn. Credit Card Securitizations: BAC securitizes originated and purchased credit card loans. BACs continuing involvement with the securitization trust includes servicing the receivables, retaining an undivided interest sellers interest in the receivables, and holding certain retained interests including subordinate interests in accrued interest and fees on the securitized receivables and cash reserve accounts."
9052,664,132,"At 4Q19, BAC held subordinate securities issued by the credit card securitization trust with a notional principal amount of"
9053,664,133,These securities serve as a form of credit enhancement to the senior debt securities and have a stated interest rate of 0%.
9054,664,134,"Generally, there are no significant ongoing activities performed in a resecuritization trust, and no single investor has the unilateral ability to liquidate the trust."
9055,664,136,Barclays Bank of America resecuritization VIEs were measured at fair value with changes in fair value recorded in trading account profits prior to the resecuritization and no gain or loss on sale was recorded. Resecuritization proceeds included securities with an initial fair value of
9056,664,137,Substantially all of the other securities received as resecuritization proceeds were classified as trading securities and were categorized as Level 2 within the fair value hierarchy.
9057,664,138,"Municipal Bond Trusts: BAC administers municipal bond trusts that hold highly-rated, long-term, fixed-rate municipal bonds. The trusts obtain financing by issuing floating rate trust certificates that reprice on a weekly or other short-term basis to third party investors."
9058,664,139,"including those for which BAC was transferor, totaled $3.7bn at 4Q19 $3.4bn at 3Q19. The weighted-average remaining life of bonds held in the trusts at 4Q19 was 10.0 years 10.8 years at 3Q19."
9059,664,140,"Customer VIEs: Customer VIEs include credit-linked, equity-linked and commodity- linked note VIEs, repackaging VIEs and asset acquisition VIEs, which are typically created on behalf of customers who wish to obtain market or credit exposure to a specific company, index, commodity or financial instrument. BACs maximum loss exposure to consolidated and unconsolidated customer VIEs totaled $2.2bn at 4Q19 $2.2bn at 3Q19 including the notional amount of derivatives to which BAC is a counterparty, net of losses previously recorded, and BACs investment, if any, in securities issued by the VIEs. BAC receives fees for structuring CDO VIEs, which hold diversified pools of fixed-income securities, typically corporate debt or ABS, which the CDO VIEs fund by issuing multiple tranches of debt and equity securities. CDOs are generally managed by third-party portfolio managers. BAC typically transfers assets to these CDOs, holds securities issued by the CDOs and may be a derivative counterparty to the CDOs. BACs maximum loss exposure to consolidated and unconsolidated CDOs totaled $304mn at 4Q19 $275mn at 3Q19. Investment VIEs: BAC sponsors, invests in or provides financing, which may be in connection with the sale of assets, to a variety of investment VIEs that hold loans, real estate, debt securities or other financial instruments and are designed to provide the desired investment profile to investors or BAC. At 4Q19 BACs consolidated investment VIEs had total assets of $104mn $158mn at 3Q19."
9060,664,141,"BACs maximum loss exposure associated with both consolidated and unconsolidated investment VIEs totaled $6.4bn at 4Q19 $6.6bn at 3Q19 comprised primarily of on- balance sheet assets less non-recourse liabilities. Leveraged Lease Trusts: BACs net investment in consolidated leveraged lease trusts totaled $1.7bn 4Q19 $1.7bn at 3Q19. The trusts hold long-lived equipment such as rail cars, power generation and distribution equipment, and commercial aircraft."
9061,664,142,The net investment represents BACs maximum loss exposure to the trusts in the unlikely event that the leveraged lease investments become worthless.
9062,664,143,"Tax Credit VIEs : BAC holds investments in unconsolidated limited partnerships and similar entities that construct, own and operate affordable housing, wind and solar projects. An unrelated third party is typically the general partner or managing member"
9063,664,144,BAC earns a return primarily 20 February 2020 14
9064,664,145,The maximum loss exposure included in the Other VIEs table was $18.9bn at 4Q19 and $17.2bn at 3Q19. BACs risk of loss is generally mitigated by policies requiring that the project qualify for the
9065,664,146,"BACs investments in affordable housing partnerships, which are reported in other assets on the Consolidated Balance Sheet, totaled $10.0bn $9.1bn at 3Q19, including unfunded commitments to provide capital contributions of $4.3bn $3.9bn at 3Q19 at 4Q19. The unfunded commitments are expected to be paid over the next five years. BAC recognized tax credits and other tax benefits from investments in affordable housing partnerships of $1.0bn $981mn in"
9066,664,147,Tax credits are recognized as part of BACs annual effective tax rate used to determine tax expense in a given quarter.
9067,664,148,expected tax benefits recognized in any given quarter may differ from 25%. BAC may from time to time be asked to invest additional amounts to support a troubled affordable housing project. Such additional investments have not been and are not
9068,664,149,"Retail bank: BACs retail banking footprint covers approximately 90% 90% at 3Q19 of the U.S. population, and BAC serves approximately 66mn 66mn at 3Q19 consumer and small business clients with approximately 4,300 4,300 at 3Q19 retail financial centers, approximately 16,600 16,800 at 3Q19 ATMs, and leading digital banking platforms with more than 38mn 38mn at 3Q19 active users, including over 29mn 29mn at 3Q19 active mobile users."
9069,664,150,"On January 1, 2019, BAC adopted the new accounting standards that require lessees to recognize operating leases on the balance sheet as right-of-use"
9070,664,151,Expanded disclosures about the nature and terms of lease agreements are required prospectively and are included in Note 9
9071,664,152,"BAC elected to retain prior determinations of whether an existing contract contains a lease and how the lease should be classified. BAC elected to recognize leases existing on January 1, 2019 through a cumulative-effect adjustment which increased retained earnings by $165mn, with no adjustment to prior periods presented. Upon adoption, BAC also recognized right-of-use assets and lease liabilities of $9.7bn. Adoption of the standards did not have a significant effect on BACs regulatory"
9072,664,153,"On January 1, 2020, BAC adopted the new accounting standard that requires the measurement of the allowance for credit losses to be based on managements best estimate of lifetime expected credit"
9073,664,154,"BACs lifetime expected credit losses are determined using macroeconomic forecast assumptions and management judgments applicable to and through the expected life of the loan portfolios, and are net of expected recoveries on loans that were previously charged off. The standard also expands credit quality disclosures beginning in 1Q20. While the standard changes the measurement of the allowance for credit losses, it does not change BACs credit risk of"
9074,664,155,"Upon adoption of the standard on January 1, 2020, BAC recorded a $3.3bn, or 32%, increase to the allowance for credit losses."
9075,664,156,decrease was recorded in retained earnings through a cumulative-effect adjustment.
9076,664,157,"For a limited number of the matters disclosed in this Note for which a loss, whether in excess of a related accrued liability or where there is no accrued liability, is reasonably possible in future periods, BAC is able to estimate a range of possible loss."
9077,664,158,"determining whether it is possible to estimate a range of possible loss, BAC reviews and evaluates its matters on an ongoing basis, in conjunction with any outside counsel handling the matter, in light of potentially relevant factual and legal developments."
9078,664,159,"respect to the matters disclosed in this Note, in cases in which BAC possesses sufficient appropriate information to estimate a range of possible loss, that estimate is aggregated and disclosed below. There may be other disclosed matters for which a loss is probable"
9079,664,160,"or reasonably possible but such an estimate of the range of possible loss may not be possible. For such matters disclosed in this Note, where an estimate of the range of possible loss is possible, as well as for representations and warranties exposures,"
9080,664,161,"management currently estimates the aggregate range of reasonably possible loss for these exposures $0 to $1.6bn $0 to $1.8bn at 3Q19 in excess of the accrued liability, if any, at 4Q19. The estimated range of possible loss, as well as BACs accrued"
9081,664,162,"liability, is based upon currently available information and is subject to significant judgment, a variety of assumptions and known and unknown uncertainties. The matters underlying the estimated range of possible loss and liability accrual are unpredictable"
9082,664,163,"and will change from time to time, and actual losses may vary significantly from the current estimate and accrual. The estimated range of possible loss does not represent BACs maximum loss exposure."
9083,664,164,"Information is provided below regarding the nature of the litigation and associated claimed damages. Based on current knowledge, and taking into account accrued liabilities, management does not believe that loss contingencies arising from pending matters, including the matters described herein, will have a material adverse effect on"
9084,664,165,"However, in light of the significant judgment, variety of assumptions and uncertainties involved in these matters, some of which are beyond BACs control, and the very large or indeterminate"
9085,664,166,"damages sought in some of these matters, an adverse outcome in one or more of these matters could be material to BACs business or results of operations for any particular reporting period, or cause significant reputational harm. Litigation expenses: Excluding expenses of internal and external legal service providers, litigation-related expense of was $142mn recognized in 4Q19 $352mn in 3Q19, $114mn in 2Q19, $73mn in 1Q19. Ambac Assurance Corporation and the Segregated Account of Ambac Assurance Corporation together, Ambac have filed four separate"
9086,664,167,"lawsuits against BAC and its subsidiaries relating to bond insurance policies Ambac provided on certain securitized pools of HELOCs, first-lien subprime home equity loans, fixed-rate second-lien mortgage loans and negative amortization pay option adjustable- rate mortgage loans. Ambac alleges that they have paid or will pay claims as a result of defaults in the underlying loans and asserts that the defendants misrepresented the characteristics of the underlying loans andor breached certain contractual"
9087,664,168,"In those actions where BAC is named as a defendant, Ambac contends BAC is liable on various successor and vicarious liability theories. These actions are at various procedural"
9088,664,169,"Ambac v. Countrywide I. BAC, Countrywide and other Countrywide entities are named as defendants in an action filed on September 28, 2010 in New York Supreme Court. Ambac asserts claims for fraudulent inducement as well as breach of contract and seeks"
9089,664,170,"On May 16, 2017, the First Department issued its decisions on the parties cross-appeals of the trial courts October 22, 2015 summary judgment rulings. Ambac appealed the First Departments rulings"
9090,664,171,"requiring Ambac to prove all of the elements of its fraudulent inducement claim, including justifiable reliance and loss causation restricting Ambacs sole remedy for its breach of contract claims to the repurchase protocol of cure, repurchase or substitution of any materially defective loan and dismissing Ambacs claim for reimbursements of attorneys fees. On June 27, 2018, the New York Court of Appeals affirmed the First Department rulings that Ambac appealed."
9091,664,172,"Ambac v. Countrywide II On December 30, 2014, Ambac filed a complaint in New York"
9092,664,173,"Ambac seeks damages in excess of $600mn, plus punitive damages. On December 19, 2016, the Court granted"
9093,664,174,"On July 21, 2015, Ambac filed an action in New York Supreme Court against Countrywide asserting the same claims for fraudulent inducement that Ambac asserted in the now dismissed Ambac v. Countrywide III."
9094,664,175,"On April 16, 2012, Ambac filed an action against BANA, First Franklin and various Merrill Lynch entities, including Merrill Lynch, Pierce, Fenner Smith Incorporated, in New York Supreme Court relating to guaranty insurance Ambac"
9095,664,176,"The complaint alleges fraudulent inducement and breach of contract, including breach of contract claims against BANA based upon its servicing of the loans in the securitization."
9096,664,177,"seeks as damages hundreds of millions of dollars that Ambac alleges it has paid or will pay in claims. On January 9, 2017, the FDIC filed suit against BANA in the U.S. District Court for the District of Columbia alleging failure to pay a December 15,"
9097,664,178,"On April 7, 2017, the FDIC amended its complaint to add a claim for additional deposit insurance"
9098,664,179,The FDIC asserts these claims based on BANAs alleged underreporting of counterparty exposures that resulted in underpayment of assessments for those
9099,664,180,"quarters and its Enforcement Section is also conducting a parallel investigation related to the same alleged reporting error. BANA disagrees with the FDICs interpretation of the regulations as they existed during the relevant time period and is defending itself against the FDICs claims. Pending final resolution, BANA has pledged security satisfactory to the FDIC related to the disputed additional assessment amounts. On March 27, 2018, the U.S. District Court for the District of Columbia denied BANAs partial motion to"
9100,664,181,"In 2005, a group of merchants filed a series of putative class actions and individual actions directed at interchange fees associated with Visa and MasterCard payment card transactions. These actions, which were consolidated in the"
9101,664,183,"In 2018, defendants reached a settlement of the putative Rule 23b3 damages class. Defendants agreed to pay an additional amount to participating class members by"
9102,664,184,BACs additional contribution was not material. The District Court granted final approval of the settlement in December
9103,664,185,"Beginning in January 2020, a number of class members who objected to the settlement appealed to the U.S. Court of Appeals for the Second Circuit."
9104,664,186,Government authorities in the U.S. and various international jurisdictions continue to
9105,664,187,"BAC is cooperating with these inquiries and investigations, and responding to the proceedings. BAC, BANA and certain Merrill Lynch entities have been named as defendants along with most of the other London Interbank Offered Rate LIBOR panel banks in a number of individual and putative class actions by persons alleging they sustained losses on U.S. dollar LIBOR-based financial instruments as a result of collusion or manipulation by defendants regarding the setting of U.S. dollar LIBOR."
9106,664,188,"All cases naming BAC and its affiliates relating to U.S. dollar LIBOR are pending in the U.S. District Court for the Southern District of New York. The District Court has dismissed all RICO claims, and dismissed all manipulation claims based on"
9107,664,189,"The District Court has also substantially limited the scope of antitrust, Commodity Exchange Act and various other claims, including by dismissing in their entirety certain individual and putative class"
9108,664,190,Plaintiffs whose antitrust claims were dismissed by the District Court are pursuing appeals in the Second Circuit. Certain individual and putative class actions remain pending in the
9109,664,191,"On February 28, 2018, the District Court denied certification of proposed classes of lending institutions and persons that transacted in euro dollar futures, and the U.S. Court of Appeals for the"
9110,664,192,"Second Circuit subsequently denied petitions filed by those plaintiffs for interlocutory appeals of those rulings. Also on February 28, 2018, the District Court granted certification of a class of persons that purchased OTC swaps and notes that referenced"
9111,664,193,"U.S. dollar LIBOR from one of the U.S. dollar LIBOR panel banks, limited to claims under Section 1 of the Sherman Act. The U.S. Court of Appeals for the Second Circuit subsequently denied a petition filed by the defendants for interlocutory appeal of that"
9112,664,194,"BAC, Countrywide and certain affiliates are named as defendants in two consolidated putative class action lawsuits filed in the U.S. District Court for the Central District of California Waldrup and Williams, et al.. Plaintiffs allege"
9113,664,195,"that Countrywide and a former Countrywide subsidiary, LandSafe Appraisal Services, Inc., arranged for and completed appraisals that were not in compliance with applicable laws and appraisal standards. Plaintiffs assert a RICO claim and seek, among other"
9114,664,196,"On February 8, 2018, the District Court granted plaintiffs motion for class certification. On May 22, 2018, the U.S. Court of Appeals for the Ninth Circuit denied defendants petition for permission to file an"
9115,664,197,"On January 21, 2020, the parties agreed to resolve the litigation for an amount that is not"
9116,664,198,"Barclays Bank of America material to BAC, and which was fully accrued as of December 31, 2019. The agreement is subject to court approval."
9117,664,200,"Loan Trust 2005-10 and various SURFOWNIT RMBS trusts filed complaints against BAC, Countrywide entities, Merrill Lynch entities and other affiliates in New York Supreme Court alleging breaches of representations and warranties."
9118,664,201,"and certain certificate-holders in the trusts agreed to settle the respective matters in amounts not material to BAC, subject to acceptance by U.S. Bank. The litigations have been stayed pending finalization of the settlements."
9324,681,1,"We initiate coverage of Abbott Laboratories ABT with a Buy rating and $56 Price Target. Strengthening product cycles in Abbott Vascular, a rebound in Nutritional Products, and a differentiated strategy in Established Pharmaceuticals are expected to drive high-single-digit EBITDA growth over the next several years, and justify a reduction in the conglomerate discount implied within the current stock price."
9325,681,2,"Abbott Vascular Outlook Brightening with an Expectation of $56.00 12 month target Sustainable Mid-Single-Digit Growth: Abbotts commercial lead 14.4% Upside with the Absorb bioresorbable vascular scaffold will enable the company to increase share within the US drug eluting stent market during 2016, and could also support a break into the Chinese market. $39.75 - $49.34 52 week range Nutritional Products Annualizing Negative Events Supports Return $74,193 Market Cap m to High-Single-Digit Growth: Headwinds from product recalls and product portfolio adjustments are annualizing, and set Abbott Nutritionals for International growth acceleration. Local investment in China also supports growing market share over the next 5 years as a consolidation of Pediatric Nutritional product suppliers likely occurs."
9326,681,3,"Established Pharmaceuticals Strategy Differentiates: Abbotts strategy with Established Pharmaceuticals within Emerging Markets, based on in licensing products into a strong distribution channel, will continue to deliver double-digit revenue growth over the next several years at high incremental margins."
9327,681,4,"Using peer valuation comps to Abbotts 6 individual operating segments, we estimate that the stock is trading at over a 20% discount to the Sum-Of-Its-Parts, and as the operating profile of the company improves over the next 12-months we think that discount should be reduced towards 5%."
9328,681,5,Valuation: Our $56 price target values ABT at 14x EV 2016 EBITDA.
9329,681,7,"Abbott has gone through a series of significant portfolio transitions during the past several years, which have altered the key value drivers for the stock. The stock has risen 55% since the announcement of the AbbVie split in January 2013, relative to a 48% move in the SP 500 Index. Despite the outperformance of ABT shares over the past 2.5 years, we would continue to be buyers of the stock based on our view that 1 Several emerging products in Vascular could diminish the overhang from poor Drug Eluting Stent market fundamentals, 2 Investment in local Chinese infrastructure for Nutritionals places Abbott in a strong competitive position within the most important Nutritional growth market globally, and 3 The stock currently trades at a deep conglomerate discount that could normalize as operating fundamentals improve. We rate ABT a Buy with a $56 price target."
9330,681,8,"Our price target for ABT assigns a Fair Value multiple of 16x EV to our 2015 EBITDA estimate, which puts ABT near the high end of its peer group, but we think our target multiple is justified by an expected 10% EBITDA CAGR through 2017 Figure 1."
9331,681,9,"Key points to Thesis: Long Term Outlook: We think Abbotts portfolio will continue to evolve over the next 5 years, but assets in Established Pharmaceuticals, Established Nutritionals, Medical Optics and Vascular will remain core holdings. Emerging markets will continue to be a primary area of capital deployment, as Abbott spent $4bn on emerging markets acquisitions over the past 2 years, 90% of total MA capital allocated, and generates 47% of total annual revenues from international emerging markets Figure 2."
9332,681,10,"As Abbott improves fundamentals within the Vascular business and investment in China boosts market share in Nutritionals, we think the company can sustain a mid- to high-single-digit growth rate over the next five years, which can lever to sustainable high-single-digit EBITDA growth. Overall we view Abbott as a large cap growth stock that has scarcity value given its strong position in emerging markets."
9333,681,11,Emerging Markets Represented 47% of Annual Sales During 2014
9334,681,12,"ABT short-term alpha performance will be driven by three key themes, 1 Late 2015 FDA submission of Absorb Bioresorbable Vascular Scaffold clinical data for approval in the US, 2 Commercialization of FreeStyle Libre Flash, and 3 Rebounding sales of Nutritional products in China. Given Abbotts outsized leverage to Emerging Markets compared to its large cap diversified peer group, the stock returns have lower correlation to overall market movements. Abbotts relatively lower market correlation implies greater idiosyncratic risk-return skew, which can make the stock a key focus point for both benchmark- agnostic and benchmark-mindful investors Figure 3."
9335,681,13,"ABT shares Trade at a Moderate 50 60% Correlation to the Major Market Indices Abbott entered into several transformative MA deals during , with the sale of the Animal Health business to Zoetis along with the divestment of the developed markets branded generic business to Mylan for $5.8bn worth of Mylan shares. We estimate that with the 40m share block of Mylan sold during 2Q15, Abbott has near $6bn in cash liquidity. We project that absent any further deals Abbott would end 2015 with a Total Debt to EBITDA ratio of 1.8x and $7.4bn in cash liquidity, which excludes the remaining 70m shares of Mylan, and have an overall MA capacity of at least $12bn Figure 4. The company has been focused on molding its Pharmaceutical business over the past several years, and is likely to remain active as a consolidator of emerging market branded pharmaceutical companies. Beyond Established Pharmaceuticals, we sense the company continues to have a keen interest in building its Medical Optics business along with Vascular. We think the Abbott is less likely to engage in Diagnostics and Nutritional transactions over the next 12-months."
9336,681,14,"Using our financial forecasts for 2015 along with the trading multiples of comparative publicly traded companies for each of Abbotts 6 operating segments, we estimate that Abbott as a consolidated entity is trading at over a 20% discount versus the sum-of-its-parts Figure 5. We have used a combination of data from company filings along with management commentary to tie-out our SOTP EBITDA estimate for the company in 2015 to our aggregate model forecast. Overall, our SOTP analysis suggests that a fair enterprise value for Abbott should be close to 16x our 2015 EBITDA forecast, versus below 14x where the stock currently trades."
9337,681,15,"Abbotts Medical Devices operating segment is comprised of three key business segments Diabetes Care, Medical Optics and Vascular. Operational growth of Abbott Medical Devices has improved over the past several years, after declining -3% during 2012, and we forecast 5% operational growth during 2015."
9338,681,16,"Abbott Vascular represented 17% of total company sales during 2014, and is further delineated into 3 business units: DESBVS, Other Coronary Products and Endovascular Products. The Drug Eluting Stent Bioresorbable Vascular Scaffold DESBVS segment is by far the largest business within Vascular Figure 7."
9339,681,17,"We forecast that Abbott Vascular will generate mid-single-digit growth on an operational basis during 2015, as adoption of the Absorb Bioresorbable Vascular Scaffold BVS provides positive momentum to the DESBVS business Figure 8."
9340,681,18,"We estimate that Abbott Vascular represented 26% of the total 2014 EBIT from the four main operating segments, Established Pharmaceuticals, Nutritionals, Diagnostics and Vascular, and contributed 28% of the EBIT growth Figure 9."
9341,681,19,"Abbott Vascular operating margin reached 36.5% during 2014, and while direct comparisons are difficult to peers given that corporate overhead is not included in Abbott business segment profit estimates, the Vascular business segment does seem to be operating towards the higher end of its peer group range Figure 10. Efficiency initiatives have boosted Vascular margins recently, but going forward, pricing stability within Drug Eluting Stents and the Absorb stent product portfolio will likely be a key driver of margin gains or losses."
9342,681,20,"After years of price declines and flat developed world procedure volumes in the Drug Eluting and Bare Metal Stent markets, Abbott will be reliant on the successful commercialization of the Absorb Bioresorbable Vascular Scaffold BVS device over the next several years to return its DESBVS business to growth. Abbotts first Bioresorbable Vascular Scaffold device has experienced rapid adoption since 2011 in Western Europe, and has held wide ranging 10 50% premium pricing over current Drug Eluting Stents, with recent estimates closer to 10%. Experience in Western Europe provides a positive indication to the ultimate potential for the Absorb product line within the US, but peak penetration of the total Stent market and medium-term pricing stability remain key areas of debate. Data supporting lower cumulative rates of Angina for patients treated with Absorb versus comparable DES procedures supports adoption, but the thicker constitution of Absorb stent versus comparable DES does limit placement in more complex interventions. The most important event for the business segment will be towards the end of 2015 with the FDA submission of Absorb clinical data for approval in the US."
9343,681,21,"During 2014, increased market penetration of Absorb BVS in international markets was offset by decreases in the overall DES market in the US along with market share losses Figure 11. Abbotts DESBVS business declined - 0.9% organically in International markets but declined -12% in the US. While the decline in the US DES market was a worsening of the trend that began in 2012, the organic decline internationally follows what had been mid- to high- single digit growth for the business unit over the past several years."
9344,681,22,"Despite growth challenges for Abbotts DESBVS business overall, the company continues to invest in its family of Drug Eluting Stents and"
9345,681,23,"The XIENCE family of drug eluting stents is generally considered to be a market leading portfolio of devices for revascularization, and the Absorb Bioresorbable Vascular Scaffold device remains a significant growth opportunity for the company."
9346,681,24,"While we expect European and International markets to remain relatively healthy, and Abbotts market share to remain strong given the rapid uptake of Absorb in those geographies, the approval of Absorb in the US will likely be the most critical factor affecting the growth of Abbotts total DESBVS segment in the coming years. In the scenario analysis below, we show that if we extrapolate recent market trends forward 3 years, BVS would need to gain 10pts of market share per year in the US at a 40% price premium to DES in order for Abbott to return to mid-single digit growth Figure 12. We think our assumptions for Absorb penetration within the US are reasonable, as management has noted that Absorb is reaching 20% of the total DES portfolio in the International markets where the product has been commercially available for several years. However, as Absorb moves towards market penetration that centers BVS as a mainstay workhorse stent, we think the premium pricing relative to DES will likely erode. Management has estimated the Absorb pricing premium to DES in Europe at around 10 20% recently."
9347,681,25,"Other Key Opportunities for Abbott Vascular XIENCE Label Expansion for Chronic Total Occlusions: During October 2014 the XIENCE DES Family became the only drug eluting stent system with an indication to treat Chronic Total Occlusions CTO within the US. CTO is found in 29 - 33% of patients that undergo cardiac catheterization which could translate into a 300,000 annual procedure volume opportunity within the US ."
9348,681,26,"However, given the high rates of off-label use of Drug-Eluting Stents , the volume gain from CTO label expansion is likely to be much lower. Total Endovascular Growth Driven by Rapid Uptake of Supera: During March 2014, Abbott received FDA approval for the Supera peripheral stent, which treats blockages in the Superficial Femoral Artery SFA. The global SFA market has been estimated to be growing at a mid- to high-single-digit rate, with the total market size estimated to be around $550m globally."
9349,681,27,"Absorb could make China a viable DESBMS market: Overall China DES is a $200m market, growing double-digits based on Percutaneous Coronary Intervention PCI growth, and has been underpenetrated, estimated at 120th of the US market. Mix of market share is local stent manufacturers with 75% share, and International companies with 25%. Absorb BVS could work well in China when ultimately launched given the cultural adversity to bare metal stent implantation. Absorb has been launched successfully in Hong Kong, around the 2011 European launch, and Abbott expects to submit Absorb for China FDA approval during 2015."
9350,681,28,"Absorb is a Bioresorbable Vascular Scaffold BVS system that elutes everolimus in a similar way to XIENCE V and then resorbs naturally into the body leaving no permanent scaffold. Absorb is comprised of four key design elements: a bioresorbable scaffold, a bioresorbable coating, everolimus and the XIENCE V delivery system. The bioabsorbable structure of the stent is made of polylactic acid, biodegradable polyester derived from lactic acid. During April 2014 the company announced it had completed enrollment of three clinical trials to support approval of Absorb BVS in the US, Japan and China. The product had previously received CE Mark in 2011."
9351,681,29,"The benefits of BVS versus DES are based on the thesis that avoiding a permanent metal structure DES that reduces vessel flexibility also reduces risks associated with stent thrombosis and restenosis. The disadvantage of BVS versus DES is the larger size thicker BVS scaffold versus the DES cage, which could create challenges with delivery in vessels that are very tortuous or narrow."
9352,681,30,ABSORB Trial: Goal of the trial was to evaluate the use of a bioabsorbable drug-eluting stent DES platform among patients undergoing elective percutaneous coronary intervention PCI for a de novo coronary lesion.
9353,681,31,"The trial was First-in-man, non-randomized, and results were presented at the American College of Cardiology Annual Scientific Session in 2007."
9354,681,32,"ABSORB II: Enrolled 500 people at 46 sites in Europe and New Zealand. The trial was designed as a 2arm randomized trial with XIENCE as the control, 2:1 Absorb BVS: XIENCE."
9355,681,33,"ABSORB III: Enrolled 2,000 people within the US and will evaluate the potential benefits of Absorb in people with coronary artery disease, a narrowing of one of more arteries that supply blood to the heart. The primary endpoint of ABSORB III is target lesion failure TLF, a combined measure of the safety and effectiveness of Absorb in comparison to the XIENCE family of drug eluting stents at one year."
9356,681,34,"ABSORB Japan: Enrolled 400 people within Japan with a primary endpoint of target lesion failure TLF at one year in comparison to the XIENCE family of drug eluting stents. ABSORB China: Enrolled 400 people within China with a primary endpoint of late loss at one year in comparison to the XIENCE family of drug eluting stents. XIENCE Family of Drug Eluting Stents: We estimate that the XIENCE family of stents held approximately 38% share of the worldwide Drug Eluting Stent DES market and 35% share of the US market during 2014 , with the next largest competitors being Boston Scientific BSX, Lavin and Medtronic MDT, Lavin. The family of XIENCE stents have been comprised of the XIENCE V and XIENCE Nano Everolimus Eluting Coronary Stent System and the XIENCE PRIME and XIENCE PRIME LL Everolimus Eluting Coronary Stent System, XIENCE Xpedition, XIENCE Xpedition SV and XIENCE Xpediation LL The company recently retired the XIENCE V and XIENCE Prime stent portfolios."
9357,681,35,"Abbott acquired the MitraClip device for percutaneous mitral valve repair through the acquisition of Evalve during 2009 for a price of $320m. The MitraClip device has been available for use in Europe since 2008, but only received FDA approval in late 2013 for Degenerative Mitral Regurgitation deemed High Risk for surgery. Management has stated that peak MitraClip sales could exceed $500m over time, as ongoing studies generate more data regarding the impact on the progression of heart failure. We expect rapid growth to continue near term and model the franchise reaching $280m in sales during 2015, which contributes 150bps of growth to Abbotts overall Medical Devices business Figure 14."
9358,681,36,"Analysis of the EVEREST II trial indicated that percutaneous repair of the mitral valve was less effective with MitraClip versus surgical repair, but the MitraClip device did produce superior safety and clinical outcomes at 12 months. Currently, the Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation COAPT Trial is in the recruiting phase. The COAPT Trial has a primary effectiveness endpoint of recurrent heart failure hospitalizations up to 24 months, which will help determine the safety and effectiveness of the MitraClip device for treatment of moderate-to-severe or severe functional mitral regurgitation in symptomatic heart failure patients."
9359,681,37,"The mitral regurgitation population is roughly 2% of the total population, or 6.8 million people in the US, and 30% of the total mitral regurgitation population has degenerative mitral regurgitation, which constitutes that majority of the surgical repair market. Globally, the market opportunity for surgical repair for degenerative mitral valve regurgitation is 6 million. The revenue opportunity for Mitral Valve implantation has been compared to the rapidly growing transcatheter aortic valve replacement market TAVR , which is currently around $1.5bn in annual sales and is expected to reach $3bn in sales by 2019 Figure 15."
9360,681,38,"MitraClip currently enjoys a competitive landscape that only incorporates surgical repair of the mitral valve. Transcatheter Aortic Valve Replacement TAVR has outpaced the development of Transcatheter Mitral Valve Replacement TMVR as the structure of the Mitral Valve is several times more structurally complex than the aortic valve. Companies such as Edwards Lifesciences are developing replacement mitral valves Figure 16, and initial efforts with FORTIS have proven feasibility, but additional development work will need to be completed over the next several years prior to a fully commercially viable product. Edwards temporarily suspended enrollment into the FORTIS trial program during May 2015 due to evidence of valve thrombosis with the mitral valve replacement device."
9361,681,39,"Revenues from sales of MitraClip are currently recorded in the Other segment under Abbott Vascular, along with sales of Bare Metal Stents BMS and Royalties from Drug Eluting Stents DES. Rapid growth of MitraClip has offset modest declines from the remainder of assets within Other Vascular over the past several years Figure 17. We forecast that $80m of incremental sales from MitraClip will offset a -$20m, or -10% decline in revenues from BMS and Royalties during 2015."
9362,681,40,"Abbotts Medical Optics business has been one of the fastest growing segments within the company, and although the segment generates only 6% of total sales, Medical Optics contributed 9% of total organic growth during 2014. The key growth driver of Medical Optics has been strong product performance in the surgical cataract market, which represents 69% of total Medical Optics sales. During 2014, double-digit growth of surgical cataract sales offset declines in the refractive and corneal business segments Figure 18. We expect Abbotts Medical Optics business to maintain recent momentum as rising penetration of Femtosecond Laser-Assisted Cataract Surgery FLACS couples with new product launches in the existing Tecnis intraocular lens franchise IOLs."
9363,681,41,"International markets represent 64% of total Medical Optics sales and are expected to continue growing high-single-digits during 2015, as emerging markets continue to rapidly increase procedural volumes for cataract. Demand for cataract surgery on a global basis is expected to continue growing rapidly through 2020, as the World Health Organization WHO has estimated that of the 285m people who were visually impaired, 80% of visual impairment is avoidable with 33% of cases a result of cataract."
9364,681,42,"surgical sales are estimated to constitute 80% of total ophthalmic surgical industry sales, at over $7.2bn annually Figure 19. The market for cataract surgical equipment is expected to continue growing high-single-digits for the remainder of the decade as emerging countries implement programs in line with the long running WHO VISION 2020 plan. Estimates place the number of cataract surgeries annually at 19 million on a global basis with 3 million in the United States. The number of surgeries is expected to grow to 32 million by 2020 as the global population ages."
9365,681,43,"Adoption of Femtosecond Laser-assisted Cataract Surgery OptiMedica began US shipments of the Catalys Precision Laser System in the US during February 2012, after an International launch in late 2011. The Femtosecond Laser supplants manual scalpel incision into the capsule of the crystalline lens of the eye, or capsulotomy, the primary step ahead of phacoemulsification in a cataract surgical procedure. Initial adopters reported that usage of a femtosecond laser increased precision, accuracy and reproducibility versus the standard manual technique, thusly justifying the introduction of an instrument that costs over $500k and incurs significant upkeep costs Figure 20."
9366,681,44,"Clinical evidence regarding outcomes of femtosecond-laser assisted cataract surgery FLACS versus manual methods look somewhat underwhelming for a procedure that already has less than a 1% surgical adverse event rate. While FLACS has been noted to make highly accurate and reproducible capsulotomies, the low variability of a trained surgeon using manual procedures lowers the utility value of the laser precision. Furthermore, FLACS presents an additional logistical issue for centers that separate the laser from the operating room, which would introduce additional time for patient transport."
9367,681,45,A metadata analysis by the Evidence-based Synthesis Program ESP Center presented to the Department of Veterans Affairs in late 2013 found no stable differences between manual corneal incisions and anterior capsulotomies followed by phacoemulsification and procedures supplanted by a femtosecond
9368,681,46,"During early 2015 a large outcomes and safety study of more than 4,000 cases at a single center also seemed to confirm the findings of the VA metadata analysis FLACS and manual surgical methods for cataract surgery seem to have no statistical difference with regard to safety ."
9369,681,47,"Although clinical data has yet to prove the utility of FLACS in one way or another, adoption of FLACS within the US has been rapid within the first three years of product availability. A robust out-of-pocket market for vision correction has helped to drive adoption of FLACS, as any additional costs incurred over the reimbursement for manual surgery are born by the patient and not Medicare or Private Insurance. A survey of surgeons during 2013 suggested that the per case incremental fee revenue varied depending on IOL Figure 21, but the calculated average incremental fee per case of $859 would suggest that the payback period for the laser would be 1,134 laser cases during a 5-year period."
9370,681,48,"Penetration of FLACS within the United States has been estimated to be 10% of all cataract surgical procedures, and is expected to reach maturity at 30% of all procedures near the 2020 timeframe . Global adoption of FLACS should continue to be a secular growth opportunity for Abbott Medical Optics as the developed world ages and emerging market consumers demand higher value healthcare services Figure 22."
9371,681,49,"Alcon is considered to be the market leader in FLACS with its LenSx platform followed by Abbotts Catalys system by OptiMedica, and then several other platforms round-out the competitive landscape Figure 23. We estimate that Abbotts OptiMedica business currently has approximately 10 15% market share of the global cataract surgical market, and has likely gained market share post the OptiMedica acquisition during 2013. Management has estimated Abbotts global market share to be closer to 25% for surgical cataract based on the specific markets where they currently compete."
9372,681,50,"Abbotts $1.2bn Diabetes Care business represented 22% of total Medical Device revenue during 2014 and was a significant detractor to overall growth, as the business declined -8% on an organic basis. A -22% organic revenue decline in the US business overwhelmed 2% growth within International markets. Management has forecasted a return to low-single-digit revenue growth in the global segment for the full year 2015, and seems to be on track, as the company reported 2.8% YoY organic revenue growth during 1Q15. Our 2015 revenue forecast for 3.7% YoY organic revenue growth is based on a combination of strong global sales ramp of the FreeStyle Libre Flash along with a stabilization of pricing within the US market Figure 24."
9373,681,51,"Rollout of Competitive Bidding Program in US Pressured Diabetes Care Revenues in 2013 and 2014 The Centers for Medicare Medicaid Services CMS implemented Round 2 of the Competitive Bidding Program on July 1, 2013, that harmonized the reimbursed bidding rate to $10.41 per 50-count box for both mail order and non-mail order diabetes test strips. Beyond the direct price decline from the $14.62 per 50-count box reimbursement that had been enacted in 2011, as a result of the Round 1 Rebid, and $37.67 national average payment for non- mail order diabetes test strips, the Round 2 implementation greatly altered market share amongst providers Figure 25. Abbotts FreeStyle Lite test strips lost at least 3% market share as a result of the National Mail Order Program, slipping from 3% to less than 1%. The bidding process for a Round 2 Recompete began in Fall 2014 and will be effective July 1, 2016. While no theoretical floor exists for pricing, and market share could remain volatile, we largely see the damage as done with the implementation of the National Mail Order Program during 2013."
9374,681,52,"FreeStyle Libre Differentiates Within Continuous Blood Glucose Meter Market Abbott received CE Mark for the FreeStyle Libre Flash Glucose Monitoring System in early September 2014. The system reads glucose levels through a silver-dollar sized sensor that can be worn on the back of the upper arm for up to 14 days. The device measures glucose every minute through a 5mm long, 0.4mm wide filament that is inserted just under the skin, which senses glucose levels in interstitial fluid and makes an estimate of plasma glucose levels. Reviews of the Libre have been positive, regarding ease of use along with length of use versus other platforms Figure 26, but some variation in device performance has been acknowledged as a function that the devices are factory calibrated versus user calibrated. Overall, the launch of the FreeStyle Libre has made strong initial inroads within Europe, and management has targeted a commercial launch in several additional ex-US countries during 2015. Abbott completed enrollment for the US trial of FreeStyle Libre in March 2015, but management has not provided a specific timeline for US commercial launch."
9375,681,53,"Estimates have placed the global market for self-monitoring of blood glucose between $6 9bn annually, which includes finger stick devices . Also, around the launch of the FreeStyle Libre Flash, Abbott management indicated the market opportunity in Europe alone was $4bn and the total global market was over $8bn. The International Diabetes Federation has estimated that 387m people are living with diabetes in the world, with 39m in North America and 52m in Europe. Prevalence rates globally have continued to rise, approximately near 110 people within the total population. The percent of the 20 year old population in US with clinically diagnosed diabetes has steadily risen, from 5.2% estimated in the estimation period to over 9% in 2014 Figure 27, and is now potentially more than 11% of the 20 year old population if undiagnosed cases are included."
9376,681,54,"Abbotts $4.7bn global diagnostics business is split into 3 key segments, with 80% of revenues generated from Core Laboratory products, 10% of sales from Molecular testing and 10% of sales from Point-of-Care testing. The Diagnostics business has generated steady mid-single-digit operational growth over the past 3 years, with Point-of-Care diagnostic sales growing mid- teens. While Point-Of-Care growth has outpaced Core Laboratory growth over the past 3 years, the outsized weighting of Core Laboratory sales make it the dominant determinant of growth within the overall business. We forecast lower overall growth for Abbott Diagnostics during 2015, with slightly stronger growth in Molecular and Point-Of-Care offsetting lower growth rates in the Core Lab business Figure 28."
9377,681,55,"We estimate that Abbott Diagnostics represented 25% of the 2014 EBIT from the four main operating segments, Established Pharmaceuticals, Nutritionals, Diagnostics and Vascular, but contributed only 15% of the EBIT growth Figure 29."
9378,681,56,"We think recent revenue growth trends are likely to continue over the next several years supporting profit growth, but the efficiency gains of recent years are likely to not be repeated as Abbott Diagnostics operating margin is now above industry comps. Operating profit margins of the Diagnostics business have improved significantly since 2009, from 11% to 23% in 2014, but yearly gains have become more subdued as the operating segment has surpassed industry peer profit levels Figure 30. Peers such as bioMerieux, Qiagen and Sysmex reported EBIT margins of 10%, 14% and 20% respectively, during the past fiscal year."
9379,681,57,"Favorable Geographical Mix Supports Higher Growth but Competition Intensity is Likely Increasing The revenue size profile of Abbott Diagnostics three major segments closely matches a generalized breakdown of the global diagnostics market, although notably, the mid- to high-single-digit growth of Abbott Diagnostics Core Lab business over the past several years seems to have outpaced the low-single- digit growth of the global core lab market Figure 31. We attribute the outperformance of Abbott Diagnostics Core Lab business versus the overall market due to Abbotts over indexing to International and Emerging Markets, as the International business of Abbott Diagnostics Core Lab business represented 80% of the total Core Lab segment during 2014."
9380,681,58,"International Markets have been a key growth driver for Abbott Diagnostics, as International Sales represented 72% of total Abbott Diagnostics sales during 2014. Operational growth in International markets has outpaced US growth by 1% in Core Lab, 9% in Molecular, while lagging exceptional double-digit growth in US Point-of-Care by -6%, although Point-of-Care is less than 10% of total Diagnostics sales Figure 32."
9381,681,59,"Management forecasted 2015 growth to be similar to that of 2014 for Abbott Diagnostics, which would be a continuation of the steady mid-single-digit growth recorded over the past 3 years. We think this is a reasonable assumption, as market growth rates continue to benefit from rapid development of Hospital systems in emerging markets such as China Figure 33. Management has estimated that the Core Lab Diagnostics market in China to be $2bn annually and is expected to grow 15% annually through 2018 ."
9382,681,60,"Longer term we think Abbott Diagnostics Core Lab business could face some increasing competitive pressures in blood testing from Beckman Coulter Danaher and PerkinElmer, as both companies have also been growing their presence in China among other emerging economies. Point-of-Care diagnostics is a smaller business to Abbott Diagnostics, but we would note that the continuing turn-around of Alere may make a continuation of growth in recent years less likely, as Abbotts i-STAT business has benefitted from missteps with Aleres Triage platform."
9383,681,61,"Abbotts Nutrition division represented 34% of total company sales during 2014, and is comprised of two key business segments, Pediatric and Adult, which constituted 56% and 44% of total segment sales respectively. The business can be further delineated into five sub-segment product areas: Infant Mother, Child, Adult, Sports Active Living, and Therapeutic Nutrition. Abbott Nutrition has been a key driver of total segment operational growth over the past several years although growth dynamics have shifted recently, with growth slowing in the Pediatric business while accelerating in Adult market Figure 34. Management guided for an acceleration of Nutritional operational growth to high-single-digits versus mid-single-digit growth during 2014, with a key catalyst being the annualization of the product recall in China that negatively impacted Pediatric revenues in early 2014. We currently forecast 7% operational growth for Abbott Nutrition in 2015, up from 5% during 2014."
9384,681,62,"We estimate that Abbott Nutrition represented 34% of the 2014 EBIT from the four main operating segments, Established Pharmaceuticals, Nutritionals, Diagnostics and Vascular, but contributed 42% of the EBIT growth, as the Nutrition business segment expanded operating margins 200bps during the year Figure 35."
9385,681,63,"Abbott Nutritional operating margins have expanded towards peers such as Mead Johnson over the past several years Figure 36. However, we would note that as Abbott continues to increase revenue exposure into emerging markets such as China, there could be a negative effect on overall margins, as it seems local competitors in China such as Synutra SYUT, Not Covered, do operate at a lower margin profile versus global companies. On the other hand, local investment by Abbott could support current business margins as local production costs would presumably also be lower."
9386,681,64,"Pediatric Nutrition Expected to Rebound Post Recalls Abbotts Pediatric Nutrition business experienced a marked slowdown in growth during 2013 and 2014 as the business faced headwinds both domestically and internationally. We forecast a reacceleration of growth in both the US Pediatric and International Pediatric businesses during 2015, as the company will lap the share losses in US Government programs and in China, that both negatively impacted the business over the past 2 years Figure 37. During the first quarter of 2015 the company posted 4.5% growth in US Pediatric, the strongest growth rate in two years, and Internationally the Pediatric business grew 11%, sustaining the growth reacceleration that began in 2H2014."
9387,681,65,"The US Pediatric Nutrition business was flat during 2013 and then declined -1% during 2014, with the primary driver being share loss in the Special Supplemental Nutrition Program for Women, Infants, and Children WIC. Accelerating share loss in WIC during 2014 was a change to the infant formula product line that caused several products to no longer meet the WIC caloric requirement. However, Abbott has maintained market leadership in the non- WIC Pediatric channel within the US, with new product launches of PediaSure Toddler brand, Similac Total Comfort and Similac with OptiGRO helping to boost retail sales."
9388,681,66,"The impact of the recall was estimated to have impacted total Pediatric sales growth in 2013 by -5% and by -3% during 2014. Despite the significant product recall by Fonterra, Abbott announced a strategic alliance with Fonterra during 3Q14 to develop local milk supply infrastructure within China, versus sole importation from New Zealand. This endeavor builds on Abbotts prior investments in local Chinese infrastructure that has included an RD center in Shanghai and a nutrition manufacturing plant in Jiaxing. During 3Q14 the company launched Similac QINTI into the Chinese market as the first domestically manufactured product at the new China facility."
9389,681,67,The alliance is subject to Chinese regulatory approval. Both companies will work with Chinese regulators to obtain necessary approvals through the course of project development.
9390,681,68,"If the alliance is successful and approved by Chinese regulators, both companies will form a joint venture. Under the JV, Fonterra and Abbott will invest a total of US$300m NZ$342m or 1.8bn RMB into the farm hub. The farm hub will produce up to 160m liters of milk annually, contain up to 5 dairy farms and more than 16,000 dairy milking cattle. The animals will either be imported or sourced from Fonterras existed farm hubs. Currently pending regulatory approval, the first farm hub is expected to be completed by 1H17 and the remainder will commence production in 2018."
9391,681,69,"The Chinese Pediatric Nutritional market will be an important growth driver for Abbott over the next 5 years, as the Chinese market is expected to be the fastest growing geography and largest overall market for infant milk formula through 2019 Figure 38."
9392,681,70,"We think Abbott has favorable prospects in China, as we anticipate that locally investing in infrastructure for milk supply along with RD centers and manufacturing plants will give the company an edge over competition regarding Government support. News reports in late 2013 suggested that the Ministry of Industry and Information Technology hopes to reduce the number of manufacturers of infant formula to 3 5 firms with revenues exceeding US$8bn per year by 2018 . Given the current fragmentation of the Chinese Infant Nutrition market, along with Abbott only holding less than 10% of the total market Figure 39, we think this sets up the company for strong growth in China over the next several years and will be a key driver of overall Pediatric Nutrition growth."
9393,681,71,"Adult Nutrition Benefits From Aging of the Global Population Abbotts Adult Nutrition business has grown at a steady mid-single-digit rate over the past several years, and we expect that trend to continue during 2014 as we forecast 6% operational growth. While the overall growth rate of the Adult Nutrition business has been steady, there has been a divergent growth trend between declines in US product sales and accelerating double-digit growth within International markets Figure 40. We forecast a continuation of recent trends during 2015 with the overall Adult Nutrition business growing 6%, comprised of a -3% decline in the US offset by 13% growth within International markets."
9394,681,72,"Abbotts Adult Nutritional business has declined over the past several years within the US as the company exited certain product lines in an effort to improve the overall margins of the business, and at the same time faced competitive pressures on their leading Ensure brand from private label sellers such as Perrigo and Wal-Mart. Abbotts share in the US meal replacement market has declined modestly over the past several years, with the company still the 1 brand, but share gains of Ensure have moderated and some of the smaller product lines such as Zone Perfect have lost share Figure 41. While only tangential competitors, companies such as Herbalife do seem to be picking up consumer wallet share in the younger demographic of meal replacement within the US. Given the current controversy over non-traditional fitness shake companies, such as Herbalife, we think it is hard to predict what the net effect on the traditional channels that Abbott sells through will be over the next several years."
9395,681,73,"We estimate that the $10.1bn worldwide meal replacement market could grow 4 6% annually over the next several decades as the global population ages Figure 42, which is in line with the 5 6% rate the industry grew over the past 3 years."
9396,681,74,"While we forecast the global meal replacement industry to grow mid-single- digits annually, Abbott may be able to augment growth with exposure to emerging markets, which have been growing double-digits, as a rise of the middle class consumer is expected to continue to occur in countries such as China over the next decade Figure 43."
9397,681,75,"Therapeutic Nutrition an Evolving Opportunity Medical Foods are specially tailored to help treat the underlying nutritional deficiencies of a specific disease. The market for Medical Foods has been estimated to $9bn with $2.1bn in the US, and has been estimated to be growing 10% annually . Market share estimates for the Medical Food industry are difficult to come by, but the main players are similar to the adult nutrition market, with Abbott, Nestle and Nutricia being market leaders. The key difference between Medical Foods and Adult Nutrition is that Medical Foods are semi regulated by agencies such as the FDA, as they produce foods that are prescribed by clinicians to help treat specific medical conditions."
9398,681,76,"Abbott Nutrition: Background Information Founded in 1903, Abbott Nutrition is a worldwide leader in nutritional science, research and development of a broad line of nutritional and therapeutic products. Abbotts products are manufactured, marketed and sold worldwide to help infants and children grow, maintain healthy and strong bodies and support the unique needs of patients with chronic illnesses. Abbott Nutrition is a business division of Abbott Labs that researches and develops science based pediatric and adult innovative products in the areas of tolerance, cognition, immunity, inflammation, metabolism, and lean body mass."
9399,681,77,"Abbott Nutrition launched 65 new products in 2014. Adult Nutrition represents 44% in this business segment and has a leading position as 1 or 2 in 25 countries, with 50 Abbott consumer brands in 100 countries. Throughout 2014, Abbott opened nutritional manufacturing plants in China, India and the US as well as an RD center in China. In addition, to further expand its footprint, Abbott announced the strategic partnership with Fonterra to develop a dairy farm hub in China."
9400,681,78,"For over 30 years, the Ensure brand has provided a variety of formulated shakes for active adults with a source of nutritional value to help reach specific nutritional goals such as enhancing the immune system, supporting the digestive tract and rebuilding muscle. The Ensure brand was launched in China as of 2014 as a long term growth opportunity."
9401,681,79,"Each bottle provides 13g of protein and 300 kcal Kilocalorie with three types of flavors: banana, strawberry, and vanilla."
9402,681,80,"For more than 85 years, Similac formulas have been developed by leading scientists and more than 280 clinical studies to help mothers and infants a strong start to a healthy life. Similac has a broad portfolio of Similac products, all specialized for different nutritional needs. Abbott launched Similac Qinti and Eleva in 2Q14 in China in an effort to recapture market share lost in the countries affected by its recall. Similac Qinti and Eleva were both launched in China and will be manufacturing at the newly developed plant."
9403,681,81,Similac Qinti - Contains the newest formulation and employs 3 QINTI technologies.
9404,681,82,"Similac Breastfeeding Supplement launched in US designed to enhance levels of DHA, lutein and Vitamin E in breast milk."
9405,681,83,"Recent productsupcoming product launches: Over the past several years, Abbotts nutrition business has averaged more than 70 new product launches annually. Abbott has brought leading infant and adult nutrition products to china which includes the launch of Ensure, Eleva and Similac Qinti."
9406,681,84,"The most recent product launch was the new Similac breast feeding supplement with DHA, lutein and vitamin E. The new product was specially designed to enhance the levels of these nutrients in breast milk. A research study concluded that lactating women did not consistently consume enough key nutrients such as DHA, lutein and vitamin E through their diets. According to The Journal of Nutrition, Lutein is an important antioxidant, supports eye health and enhances infant growth development. In addition, as noted in The Journal of Pediatrics, DHA helps support Infant brain development. However, Infant brain development is highly susceptible to oxidation which vitamin E protects from."
9407,681,85,"In December 2014, with the support of the Patients Association, Abbott Nutrition launched the I-CARE Checklist to help people spot signs of malnutrition in their older relatives and friends and to take action. Malnutrition is a serious condition that occurs when a person does not get enough nutrients. This could be because their diet is inadequate or because they have problems absorbing nutrients from food. In the UK, 1 in 10 people aged over 65 are malnourished. In addition, 88% of people do not recognize the most common signs of malnutrition and only 15% are concerned that their older relatives are not eating well."
9408,681,86,"2013 China Recall Fonterra supplied whey powder that contained bacteria that could cause botulism to Danone. Abbott recalled two batches of Gain Advance Stage 3 infant formula in China. Although the products were not supplied with the contaminated ingredient, the company indicated that it recalled its products because they were packaged on Fonterras production line. Only 112 boxes of more than 7,000 produced had been sold."
9409,681,87,"The Abbott Fund Institute of Nutritional Science Established in 2007, The Abbott Fund Institute of Nutritional Science AFINS is the result of a partnership between the Abbott Fund, the nonprofit organization Project Hope and Shanghai Childrens Medical Center SCMC. This collaborative partnership helps improve clinical pediatric nutrition practices through professional training, innovative research development of nutrition supports protocols, and community outreach."
9410,681,88,"Abbott Established Pharmaceuticals represented 15% of total company sales during 2014, and is entirely focused on selling branded generics into emerging markets. The two reporting segments within Established Pharmaceuticals are delineated by geography, Key Emerging Markets and Other Emerging Markets, with Key Emerging Markets primarily comprised of Brazil, China, India and Russia, with the largest single geography being India Figure 44."
9411,681,89,"Operational growth rates for the Established Pharmaceuticals business and its sub segments have been clouded by acquisitions and divestitures, but the management team has highlighted that the business is growing high-single- digits organically, and that Abbott is slightly outpacing overall market growth rates Figure 45."
9412,681,90,"Abbott management has embarked on a unique strategy with the Established Pharmaceuticals business, focusing efforts 100% in Emerging Market countries, and on 5 core therapeutic areas, Anti-Infectives, Cardio metabolic, Gastroenterology, PainCentral Nervous System and Anti-Infectives. The company also has an influenza vaccine franchise, but it is expected to receive less aggressive investment versus the 5 core areas. Established Pharmaceutical assets mostly target out-of-pocket sales, versus insured reimbursement, in areas where brand focus can dominate local competitors."
9413,681,91,"Abbott has expanded into Latin America and Russia with recent acquisitions of CFR Pharmaceuticals for $3.4bn LatAm and Veropharm for $305m Russia, and is actively looking to build a larger presence within India."
9414,681,92,"We estimate that Abbott Established Pharmaceuticals represented 15% of the 2014 EBIT from the four main operating segments, Established Pharmaceuticals, Nutritionals, Diagnostics and Vascular, and contributed a proportionate 16% of the EBIT growth Figure 46."
9415,681,93,"Abbott Established Pharmaceuticals operating margin reached 20% during 2014, and although direct comparisons to generic companies such as Dr. Reddys and Sanofi are difficult given the nuances in product mix, Abbotts Established Pharmaceutical margins generally seem in line with industry peers Figure 47."
9416,681,94,"Right now the Established Pharmaceutical business is in investment mode, but longer term, management thinks that there is a margin expansion opportunity, as Abbott still has some legacy European plants that are not optimal for operations and the company will likely move more cost to local geographies over time."
9417,681,95,"Furthermore, RD expense is more weighted towards Development versus Research for the Established Pharmaceutical strategy, as Abbott takes licensed assets, develops them into commercial products, and then iterates products and registers across geographies. The net effect of this strategy should produce high incremental margins on revenues."
9418,681,96,"Background Information Abbott Established Pharmaceuticals EPD, established in 2010 and headquartered in Basel Switzerland, offers highly qualified and affordable branded generic medicines that successfully treated patients for many years. In 2014, Abbott took several steps in the established pharmaceutical segment by strengthening its product portfolio, building geographic presence and increasing focus on growth markets. These products are generally sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. In 2014, it expanded this business through two acquisitions, CFR pharmaceuticals and Veropharm, which significantly enhanced the portfolio and presence in Latin America and Russia."
9419,681,97,"On September 26, 2014, Abbott acquired CFR Pharmaceuticals S.A. CFR. Abbott purchased 99.6% of CFRs ordinary shares for $3.4bn. Abbott established itself among the top 10 pharmaceutical companies in Latin America and further expanded the companys presence in rapidly growing markets through the acquisition of CFR."
9420,681,98,"On December 12, 2014, Abbott acquired Veropharm, a leading Russian pharmaceutical manufacturer. Abbott acquired Veropharm for 16.7bn Rubles US$305m and through the acquisition, Abbott established a manufacturing footprint in Russia and obtained a portfolio of medicines that were well aligned with Abbotts pharmaceutical therapeutic areas of focus in womens health such as the central nervous system, cardiovascular and gastroenterology."
9421,681,99,"Abbott is the number one pharmaceutical company in India, Chile, Colombia and Peru and top five in Russia. Abbott Established Pharmaceuticals has 27 manufacturing sites, 10 pharmaceutical development sites, 1500 products in its portfolio in over 88 countries in which in which they have commercial presence."
9422,681,100,"Key Products Figure 48: Abbotts established pharmaceuticals business focuses mainly on country specific portfolios that are made up of global and local pharmaceutical brands that best meet the needs for patients in each country. Abbott has more than 300 branded generic development projects, and over the next several years Established Pharmaceuticals plans to expand its product portfolio in its key markets through the development and launch of new branded generics with the aim to be among the first to market a new branded generic for a particular pharmaceutical product, further geographic expansion of existing brands, new product enhancements and strategic licensing activities. Abbott is also actively working on development plans for several key brands such as Creon and Influvac. Based on the product, the development activities focus on new data, markets, formulations and combinations or indications."
9423,681,101,"We think management has executed several impressive acquisitions over the past decade including Knoll, Advanced Medical Optics, CFR, Veropharm, Topera, Idev Technologies, OptiMedica, etc. which aligns Abbott in a favorable position for growth and profitability. We think that the recent additions of CFR and Veropharm will contribute a value-add to its established pharmaceuticals business which should provide a significant footprint in both Latin America and Russia. Furthermore, the sale of Abbotts EPP business to Mylan should help Abbott refocus its efforts on emerging markets and profit from the increased demand. We see that managements efforts to improve efficiency through streamlining the company has developed success and improved margins for Abbott and think that the foundations are well developed for future growth."
9424,681,102,"Miles D. White, 60, is Chairman and Chief Executive Officer of Abbott Laboratories. Mr. White joined Abbott in 1984 and has been the Chairman and CEO since 1999 and 1998, respectively. Currently, he serves as a director of Caterpillar Inc. and McDonalds Corporation. In addition, he also is the Chairman of The Culver Educational Foundation and serves on the executive Board at Kellogg School of Management. Mr. White has valuable business, management and leadership experience that can be applied to ensure that the companys business continues to grow over the next several years."
9425,681,103,"On June 1, 2015 Mr. Thomas Freyman was appointed EVP, Finance and Administration and Brian Yoor was appointed SVP, Finance and Chief Financial Officer, with Mr. Yoor continuing to report to Mr. Freyman. Mr. Yoor has served as VP, Investor Relations since 2013, and as Divisional VP, Controller Diagnostics Products from 2010 to 2013 Figure 49."
9426,681,104,"Determinants of Variable Compensation Business unit leaders and functional leaders at Abbott are awarded performance compensation based on annual goals for EPS, Financials Sales, net income, and OperationsStrategic Innovation pipeline. We appreciate the blend of EPS with ROA and OCF, as ROA targets can help maintain management discipline and avoid growth for the sake of growth to hit annual EPS targets Figure 50."
9427,681,105,"Over the past 4 years we estimate that ABT has exceeded quarterly analyst estimates 88% of the time, but that the stock has only produced positive alpha on these quarterly surprises 47% of the time. However, a macro pattern does seem to suggest that investors are rewarded for positive results, as the string of negative stock returns during the 4Q13 to 3Q14 period coincided with negative headline events such as the product recalls within the Nutritional segment Figure 51."
9428,681,106,"Quarterly results over the next 12-months could produce positive event alpha for investors, as accelerating operational growth across Vascular, Nutritionals and Established Pharmaceuticals could drive higher incremental margins versus what is currently expected by our estimates and the street Figure 52."
9429,681,107,"Abbott Labs was founded by Dr. Wallace Calvin Abbott, a physician in Chicago, in 1888 and is headquartered in Abbott Park, Illinois. Abbott Labs is a diversified healthcare company that develops, manufactures and markets healthcare products and services ranging from Prevention Diagnosis to Treatment Cure. It serves customers in over 150 countries and currently employs 77,000 employees as of December 31, 2014."
9430,681,108,"In October 2011, Abbott announced plans to separate into two publically traded healthcare companies. On January 1, 2013, Abbott remained a diversified medical products company consisting of nutritional products, diagnostic devices, vascular and established pharmaceutical products, meanwhile, AbbVie divested from Abbott, continued to maintain Abbotts portfolio of proprietary pharmaceuticals and biologics. Below we provide a current breakdown of the company business by operating segment Figure 53."
9431,681,109,"Appendix Analyst Certification I, Dane Leone, hereby certify that the views about the companies and securities discussed in this report are accurately expressed and that I have not received and will not receive direct or indirect compensation in exchange for expressing specific recommendations or views in this report."
9432,681,110,"Regulatory Disclosures Analyst Stock Ratings Definitions BTIG LLCs BTIG ratings, effective May 10, 2010, are defined as follows: BUY A stock that is expected at initiation to produce a positive total return of 15% or greater over the 12 months following the initial recommendation. The BUY rating may be maintained following initiation as long as it is"
9433,681,111,"deemed appropriate, notwithstanding price fluctuations that would cause the target to fall outside of the 15% return. SELL A stock that is expected at initiation to produce a negative total return of 15% or greater over the next 12 months following the initial recommendation. The SELL rating may be maintained following initiation as long as it"
9434,681,112,"is deemed appropriate, notwithstanding price fluctuations that would cause the target to fall outside of the 15% return. NEUTRAL A stock that is not expected to appreciate or depreciate meaningfully over the next 12 months. NOT RATED A stock that is not rated but that is covered by BTIG."
9435,681,113,"Distribution of Ratings and Investment Banking Clients BTIG must disclose in each research report the percentage of all securities rated by the member to which the member would assign a buy, neutral or sell rating. The said ratings are updated on a quarterly basis."
9436,681,114,must also disclose the percentage of subject companies within each of these three categories for whom the member has provided investment banking services within the previous twelve months.
9437,681,115,"BUY: 55% NEUTRAL: 40% SELL: 5% Stocks in coverage as of the end of the most recent calendar quarter December 31, 2014: 127 The percentage of Investment banking services is calculated as of December 31, 2014."
9438,681,117,"For purposes of FINRA ratings distribution rules, BTIGs stock ratings of Buy, Neutral and Sell fall into Buy, Hold and Sell categories, respectively."
9439,681,118,Our $56 price target values ABT at 14x EV 2016 EBITDA.
9440,681,119,Risks Key Risks to our Buy Rating: 1 Abbott faces significant competitive pressures and may not be able to grow revenues at the rates we currently forecast. 2 Abbott operates as a diversified conglomerate which is reliant on effectively integrating acquisitions into its organization. If the company fails to properly integrate its many
9441,681,120,"acquisitions, operating results may not reach our current estimates. Recent management changes could cause unexpected disruption and prevent the company from executing on its many strategic initiatives."
9442,681,121,Other Disclosures Additional Information Available Upon Request General Disclosures Research reports produced by BTIG LLC BTIG are published for and intended to be distributed solely to BTIG institutional and corporate clients. Recipients of BTIG reports will not be considered clients of BTIG solely because
9443,681,122,they may have received such BTIG report.
9444,681,123,"The equity research analysts responsible for the preparation of this report receives compensation based upon a variety of factors, including the quality and accuracy of research, internalclient feedback, and overall Firm revenues. BTIG reports are based on public information and BTIG considers the same to be reliable, comprehensive information, but makes no representation or warranty that the reports are accurate or complete. BTIG opinions and information provided in this report are as of the date of the report and may change without notice."
9445,681,124,This research report is not an offer to buy or sell or solicitation of an offer to buy or sell any security in any jurisdiction where such an offer or solicitation would be illegal. This research report was not drafted specifically for
9446,681,125,any particular individual or entity and is not a personal recommendation to participate in any particular trading strategy or transaction. Any recipient of this research report should obtain independent advice specific to their
9447,681,126,"Facts, views or opinions presented in this report have not been reviewed by, and may not reflect information known to, employees or other professionals in the BTIG Group BTIG Group includes, but is not limited to, BTIG and its parents, subsidiaries andor affiliates. BTIG Group employees, including Sales Representatives and Traders, may provide oral or written commentary or advice that may be inconsistent with the opinions andor views expressed in this research report. BTIG Group employees andor its affiliates not involved in the preparation of this research report may have investments in securities or derivatives of securities of companies mentioned in this report that are inconsistent with the views discussed in this report."
9448,681,127,Investors in securities products bear certain risks in conjunction with those investments.
9449,681,128,"from, any investments may vary because of changes in interest rates or foreign exchange rates, securities prices or market indexes, operational or financial conditions of companies or other factors within or beyond the companies control. Recipient of the research reports should be aware that investments in equity securities may"
9450,681,129,"pose significant risks due to the inherent uncertainty associated with relying on forecasts of various factors that can affect the earnings, cash flow and overall valuation of a company. Any investment in equity securities should"
9451,681,130,"Further, past performance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied, is made regarding future performance."
9452,681,131,"The trademarks and service marks contained herein are the property of their respective owners. Third-party data providers make no warranties or representations of any kind relating to the accuracy, completeness, or timeliness of the data they provide and shall not have liability of any damages of any kind relating to such data."
9453,681,132,"any portion hereof may not be reprinted, sold or redistributed without the written consent of BTIG."
9454,681,133,The recipient acknowledges that all research and analysis in this report are
9455,681,134,"the property of BTIG and agrees to limit the use of all publications received from BTIG within his, or her or its, own company or organization. No rights are given for passing on, transmitting, re transmitting or reselling the"
9456,681,135,"Jurisdiction and Dissemination BTIG is a U.S. broker-dealer and member of FINRA and SIPC. BTIG Australia Limited ACN 128 554 601, member of ASIC and ASX BTIG Hong Kong Limited, an Exchange Participant of SEHK and licensed and regulated by the SFC BTIG Ltd, member of the LSE, authorized and regulated by the FSA and BTIG Singapore Pte Ltd, registered and licensed with MAS are all separate but affiliated entities of BTIG. Unless governing law permits otherwise, you must contact a BTIG entity in your home"
9457,681,136,"jurisdiction for further information, or if you want to use our services in effecting a transaction."
9458,681,137,"and Hong Kong, further information may be obtained from BTIG Singapore Pte Ltd and BTIG Hong Kong Limited, respectively."
